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Mohammad Zeeshan Ozair, PhD, MD
The Rockefeller University 2015
The formation of the mammalian cerebral cortex is a complex multi‐tiered process that
involves three major milestones: 1) neural induction and folding of the neuroepithelium,
2) areal patterning and generation of various progenitor types, and 3) corticogenesis. Our
current understanding of the molecular and cellular basis of cortical development comes
largely from mouse studies due to the genetic tractability of this model system. However,
as primate studies have shown, the primate brain is unique in terms of its progenitor and
neuronal composition, cortical areas, scale, and gene expression. Limitations in the
availability of non‐human primate and human fetal material, the longer timescale of
developmental processes, as well as the ethical considerations involved preclude direct
experimental observations in both these organisms. However, human pluripotent stem
cells (hPSCs) allow a window into early human fetal development and permit
experimental manipulation of developmental events, thereby enabling molecular and
cellular dissection of corticogenesis.
The default model of neural induction, described originally in amphibians, posits that
induction of telencephalic (forebrain) fate in an embryo requires elimination of TGFβ
signaling. Using transgenic hPSCs, we show that inducible expression of a cell‐intrinsic
inhibitor of canonical TGFβ signaling – SMAD7 – is sufficient to directly convert hPSCs to
forebrain fate as seen by gene expression and immunocytochemical analysis of several

transcription factors. Moreover, this conversion is direct and does not involve induction
of non‐neural fates. Our findings suggest a conservation of the default model in humans.
Additionally, we also show that FGF‐MEK signaling has no direct role in hPSC neural
induction, thereby resolving an existing debate in the field.
We were able to derive neuroepithelium from PSCs of multiple species (mouse, primates,
and human) with small molecule inhibitors of TGFβ signaling. In order to demonstrate
that in vitro generated neuroepithelium is comparable to the in vivo germinal zone of an
embryo, we utilized transgenic lines expressing FUCCI (fluorescently ubiquitination cell
cycle indicators). Together with single‐cell analysis, we were able to demonstrate self‐
organization in radial progenitors, interkinetic nuclear migration, as well as requirement
for Notch signaling for progenitor maintenance, all of which are hallmarks of human
neural progenitors in vivo. Region‐specific marker analysis, we conclude that in vitro hPSC‐
derived neural progenitors are similar to their in vivo counterparts based on several
measurements.
Within telencephalic territory generated by TGFβ inhibition, we demonstrate that the in
vitro derived neuroepithelium can be patterned on the rostrocaudal axis by manipulating
WNT signaling. Small molecule inhibitors of WNT signaling promoted expression of frontal
markers; conversely, small molecule activators of WNT promoted expression of
occipitotemporal markers. Importantly, WNT activation had to be moderate; higher levels
of WNT activation resulted in switch of neuroepithelial identity from forebrain to
midbrain. This finding provides insights into arealization in the mammalian cortex and

suggests that exposure to different levels of WNT signaling early on may act as a selector
between generation of a six‐layered neocortex or a three‐layered archicortex.
Lastly, we utilize our reductionist in vitro corticogenesis model to establish that neural
progenitors can be differentiated into various classes of projection neurons. By utilizing
genome modification strategies in hPSCs, we observe that single neural progenitors
possess the capacity to give rise to callosal projection neurons (CPNs) and subcortical
projection neurons (SCPNs), thereby lending support to the “Progressive Restriction”
model of corticogenesis. Additionally, based on analysis of human fetal tissue at various
stages, and further confirmation with BrdU labeling studies during in vitro differentiation,
we propose that progressive progenitor restriction manifests during corticogenesis as a
progressive limitation in the ability of their daughter neurons to express various
projection neuron class‐determinants over time. Co‐expression of CPN and SCPN fate
determinants is rarely observed during mouse development, even though recent mouse
studies clearly show the requirement of CPN genes in SCPN formation. This suggests that
neuronal restriction may be evolutionary conserved and this may have implications for
diseases such as autism where laminar differentiation is affected. Neuronal restriction
provides a conceptual link between how defects in progenitors could affect laminar
development and neuronal hodology, which in turn underlies neuronal circuit formation.
Finally, by lineage‐tracing CUX2 positive progenitors in transgenic hPSC‐derived
neuroepithelium, we show that a small fraction of CPNs in our in vitro corticogenesis
paradigm may be derived from lineage‐restricted progenitors. Given the large numbers
of progenitors that display multi‐laminar differentiation ability, we conclude that lineage‐

restricted progenitors are not a major source of CPNs in our system, but may represent a
transient population derived from multipotential progenitors.
Thus, by combining human genome modification technologies with the default model of
neural induction, we are now able to probe fundamental questions of human
corticogenesis. Using genetic tools, we have established that hPSC‐derived neural
progenitors retain most characteristics of their in vivo mammalian counterparts and have
begun to uncover mechanistic principles for generation of the cortical projection neuron
classes. Together, our findings open new avenues for study of human brain development,
disease modelling, and drug screening using hPSCs. Moreover, the genetic and analytical
tools we describe here can be used for in vitro studies of cell cycle dynamics, self‐
organization, lineage tracing, and live imaging of multiple PSC‐derived tissue types.
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CHAPTER 1: INTRODUCTION
The development of the cerebral cortex in all mammals can be broadly divided into three
overlapping phases: 1) neural induction and folding of the neuroepithelium, 2) forebrain
patterning, and establishment of various progenitors in the radial plane, and lastly 3)
corticogenesis (Figure 1.1). Neural induction from the embryonic epiblast is the first step
in the development of the central nervous system (CNS) in all vertebrate embryos. The
resulting neuroepithelium will roll into a fluid‐filled tube and separate from the overlying
epidermis. This process of neural tube formation is referred to as neurulation. The neural
tube is now surrounded by a layer of neuroepithelium that will mature further into the
various progenitors during radial patterning. These progenitors will subsequently give rise
to the entire repertoire of neurons found in the CNS during the corticogenesis phase.
Corticogenesis itself encompasses several events: neurogenesis, axonal guidance and
synaptogenesis, and gliogenesis. Neurogenesis involves generation of neurons to
populate the various cortical layers, while axonal guidance and synaptogenesis occur in
tandem and will enable local and long distance circuit formation in the CNS. Gliogenesis
follows neurogenesis and leads to generation of astrocytes and oligodendrocytes, which
support maturation of the circuits and conduction of action potentials, respectively.
In human embryos, neural induction occurs over a two week period (Days 5‐19 in Figure
1.1), while neural tube closure occurs between Days 22‐24. Areal and radial patterning of
the neuroepithelium initiates around this time and will continue for the rest of the first
trimester and early part of the second trimester. Corticogenesis, specifically
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neurogenesis, starts downstream of the conversion of the neuroepithelium into radial
glial cells around post conception week (PCW) 6. Axonal pathfinding initiates after PCW10
and continues till the beginning of the third trimester. Synaptogenesis and gliogenesis
continue well into postnatal life.
In this chapter, I will focus on the molecular and cellular basis of neural induction, the
patterning events occurring during corticogenesis, and cortical progenitors and their
cellular diversity. I will also present a brief overview of embryonic stem cells to facilitate
an understanding of the model system I am using for my experiments. Together, these
ideas form the basis for this thesis. I will discuss them in the context of mammalian
embryonic development, with evolutionary examples where they are instructive.

Figure 1.1: Morphological changes in a human embryo from blastula to the initiation of
corticogenesis. From the Carnegie Collection. Scale bars: 1mm for corticogenesis, 200µm for
others.
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NEURAL INDUCTION AND EARLY PATTERNING IN VERTEBRATES
The molecular mechanisms and developmental milestones associated with neural
induction are largely conserved across the evolutionary tree (Levine and Brivanlou, 2007;
Muguruma and Sasai, 2012). In amphibians – where it was originally described – neural
induction initiates after the fertilized egg undergoes a series of divisions to generate a
fluid filled mass of cells called a blastula (blastocyst in mammals). Three different
territories emerge in the blastula: ectoderm, mesoderm, and endoderm, which are
collectively referred to as germ layers, while the process by which they arise is called
gastrulation. Each germ layer is fated to generate different tissues as the embryo matures.
The primitive ectoderm (epiblast in mammals) covers the outside of the embryo and
forms different tissue derivatives depending on its position along the embryonic dorsal‐
ventral (D‐V) axis. During gastrulation, neural induction occurs in the most dorsal region
of the ectoderm, and morphologically manifests as thickening of the ectoderm into a flat,
raised structure called the neural plate. The neural plate will undergo neurulation as
described above and will form the brain at the anterior end and the spinal cord at the
posterior end. Hence the entire CNS of the amphibian embryo is derived from the dorsal
ectoderm.
The ventral region of the ectoderm follows a different fate: it will form the epidermis,
which gives rise to skin and its derivatives. The neural crest forms at the junction of the
dorsal and ventral boundaries, which correspond to the edge of the neural plate. Neural
crest cells are highly migratory in nature and invade the developing embryo where they
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will eventually give rise to the peripheral and enteric nervous system, craniofacial
cartilage and bone, pigmented melanocytes, as well as smooth muscle cells. Ectodermal
cells at the most anterior edge of the neural‐epidermal boundary give rise to placodal
areas that will form sensory organs – such as the ear, nose, and eyes – as well as some
cranial sensory ganglia (Figure 1.2). At the start of gastrulation, cells from any part of the
ectoderm can still develop as either epidermis or neural tissue, but by the end of
gastrulation commitment has occurred (Holtfreter, 1955).

Figure 1.2: Fate map of the anterior border of the neural plate in Xenopus embryos.

These events described above are characteristic of all vertebrates, although the actual
timing and topology may vary in different species. Thus, neural induction is an
evolutionarily conserved requirement in the establishment of the nervous system in
vertebrates and partitions the primitive ectoderm into epidermal and neural primordia
upon gastrulation. But how does a mass of uncommitted cells become committed to a
neural fate versus epidermal or mesendodermal fate? What are the molecular
mechanisms that contribute to this commitment? Clues to these answers arose from the
classic transplantation experiments of Hilde Mangold and Hans Spemann and
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subsequently from in vitro explants of the dorsal ectoderm in the presence or absence of
specific growth factors.

NEURAL INDUCTION: FROM EXPERIMENTAL EMBRYOLOGY TO THE DEFAULT MODEL
The Mangold‐Spemann experiments and animal cap assays
The fundamental insight into how the neural plate is established came from the famous
observations of Hilde Mangold and Hans Spemann in the newt (Triturus) (Spemann and
Mangold, 1924). In their experiment, tissue from the dorsal mesoderm of an early newt
gastrula was grafted to the ventral side of a second embryo. The host embryo developed
a second set of dorsal axial structures on the ventral side, including a well‐organized
second nervous system. This experiment suggested that signals from the dorsal
mesodermal region were responsible for diverting nearby ectoderm to a neural fate
(Figure 1.6B). This region became known to amphibian embryologists as "Spemann’s
organizer". In normal development, cells of the organizer involute into the embryo during
gastrulation, giving rise to dorsal structures in the mesoderm such as muscle and the
notochord that underlie the future neural plate. Lineage‐tracing experiments revealed
that while the entire mesoderm of the secondary axis was derived from the progeny of
the grafted cells, the entire CNS, was derived from the host, with the exception of the
floor plate (Gimlich and Cooke, 1983). This suggests that signals from the organizer caused
ventral ectodermal cells – that normally would have given rise to the epidermis – to
convert instead to a neural fate. Similar findings are also observed in fish, where grafting
5

pieces of organizer (called the shield in fish) induces a secondary axis in the host fish
(Oppenheimer, 1936; Oppenheimer, 1953). Grafting experiments carried out in the chick
and mouse embryos (where the organizer is called the node) show similar results
(Waddington, 1952; Beddington, 1994), highlighting the evolutionary conservation of the
"organizer" as source of signal(s) that is sufficient to generate the entire nervous system.
To probe the mechanism by which organizer grafts were giving rise to a secondary axis,
the ectoderm of the amphibian blastula (called the animal cap) can be grown as explants
in pond water. By itself, the isolated animal cap only forms epidermal tissue (Holtfreter,
1955), but when recombined with explants derived from another portion of the embryo,
the same explant can generate other cell types. For instance, mesodermal derivatives
arise in explants exposed to early endoderm while neural tissue can be induced after
exposure to dorsal mesoderm (including the organizer) (Nieuwkoop, 1951; Slack and
Forman, 1980). This demonstrates the potential of animal cap cells to form both
mesodermal and ectodermal derivatives, depending on the inductive interactions that
were encountered over the course of early development. Since isolated animal cap
explants were observed to undergo epidermal differentiation, it reinforced the view from
the Spemann‐Mangold experiments that the ectoderm forms epidermis as a default state.
More surprising was the fact that simple cell dissociations of the animal cap led to
conversion of cells from epidermal to neural fate directly, without previous or
concomitant induction of mesoderm (Godsave and Slack, 1989; Sato and Sargent, 1989).
To explain these results, neural inducers were proposed to be widely distributed and
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under negative control in the animal cap by factors that could be lost by dissociation (Sato
and Sargent, 1989), but the nature of either the inducer or its inhibitor remained elusive.

The role of TGFβ family members in embryonic differentiation
The field of embryology benefited from the introduction of modern molecular techniques
to complement classical experimental embryology in the clawed African frog Xenopus.
These approaches soon led to the discovery that physiological amounts of polypeptide
growth factors of the fibroblast growth factor (FGF) and transforming growth factor beta
(TGFβ) family were sufficient to impose mesodermal fates in animal caps. For example,
when treated with increasing thresholds of Activin, a member of the TGFβ family, animal
caps respond by forming ventral, lateral and dorsal mesoderm (including the organizer)
(Kurth et al., 2005). Work in a variety of vertebrate model systems has established the
pivotal role of these growth factors in the formation of mesodermal and organizer tissues
in the embryo (Schier, 2009). Of note, animal caps also undergo some degree of neural
induction when treated with high concentrations of a mesodermal inducer such as
Activin, suggesting that neural tissue is also induced by growth factor action.
Experimentally, the difference between indirect versus direct neural induction can be
assessed by examining tissue specific markers, where direct induction is characterized by
the expression of neural markers (NCAM) in the absence of mesodermal/organizer‐
specific molecular markers (brachyury, goosecoid). Expression of both markers, however,
is a strong indication of an indirect cascade where one signaling factor induces responding
cells to release additional inducing factors. In Activin‐induced neural induction of the
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animal cap, both mesoderm and neural markers are found, suggesting that neural
induction in this instance is likely to be secondary to the inductive effect of the organizer.
It was during the studies of the Activin receptor, one of the first TGFβ family receptors
cloned in mammals (Mathews and Vale, 1991) and in Xenopus, that the nature of direct
neural inducers began to emerge.

The TGFβ pathway
There are two major branches of the TGFβ superfamily: the Activin/Nodal branch and
BMP branch (Figure 1.3). On binding of ligands to their cognate receptors, signaling is
induced by ligand‐dependent dimerization of type II receptors with type I receptors
through serine‐threonine kinase activity. The type I receptor in turn induces signaling by
either the canonical pathway, via receptor‐associated SMAD proteins (R‐SMADs), or by
the non‐canonical pathway which involves MAPK and NF‐κB pathway components (Taylor
and Wrana, 2008; Poorgholi Belverdi et al., 2012). The Activin/Nodal branch utilizes
SMAD2/3 as its receptor SMAD, while the BMP branch utilizes SMAD1/5/8. For both
classes of receptor SMADs, SMAD4 is an essential cofactor (referred to as co‐SMAD) for
their translocation into the nucleus. There are also multiple ligands and inhibitors of each
branch in the extracellular space as shown in Figure 1.3; a few of them will be discussed
in the following sections. In addition to extracellular inhibitors, there are also two
intracellular inhibitors of signaling (inhibitory SMADs): SMAD6 and SMAD7. SMAD6
inhibits the BMP‐SMAD1/5/8 branch as well as the non‐canonical branches of signaling,
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while SMAD7 is a specific inhibitor of the canonical branches of both pathways (Yan et al.,
2009; Jung et al., 2013).

Figure 1.3: Schematic showing the two main TGFβ pathways: the Activin/Nodal and the BMP
branches.
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The molecular basis of neural induction
Serendipitously, a role for TGFβ signaling in neural induction was suggested by studies of
mesodermal induction in Xenopus. In order to determine if Activin signaling is necessary
for mesoderm induction in vivo, a dominant negative Activin receptor (DN‐ActRIIB) was
injected into a 2‐cell stage embryo to challenge the inducing activity of Activin (Figure 1.4)
(Hemmati‐Brivanlou and Melton, 1992). Like many dominant‐negative mutants, DN‐
ActRIIB is known to be broad acting and capable of blocking all TGFβ ligands, including
Nodals, BMPs, and GDFs. When expressed in early embryos, DN‐ActRIIB completely
inhibits endogenous mesoderm induction, in line with the idea that TGFβ signaling
through the ActRIIB receptor is necessary for mesoderm induction in vivo. DN‐ActRIIB
expression in animal caps also completely blocks mesoderm induction by Activin.
Unexpectedly, however, when expressed alone in control animal caps in pond water (i.e.
not exposed to any ligand), it leads to a strong conversion of fate directly from epidermal
to neural, in the absence of neural‐inducing signals from Spemann’s organizer (Figure
1.4). Furthermore, it was subsequently shown that the neural cells induced by DN‐ActRIIB
are of forebrain identity, but not of hindbrain or spinal cord (Chang and Harland, 2007),
suggesting that TGFβ inhibition has the dual effect of determining the lineage choice of
the animal cap as well as its antero‐posterior (A‐P) identity. These precepts would give
rise to a new model of neural induction: the default model.
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Figure 1.4: Injection of dominant‐negative activin receptor (which blocks all TGFβ signaling) in
two‐cell stage Xenopus embryos converts prospective epidermal tissue into neural tissue. Modified
from Sanes et al. (Sanes et al., 2012).
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The "Default Model" of neural induction
That neural tissue could be induced by cell dissociation or by expression of a dominant
negative Activin receptor were distinct observations with one common denominator:
they both made sense if traditional thinking about neural induction was inverted. In this
revised view, the default fate for animal caps would not be epidermal, but neural.
Ongoing signals in the explants repress the natural tendency of the cells to become neural
by inducing the epidermal fate. When this signaling is interrupted (by either expression
of DN‐ActRIIB or by cell dissociation), cells assume a neural fate. This became known as
the default model of neural induction (Hemmati‐Brivanlou and Melton, 1992, 1994). The
implication of this model is that vertebrate embryonic cells will become forebrain tissue
unless told otherwise (see next section) (Hemmati‐Brivanlou and Melton, 1997).
Although the default model was based partially on over‐expression of an artificial
dominant negative receptor, one of its predictions is the presence of endogenous
epidermal‐inducing signal(s) as well as an organizer‐derived inhibitor(s) of this signal. In
this scenario, neural inducers from the organizer locally antagonize these epidermal
inducing signals, allowing the dorsal ectoderm to follow its “default” neural fate. Indeed,
these endogenous signals and their inhibitors were found in subsequent studies described
below, as predicted by the model.
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Neural tissue induced by TGFβ inhibition is forebrain by default
The early neural plate is already specified to form different parts of the nervous system
immediately downstream of neural induction. As discussed above, the anterior end of the
embryo will form forebrain, midbrain, and hindbrain in succession, while the posterior
end will form the spinal cord. This is a property conserved in all vertebrates studied (Rallu
et al., 2002). Working with Axolotl explants, Nieuwkoop was the first to observe that
newly formed neuroepithelium adopts an anterior identity by default (“activation”), while
generation of posterior neural tissues required caudalization of this anterior
neuroepithelium (“transformation”) (Nieuwkoop and Nigtevecht, 1954). This “activation‐
transformation” model thus predicts that “activation” by direct neural inducers should
give rise to neural tissue with an anterior identity. Indeed, it has now been shown in
multiple contexts that all direct neural inducers that inhibit TGFβ signaling induce neural
tissue of anterior (forebrain) character. Thus the default model provides a molecular
explanation to the “activation” aspect of Nieuwkoop’s model.
We now know that “transformation” involves a complex set of inductive signals generated
by the extra‐embryonic endoderm, the axial mesoderm (notochord), non‐neural
ectoderm, and paraxial mesoderm that will pattern the neural plate into different regions
along the embryonic axes. These signals include BMPs and Sonic Hedgehog (Shh) in the
D‐V axis, and WNTs, FGFs, and Retinoic acid (RA) in the A‐P axis (Chizhikov and Millen,
2004; Kurth et al., 2005; Liu and Niswander, 2005; Fuccillo et al., 2006).
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Epidermal induction
To dissect the identity of epidermal inducing signals, dissociated animal cap can be
subjected to purified proteins, and the fate of the cells determined with molecular
markers (Wilson and Hemmati‐Brivanlou, 1995). Since animal cap cells are neuralized
upon dissociation, candidate factors can be tested for the ability to suppress neuralization
and restore epidermal specification, thus replacing endogenous signals lost on dispersion.
As expected, treating these cells with Activin blocks neuralization by inducing mesoderm.
Another member of the TGFβ superfamily, BMP4, not only suppresses neuralization, but
is also a potent epidermal inducer (Wilson and Hemmati‐Brivanlou, 1995). Significantly,
the dominant‐negative Activin receptor not only blocks signaling by BMP4, but also by
BMP2 and BMP7, which are epidermal inducers in this assay (Suzuki et al., 1997). Indeed,
the expression pattern of BMPs is in accord with their proposed role as neural inhibitors:
BMP4 RNA is found throughout the ectoderm at the start of gastrulation, subsequently
disappearing from the prospective neural plate (Figure 1.5) (Fainsod et al., 1994;
Hemmati‐Brivanlou and Thomsen, 1995; Schmidt et al., 1995). Epidermal differentiation
is also blocked in animal caps after inhibiting endogenous BMP signaling using dominant‐
negative BMP receptors (Sasai et al., 1995; Schmidt et al., 1995; Xu et al., 1995), dominant
negative BMP4 or BMP7 ligands (Hawley et al., 1995), or antisense BMP4 RNA (Sasai et
al., 1995), suggesting further that the BMP family are essential epidermal inducing factors
in vivo. The requirement of BMP signaling in epidermal induction and blocking neural
induction has now been validated in both mouse and humans ESCs (Coraux et al., 2003;
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Metallo et al., 2008) as well as mouse embryos (Davis et al., 2004; Di‐Gregorio et al.,
2007).

Figure 1.5: Schematic of graded BMP activity in the gastrula and neurula ectoderm in the Xenopus
embryo. A schematic fate map of the early gastrula shows the approximate positions of the
future neural plate (NP), border region, and epidermis, viewed from the dorsal side. Diffusible
antagonists produced in the organizer region of the mesoderm result in a graded distribution of
BMP signaling in the neighboring ectoderm. The relative positions of epidermis (EP), NP,
organizer, cement gland (CG), and neural crest (NC) are shown. Sensory placodes form at various
positions in the border region. Dorsal view of the neurula fate map with BMP activity levels
superimposed.

INDUCERS OF NEURAL FATE IN VIVO
Endogenous neural inducers are inhibitors of TGFβ signaling and are expressed in the
organizer and primordial endoderm
Independent approaches in Xenopus led to the identification of the endogenous neural
inducers. Screening of cDNA libraries for embryonic inducing activity led to the discovery
of noggin, the first endogenous direct neural inducer (Smith and Harland, 1992). The
second involved isolating organizer‐specific genes. This led to the identification of chordin
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(Sasai et al., 1994). Finally, testing the activity of candidate TGFβ inhibitors led to the
characterization of follistatin (Hemmati‐Brivanlou et al., 1994). All three genes are
secreted proteins, specifically expressed in the organizer, and with direct neural‐inducing
ability (Figure 1.6A). Together, they confirm that the organizer is indeed the major source
of signals that induces neural tissue in vivo.
Biochemical characterization of noggin, chordin, and follistatin have established that they
are potent extracellular inhibitors of BMP signaling (Figure 1.3). They bind with high
affinity to the ligands, thus preventing them from activating their cognate receptors
(Piccolo et al., 1996; Zimmerman and Mathews, 1996). In Xenopus, a high gradient of BMP
signaling on the ventral side of the ectoderm promotes epidermal fate, whereas on the
dorsal side BMP signaling is kept low by organizer generated BMP inhibitors, thus
promoting a neural fate (Figure 1.5). There is now an extensive list of secreted BMP
inhibitors, with many that are expressed in the organizer (node in mammals). Nearly all
of these that have been tested in the animal cap assay have been shown to act as a direct
neural inducer. Together, BMP ligands and their inhibitors establish a gradient of BMP‐
SMAD1/5/8 activity in the developing embryo that will result in distinct fates within the
ectoderm. Hence high levels of BMP will induce epidermis, while low levels are permissive
for neural fate. Intermediate levels of BMP activity at the border of the neural plate and
the epidermis will induce neural crest and neural placodal fates (Figures 1.2 and 1.5).
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Figure 1.6: The organizer acts as a neural inducer by releasing TGFβ inhibitors. A) Cross‐section
through the Xenopus embryo at gastrula stage showing the organizer (blue cells). TGFβ inhibitors
released by the organizer induces neural fate (in red) in the overlying ectoderm. Transplantation
of the organizer into the ventral side of a host embryo gives rise to a duplication of the body axes
due to the inductive activity of the organizer. This was essentially the experiment carried out by
Spemann and Mangold in Newt embryos. Cb: Cerberus, Chd: Chordin, Ng: Noggin. Modified from
Sanes et al. (Sanes et al., 2012).
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Following the discovery of endogenous BMP inhibitors, another class of neural inducers
was also found in prospective endoderm of Xenopus embryos, away from the classical
organizer. This head inducer was identified in a differential screen for cDNAs enriched in
the dorsal region of Xenopus embryos and named Cerberus (Bouwmeester et al., 1996).
Cerberus is an inhibitor of the Nodal, BMP and WNT pathways in Xenopus, but is
predominantly a Nodal inhibitor in mouse (Piccolo et al., 1999; Perea‐Gomez et al., 2002).
Two other neural inducers, Lefty1 and Lefty2 were initially identified based on their
homology to TGFβ ligands and later identified as Nodal inhibitors that were found to have
neural inducing activity in Xenopus animal caps (Meno et al., 1997; Hamada et al., 2002).
Homologues of both Lefty and Cerberus have also been found in Xenopus, zebrafish,
chicken, and mouse in analogous expression patterns (Shen, 2007). Unlike Cerberus,
Xenopus lefty (called xantivin) is not expressed in the organizer and does not appear to
have neural inducing activity in neural caps by itself (Cheng et al., 2000). However, knock‐
down of endogenous lefty with morpholinos in the embryo leads to a strong reduction in
forebrain markers (Tanegashima et al., 2004). In mouse embryos, both Lefty1 and
Cerberus‐like are released by an extra‐embryonic structure called the anterior visceral
endoderm (AVE); this is in contrast to BMP inhibitors, which are released by the
organizer/node. In addition to promoting neural induction, Nodal inhibitors also have a
conserved and well‐studied role in left‐right patterning of the embryo (Shen, 2007).
Xenopus animal cap cells pass through a competence phase when they respond to
Activin/Nodal signaling by forming mesendodermal derivatives, followed by a second
phase when they become epidermis in response to BMP signaling. In the default model
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therefore, a neural fate ensues only when animal cap cells avoid both mesoderm and
epidermal inducing signals. This explains why co‐inhibition of both BMP‐SMAD1/5/8 and
Activin/Nodal‐SMAD2/3 branches of the TGFβ pathway induces a neural fate more
potently than each alone (Chang and Harland, 2007) in a manner similar to DN‐ActRIIB,
which interferes with both Activin/Nodal and BMP signaling. In addition to these
endogenous inhibitors, small molecules that block the different branches of the TGFβ
signaling have also been characterized. As with endogenous inhibitors, they have now
been shown to act as direct neural inducers when tested in the context of animal cap
explants or in mammalian pluripotent stem cells (PSCs), as will be discussed later.

Figure 1.7: Taxonomy of the bilaterian group of animals. As the name suggests, bilaterians have
bilateral symmetry, with an anterior‐posterior, dorsoventral and left‐right axis. Adapted from
Hedges and Kumar (Hedges and Kumar, 2009).
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Evolutionary conservation of the requirement of TGFβ inhibition for neural commitment
Inhibition of ongoing TGFβ signaling to delineate neural and non‐neural ectoderm is a
commonly utilized module during evolution in bilaterian animals (Figure 1.7) (Hartenstein
and Stollewerk, 2015). In the fruitfly Drosophila (anthropoda) for example, short
gastrulation (sog) is a homolog of the organizer‐specific BMP‐inhibitor chordin. Sog was
identified in a systematic screen for genes involved in patterning the Drosophila embryo
along the D‐V axis (Zusman et al., 1988). As in vertebrates, the dorsal and ventral regions
of the ectoderm of the Drosophila embryos generate different fates. However, as the
embryonic axis is flipped in arthropods compared to chordates, the epidermis forms in
the dorsal regions, while neural tissue arises ventrally. Nonetheless, the molecular
circuitry involving inhibition of BMP in segregating dorsal from ventral ectoderm operates
precisely in the same manner as in vertebrates (Holley et al., 1995; Eldar et al., 2002).
Drosophila correlates of BMP signaling, including ligands, receptors and inhibitors such as
Sog generate an activity gradient of Dpp, a BMP‐like ligand, from high dorsal to low
ventral, thus specifying epidermal and neural tissue, respectively (Mizutani et al., 2005).
Indeed, Sog has been shown to directly promote neuroectoderm specification in
blastoderm drosophila embryos by inhibiting the anti‐neurogenic and dorsalizing activity
of Dpp (Biehs et al., 1996). This activity of Sog is also shared by other arthropods, such as
spider and beetles (Mizutani and Bier, 2008). Similarly, inhibition of HrBMPb, the ascidian
homolog of BMP, is required for induction of rostral neural lineages in sea squirts (a
representative of urochordates) and BMP overexpression results in a fate switch of the
presumptive neural cells to epidermal lineages (Miya et al., 1997). Similarly, lancelets
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(which are cephalochordates) have been shown to possess a ventral‐high dorsal‐low
gradient of BMPs, and addition of exogenous BMPs ventralizes the embryo while
preventing expression of neural markers (Yu et al., 2007b). Likewise, in annelids (which
are lophotrochozoates) inhibition of BMP signaling is required to specify
neuroectodermal fate, which lies in the ventral territory (Kuo and Weisblat, 2011). A
notable exception to this rule is found in hemichordates, which lack an organized CNS and
do not have segregation of the ectoderm into neurogenic and epidermal territories.
Exposure of these embryos to exogenous BMPs does not repress neural markers, and
conversely, BMP knockdown does not promote neuralization, even though it has a role in
D‐V patterning in these embryos (Lowe et al., 2006). Neural fate choice in nematodes is
also not reliant on BMP inhibition, since they have a fixed lineage map at the onset of
embryogenesis (Hartenstein and Stollewerk, 2015). Taken together, these observations
suggest that D‐V patterning by the BMP pathway is an ancient mechanism that evolved
early in bilaterians and was subsequently utilized by many members of protostomes and
deuterostomes as a means of establishing segregating neural‐epidermal fates in the early
embryo (Figure 1.7) (Mizutani and Bier, 2008; Hartenstein and Stollewerk, 2015). The
requirement for TGFβ inhibition in neural induction has remained highly conserved across
hundreds of millions of years of evolution in vertebrates as well, and has been
demonstrated in mouse embryos as well as human and non‐human primate (NHP)
embryonic stem cells. I will focus on mammals in the sections below.
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TGFβ inhibition is required for neural induction in vivo in mammals, and there is
significant redundancy among TGFβ inhibitors
As stated previously, a requirement for inhibition of both branches of the TGFβ pathway
(i.e. Nodal and BMP branches) has been shown in vivo in Xenopus (Chang and Harland,
2007). In mouse embryos, knockout of both branches has not been reported, presumably
due to the severe embryonic malformations of the mutations. However, mutant embryos
that have lower activity of only one branch give a phenotype consistent with the
predictions of the default model. For example, knockout of the predominant BMP
receptor in the mouse epiblast, Bmpr1a, results in expansion of the neural domain to
cover nearly the entire epiblast. This neuralized epiblast expresses several markers of
forebrain territory (Figure 1.8A) (Di‐Gregorio et al., 2007). Moreover, the expression of
Nodal is completely lost in these embryos, as is the expression of mesodermal markers.
In early mouse embryos, Nodal is the predominant ligand for the Activin/Nodal pathway.
This suggests that the anterior neural fate conversion in the epiblast is direct and due to
inhibition of both branches of TGFβ.
Conversely, knockout of Nodal in mouse embryos results in severe gastrulation defects.
The mesendoderm fails to be specified, along with the AVE, which secretes Nodal
inhibitors such as Lefty1 and Cerberus‐like (Shen, 2007). Nevertheless, the epiblast
undergoes a precocious, near‐complete neural conversion and expresses several markers
of forebrain fate, suggesting a direct conversion (Brennan et al., 2001; Camus et al., 2006).
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Cripto (also called TDGF1 in humans) is an essential co‐receptor for Nodal signaling and
increases its binding affinity to its primary receptor ALK4 (Yeo and Whitman, 2001). As
with Nodal knockouts, Cripto knockout embryos also have severe gastrulation defects;
unlike nodal knockouts, mesendodermal markers are specified but displaced to the
proximal epiblast while the AVE is also present (Ding et al., 1998; Liguori et al., 2003).
Notably, the distal epiblast in Cripto knockout consists mostly of neuroectoderm, with
expression of several markers of forebrain identity. Since Nodal is required for
maintenance of BMP expression in the gastrulating embryo (Shen, 2007), both TGFβ
branches are effectively repressed in Nodal and Cripto knockouts.
There is a robust functional redundancy in Nodal and BMP ligands and their inhibitors
that mediate neural induction. Hence, mutations that eliminate only one inhibitor tend
to have mild to no phenotypes on their own. For example, a loss‐of‐function mutation in
Zebrafish chordin (the chordino mutant), a BMP inhibitor, causes only a reduction in the
size of the neural plate (Schulte‐Merker et al., 1997). Similarly, mouse embryos that lack
just one of the BMP antagonists, chordin or noggin by knockout mutations have a
relatively normal nervous system (McMahon et al., 1998; Bachiller et al., 2000). However,
the full consequence of unopposed BMP signaling becomes apparent when several
inhibitors are removed at the same time. For instance, a complete loss of neural tissue is
observed when all three BMP antagonists ‐ i.e. chordin, follistatin and noggin ‐ are
simultaneously targeted using morpholinos both in Xenopus (Khokha et al., 2005) and
zebrafish (Dal‐Pra et al., 2006). Likewise, the mouse double noggin/chordin mutants lacks
all anterior neural structures (Figure 1.8B) (Bachiller et al., 2000). Conversely, multiple
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BMP ligands are required for epidermal differentiation: at least three of the four BMPs,
BMP2/4/7, need to be disrupted in Xenopus embryos to expand the neural plate, but even
then, some ventral epidermal tissue remains. Taken together, the Bmpr1a, Nodal, Cripto,
and Noggin/Chordin mouse knockouts provide strong evidence for the necessity of TGFβ
inhibition and applicability of the default model of neural induction in vivo.
Multiple inhibitors of the Nodal pathway are also found in the anterior half of mouse
embryos, of which Lefty1 and Cerberus‐like are the best studied. Unlike BMP inhibitors,
which are released by the node, both these inhibitors are released by the AVE. Here they
promote anterior neural development by protecting the overlying forebrain from
mesendodermal inducing Nodal signals (Shen, 2007). As with BMP inhibitors, Nodal
inhibitors also appear to be redundant, as deletion of Cerberus‐like alone has no effect
on anterior neural development (Belo et al., 2000). Likewise, depletion of Cerberus in
Xenopus with morpholinos is not sufficient to prevent head formation by itself (Silva et
al., 2003). In mice, double knockout of Cerberus‐like and Lefty1 are embryonic‐lethal and
associated with severe defects, including expansion of the extra‐embryonic endoderm,
patterning of the mesoderm, and multiple primitive streaks (Perea‐Gomez et al., 2002).
The effect on neural fate in these embryos has not been explored systematically yet.
Thus, neural induction in vivo probably depends on multiple ligands and inhibitors as a
means to fine‐tune TGFβ signals during patterning of the early embryo.
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Figure 1.8: Absence of BMP signaling promotes forebrain fates in mouse embryos while excessive
BMP signaling prevents forebrain induction. A) Bmpr1a‐/‐ mice display premature expression of TxF
dilineating forebrain territory including Hesx1, Foxg1, and Six3. Sox1 is a general neural marker.
B) Chordin and noggin double knockout mouse embryos, but not chordin knockouts alone, fail to
form forebrain and midbrain structures. Adapted from Bachiller et al. and Di‐Gregorio et al.
(Bachiller et al., 2000; Di‐Gregorio et al., 2007).

25

FGF signaling and neural induction
Differential TGFβ signaling provides an instructive mechanism for restricting neural tissue
to one part of the embryo on A‐P axis (Levine and Brivanlou, 2007). The default model,
however, leaves open the possibility that other factors are involved in neural induction,
including those that operate in a more permissive fashion to grant the nascent ectoderm
(epiblast in chick and mammals) competence to respond to TGFβ inhibition. The best
evidence for a factor in this category are ligands of the FGF and IGF family, both of which
bind to tyrosine kinase receptors and signal via the MAPK cascade. FGF signaling has been
shown to inhibit BMP signaling in the Xenopus embryo by several mechanisms: for
instance, FGF signaling through MAPK can promote phosphorylation of the linker domain
and degradation of SMAD1, thereby functionally reducing BMP signaling (Pera et al.,
2003). In addition, FGFs can also inhibit BMP activity indirectly, by inducing the expression
of a protein called Zeb2 (also known as SIP1/Zfhx1b), a zinc‐finger homeodomain protein
that binds to and represses the transcriptional activity of the SMAD protein (Sheng et al.,
2003). For much of the neural plate, the role of FGF signaling is likely to be minor, since
neural induction by the BMP inhibitors occurs readily in Xenopus in the absence of FGF
signaling (Wills et al., 2010). As discussed below, this has now been shown to be the case
in mammalian PSCs.
The strongest argument for a role of FGF signaling in neural induction has come from
studies in the chick embryo, where inhibition of FGF represses expression of neural
markers even in the presence of BMP inhibitors (Stern, 2005). It has been suggested that
in chick, BMP inhibition is more important for maintenance of neural markers in the
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neural plate rather than their initial induction. Based on our current understanding, there
are two important caveats to these observations: first, these studies were carried out
before the differences in signaling pathways naïve and primed pluripotent cells were
recognized in mouse and human embryos. As will be discussed below, it is now
appreciated that FGF signaling promotes the transition of “naïve” inner cell mass cells to
“primed” epiblast cells, which possess the competence to generate neuroectoderm upon
TGFβ inhibition. Therefore it remains possible that FGF plays an important but permissive
role, rather than an instructive role in chick neural induction as well. This is consistent
with the observation that exposure 5 hours of FGFs is sufficient to make the chick epiblast
competent to respond to BMP inhibitors and promote neural fate (Streit et al., 1998).
Whether the pre‐FGF chick epiblast resembles a naïve pluripotent state is not currently
known. The second caveat in nearly all chick neural induction studies is that BMP signaling
inhibition is not accompanied with concurrent Activin/Nodal inhibition (Wilson et al.,
2000; Wilson et al., 2001; Linker and Stern, 2004). Co‐inhibition of both BMP and
Activin/Nodal branches is synergistic and required for inducing anterior neural fate
(Chang and Harland, 2007). While it remains plausible that in chick the neural induction
circuitry is wired to favor FGF signaling over TGFβ inhibition, a role for FGF signaling in
promoting progression of an epiblast fate, followed by TGFβ inhibition for neuralization
intuitively explains many of the observations and resolves many contradictions in chick
neural induction experiments. Hence, studies specifically addressing these issues are
required to clarify the role of FGF signaling in chick neural induction.
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NEURAL INDUCTION IN MAMMALIAN EMBRYONIC STEM CELLS
Mouse and Human Pluripotent Stem Cells (PSCs)
About thirty years ago, mouse embryonic stem cells (mESCs) were derived from the
blastocysts of the pre‐implantation mouse embryo (Evans and Kaufman, 1981; Martin,
1981). These cells provided the functional definition of ESCs: unlimited proliferation with
the ability to differentiate into cells from each of the three embryonic germ layers ‐
ectoderm, mesoderm, and endoderm. These properties of ESCs are referred to as self‐
renewal and pluripotency, respectively. While self‐renewal is a purely in vitro property,
pluripotency has now been definitively demonstrated by the ability of ESCs to contribute
to all tissues (including the germ cells) in developing embryos. In this assay, called morula
aggregation, labeled mESCs are introduced into a wild type morula and allowed to
develop normally; the resulting embryo is thus a chimera of two different starting cell
populations (Bradley et al., 1984). Even more stringently, mESCs have been shown to
generate entire mice in the tetraploid embryo complementation assay (Nagy et al., 1993).
In this assay, tetraploid host cells are generated by application of an electric current.
When cultured mESCs are mixed together with the tetraploid cells, the resulting embryo
is derived exclusively from the diploid mESCs, whereas the tetraploid cells contribute
exclusively to extra‐embryonic tissue. This advance has enabled manipulation of the
mouse germline.
Following the discovery of mESCs, NHP and human embryonic stem cells (hESCs) were
subsequently derived from blastocysts (Thomson et al., 1998). Like mESCs, hESCs
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demonstrate the hallmark characteristics of self‐renewal and pluripotency. While the gold
standard pluripotency

assays of

morula

aggregation

or

tetraploid

embryo

complementation are ethically infeasible using human cells, hESCs have passed several
standard tests for pluripotency including embryoid body differentiation and teratoma
formation assays.
Over the past decade, somatic cells from both mouse and humans have also been
reprogrammed to a pluripotent state (Takahashi and Yamanaka, 2006; Takahashi et al.,
2007). The reprogrammed cells are called induced pluripotent stem cells (IPSCs) and were
first generated by overexpression of a combination of four transcription factors (TxFs):
POU5F1, SOX2, cMYC and KLF4 in the appropriate culture conditions. They display
properties largely indistinguishable from their mouse and human ESC counterparts
including pluripotency, self‐renewal, teratoma formation, and the ability to contribute to
germ layers on tetraploid complementation in the case of mouse IPSCs (Kang et al., 2009;
Hanna et al., 2010).
The principal promise of stem cell biology is their utilization for novel in vitro models of
poorly understood diseases and for cell replacement strategies in translational medicine.
From a developmental perspective however, mouse and human PSCs provide an in vitro
platform to test hypotheses and investigate mechanisms controlling embryonic fate
determination. For the mouse system, ESCs serve to complement in vivo approaches, but
for humans, ESCs constitute the only experimental window into early human
embryogenesis.
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Similarities and differences in the pluripotent state of mouse and human ESCs
Both mouse and human ESCs express identical embryonic TxFs such as OCT4 (POU5F1),
SOX2 and NANOG during pluripotency, and form teratomas when grafted into adult mice
(Hanna et al., 2010). However, there are also important differences between the two,
including: signaling requirements, X‐chromosome status, and growth characteristics.
These differences are due to the fact that mESCs represent an earlier stage of
development than hESCs as described below.
Mouse ESCs require LIF, BMP, and WNTs for the maintenance of a naïve (or “ground”)
state of pluripotency (Figure 1.9A) (Ying et al., 2008). Treatment of these cells with FGFs
and Activin, and/or WNT inhibition induces a rapid conversion of mESCs to epiblast stem
cells (EpiSCs) that self‐renew and maintain pluripotency, but acquire the gene expression
signature of post‐implantation epiblast cells (Guo et al., 2009; ten Berge et al., 2011). This
suggests that these signaling pathways also contribute to the transition from naïve to
primed pluripotency in vivo. Mouse EpiSCs have distinct signaling requirements—
Activin/Nodal and FGF—compared to mESCs (Hanna et al., 2010) and display and can also
be derived directly from both pre‐ and post‐implantation embryos (Brons et al., 2007).
Unlike mESCs, hESCs are dependent on Activin/Nodal, FGF, and Insulin signaling for
maintenance of pluripotency (Figure 1.9B) (James et al., 2005; Vallier et al., 2005; Bendall
et al., 2007; Vallier et al., 2009b; Vallier et al., 2009c; Singh et al., 2012). This property is
similar to mEpiSCs, even though hESCs are derived from an equivalent embryonic source
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as mESCs: the inner cell mass of pre‐implantation blastocysts. It is thought that the
derivation process accelerates the transition of hESCs to a more advanced stage of
pluripotency than mESCs (Vallier et al., 2009a; Hanna et al., 2010). They are closer to the
aforementioned EpiSCs in their developmental potential as well as their exclusive reliance
on aerobic glycolysis, unlike mESCs (Zhou et al., 2012). Based on functional assays, it
seems likely ‐ though not formally proven ‐ that the pluripotent cells of Xenopus animal
caps are closer to the primed pluripotent state of mEpiSCs and hESCs than to the naïve
state of mESCs since they can give rise to all the germ layer derivatives in the absence of
priming (Dixon et al., 2010; Theunissen et al., 2011; Scerbo et al., 2012). It has been shown
that NHP PSCs, such as from cynomolgus monkeys (Macacca fascicularis) also have similar
signaling requirements as their human counterparts and exist in a primed state of
differentiation (Ono et al., 2014). IPSCs derived from mouse, NHPs, and humans share
identical signaling properties for maintenance and differentiation to the ESCs of the
species from which they were derived. Hence, mouse IPSCs require LIF, BMPs and WNTs
for maintaining pluripotency, while human and NHP IPSCs require Activin/Nodal, FGF and
Insulin signaling (Yu et al., 2007a; Liu et al., 2008; Nakagawa et al., 2008; Park et al., 2008).
More recently, several groups have isolated “naïve” hESCs that resemble mESCs more
closely in terms of growth characteristics, morphology, dependence on LIF and WNT
signaling, gene expression patterns, and epigenetic characteristics (Chan et al., 2013;
Gafni et al., 2013; Theunissen et al., 2014; Ware et al., 2014). Similar cells have been
isolated from monkey ESCs as well (Fang et al., 2014). Whether these cells are correlates
of an in vivo population or a synthetically stabilized in vitro state of pluripotency is not
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clear at present. It is also unknown if the different naïve hESCs generated by the various
groups represent different pluripotent states of the same cell type, or different cell types
altogether.

Figure 1.9: Signaling pathways are different between mouse and human PSCs. A) Mouse PSCs
depend on LIF‐STAT, canonical WNT, and inhibition of FGF‐MEK signaling for self‐renewal. B)
human PSCs are dependent on FGF‐MEK, INSULIN‐PI3K, and ACTIVIN/NODAL‐SMAD2/3 signaling
for self‐renewal. Once mouse PSCs convert to EpiSCs, they share the same pathways as hESCs,
suggesting that hESCs represent a later stage of development compared to mESCs.

Neural induction in mouse ESCs/EpiSCs and the role of FGF signaling
Neural induction paradigms in mESCs have evolved over the past decade from culturing
ESCs as EBs in serum‐ and RA‐ containing medium to co‐culturing ESCs with cell lines
possessing neural‐inducing activity, and now to defined culture conditions utilizing some
combinations of growth factors or small molecules. Here I will focus on the role of RA in
neural differentiation, as it is well characterized and informative with respect to the
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default model and address the controversy surrounding the role of FGF signaling in mouse
neural induction.
A role for FGF in neuralization of mESCs had been suggested early on in many
independent studies of neural differentiation in mESCs (Tropepe et al., 2001; Ying et al.,
2003). Most of these studies, however, did not address whether FGF was acting directly
or indirectly as a neuralizing factor. We now know that mESCs require FGF signaling to
progress from a naïve to primed state of pluripotency i.e. the epiblast‐like EpiSC state
(also referred to as ‘primitive ectoderm’ in some of these studies), before they are
competent to undergo neural induction (Kunath et al., 2007; Stavridis et al., 2007; Guo et
al., 2009). Hence, as with chick embryos, it remains possible that the observed
requirement for FGF signaling will be related to its role in priming mESCs for germ layer
differentiation, rather than neural induction per se. This is supported by the fact that FGF
signaling inhibits, rather than promotes neural induction in EpiSCs (Stavridis et al., 2007;
Engberg et al., 2010; Greber et al., 2010; Sterneckert et al., 2010). Furthermore, small
molecule inhibition of FGF signaling in ex vivo cultures of epiblast stage embryos
accelerates anterior neural induction in control embryos (Di‐Gregorio et al., 2007). In the
EpiSC state, inhibition of Activin/Nodal and BMP signaling can induce anterior neural
commitment from this cell type, thus revealing the default pathway of neural induction
in this cellular context (Najm et al., 2011). It is worth noting that FGF signaling can also
directly inhibit SMAD signaling by promoting the degradation of SMAD1 via linker
phosphorylation in Xenopus animal caps, but this activity has not been demonstrated in
mammalian PSCs (Pera et al., 2003; LaVaute et al., 2009). Thus, the requirements for FGF
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can be explained by its role in the transition of mESCs to EpiSCs, which are then primed
for differentiation and resemble human ESCs more closely.
It has been established for a long time that retinoic acid can direct the differentiation of
mESCs and teratocarcinoma cells into a neural fate (Jones‐Villeneuve et al., 1982; Strubing
et al., 1995). While BMP4 can inhibit this neural inducing activity of RA (Finley et al., 1999;
Engberg et al., 2010), it was unknown until recently whether RA acts through a separate
parallel pathway to promote neural fate in mESCs or if it promotes transition to an EpiSC
fate. RA acts via a bimodal mechanism to a) repress the pluripotency signaling pathways
in mESCs and b) subsequently promote a neural fate. First, RA accelerates the transition
of ESCs to EpiSCs by upregulation of Fgf8‐MEK signaling and concurrent inhibition of WNT
signaling (Engberg et al., 2010; Stavridis et al., 2010). Once the cells are in an EpiSC state,
RA represses expression of Fgf4 as well as Nodal to promote a neural fate; the latter is
achieved via inhibition of WNT signaling through a yet unknown cross‐interaction
(Engberg et al., 2010; Stavridis et al., 2010). It is worth noting that it has been previously
shown that RA inhibits WNT signaling in mESCs/EpiSCs through induction of an
extracellular inhibitor of WNTs, Sfrp2 (Aubert et al., 2002; Glaser and Brustle, 2005).
Hence, the mechanistic studies of RA function also support the requirement of FGF
signaling in transition from mESCs to mEpiSCs rather than in neural induction.
Additionally, they also reveal the absolute requirement of inhibition of TGFβ signaling in
EpiSCs for acquisition of neural fate.
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Other protocols have also been developed for neural induction from mESCs that involve
acceleration of transition of mESCs to EpiSCs. For example, differentiation of mESC
aggregates (called “embryoid bodies”) with small molecule inhibitors of TGFβ and WNT
signaling can also recapitulate major spatial and temporal milestones of cortical
development and generated functional neurons with forebrain identities (Watanabe et
al., 2005; Eiraku et al., 2008). The WNT inhibitor in this paradigm facilitates the transition
of mESCs to EpiSCs initially, as discussed above; indeed, inhibition of endogenous WNT
signaling in mESCs has been shown to readily promote their conversion to EpiSCs (ten
Berge et al., 2011). Subsequently, WNT inhibitors serve to prevent the WNT‐like
posteriorizing activity of an undefined, albumin‐rich component of the culture medium
(Fasano et al., 2010; Menendez et al., 2011; Blauwkamp et al., 2012; Nakano et al., 2012).
Interestingly, exogenous BMP4 completely abolishes neural induction in this setting
(Kamiya et al., 2011). Taken together in light of emerging concepts, studies of mESC neural
differentiation strongly support the relevance of the default model in mouse EpiSCs.

Neural induction in hPSCs
Many of the same protocols that have been used for neural induction in mESCs have also
been adapted for neural differentiation of hESCs. Since hESCs do not survive as single
cells, most early studies used cell aggregation approaches in the absence of exogenous
factors to achieve differentiation. These so‐called ‘embryoid bodies’ can be differentiated
into anterior (forebrain) neural derivatives, expressing the neural determinant TxF PAX6
(Zhang et al., 2001; Pankratz et al., 2007). This could be interpreted to imitate a default
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pathway of differentiation in the absence of exogenous signaling. Indeed differentiating
cells in these paradigms display low levels of BMP‐SMAD1/5/8 signaling, presumably due
to the high‐level expression of several soluble BMP antagonists such as Noggin, Follistatin,
and Gremlin as well as intracellular inhibitors of BMP signaling such SMAD6. Several other
differentiation protocols regularly include Noggin in serum‐free medium to promote
neuralization of hESCs (Itsykson et al., 2005; Yao et al., 2006). Hence these studies suggest
that in the absence of exogenous morphogens or in the presence of BMP inhibitors, hESC
aggregates take on an anterior neural fate.
Separately, inhibition of Activin/Nodal‐SMAD2/3 signaling has also been shown to be a
prerequisite for neuroectodermal differentiation in hESC cultures (Vallier et al., 2004;
Patani et al., 2009; Vallier et al., 2009b; Chng et al., 2010). Combining the classical
observations made in Xenopus animal cap explants with these studies in hESCs, Chambers
et al. utilized small molecule inhibitors of Activin/Nodal and BMP signaling to
demonstrate conversion of hPSCs to a neural fate (Chambers et al., 2009). As would be
expected from the default model, the neuralized cells are of anterior identity, expressing
the forebrain TxF OTX2. The primitive neuroepithelium generated from this protocol can
be subsequently patterned into multiple regional CNS derivatives, including ventral
telencephalon, hypothalamus, cranial placodes, midbrain, floor plate, and spinal cord in
the presence of appropriate signaling cues (Christopher et al., 2010; Kriks et al., 2011;
Dincer et al., 2013; Maroof et al., 2013; Maury et al., 2015). This paradigm provides
support for the “activation‐transformation” model of Nieuwkoop discussed above (Figure
1.10).
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A role for endogenous FGF signaling has been as a requirement for neural induction in
some studies, since small molecule inhibitors of FGF signaling reduce the number of cells
expressing PAX6 (Zeng et al., 2010; Yoo et al., 2011). However, in these studies FGF or FGF
inhibitors were added at late stages of differentiation, a time point at which the cells have
already initiated the neural program (Zhang et al., 2001; LaVaute et al., 2009; Yoo et al.,
2011). This suggests that FGF signaling does not directly promote neural induction in
these experiments, but rather has a proliferative role for the early neuroepithelium. In
support of this idea, exogenous FGF increases the size of neural colonies without changing
the efficiency of neural induction (Pankratz et al., 2007). Indeed, it has since been shown
that FGF signaling directly inhibits induction of PAX6 in hESCs and prevents
neuroepithelial differentiation (Greber et al., 2011). This is in line with the inhibitory role
of FGF in neural induction of EpiSCs derived from mouse embryos (Greber et al., 2010).
Together, the available evidence suggests that FGF has no role in neural induction of
hESCs in the presence of TGFβ inhibitors. It is worth noting that FGF does play a role in
areal specification of the neuroepithelium, as it does in vivo. For instance, FGF8 promotes
expression of anterior telencephalic areal TxFs in neuralized hESCs, while FGF2
upregulates expression of spinal cord markers (Patani et al., 2009; Chng et al., 2010; Lupo
et al., 2013).
More recent studies have shown that neuroectoderm generated by TGFβ inhibition in
hESCs/hIPSCs that can also recapitulate many aspects of corticogenesis, including human
specific aspects which will be discussed in sections below (Shi et al., 2012; Kadoshima et
al., 2013). The serum free embryoid body protocol involves aggregation of hESCs followed
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by inhibition of Activin/Nodal and WNT (Kadoshima et al., 2013). WNT inhibitors in this
system serve to prevent mesendodermal and neural crest differentiation in the initial
phases, and subsequently block the effect of WNT‐like posteriorizing signals in the culture
medium.

Figure 1.10: Schematic of induction of anterior neural fate (dorsal telencephalic) in hESCs by a
“default mechanism”. Inhibition of TGFβ in the absence of other growth factors or morphogens is
sufficient to recapitulate the developmental trajectory uptil early neuroepithelium by blocking all
alternative fates.

In summary, work in hESCs provides the strongest evidence so far of the conservation of
molecular mechanisms underlying neural fate specification from Xenopus to humans and
conforms to the predictions of the default model (Figure 1.10).
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PATTERNING AND PROGENITOR DIVERSITY DURING MAMMALIAN CORTICOGENESIS
Neural tube closure and establishment of the telencephalic territory
In mammalian embryos, as in Xenopus, the origins of the CNS can be traced to
gastrulation, where the inhibitors released by the node and AVE coordinately induce the
earliest neuroectodermal cells in anterior part of the embryo that forms the neural plate.
These neuroectodermal cells possess epithelial characteristics and display an apical‐basal
polarity – hence they are referred to as neuroepithelium. As stated above, the first neural
specific TxF expressed by these cells differs between mice and NHPs: mouse
neuroepithelium expresses Sox1, while the NHP neuroepithelium expresses PAX6 (Zhang
et al., 2010). Under the influence of local signaling centers, the neuroepithelium
undergoes spatial patterning in the antero‐posterior (AP) axis; the anterior most part of
the neural plate will assume a forebrain (prosencephalon) identity, and subsequent
segments will be patterned into midbrain (mesencephalon), hindbrain and spinal cord
(together called rhombencephalon). The signals patterning the neural tube in the AP axis
include FGF8 for forebrain (originating in the anterior neural ridge), WNT3A for midbrain
(isthmic organizer), WNT3A and retinoic acid (RA) for hindbrain (arising in the isthmic
organizer and somitic mesoderm respectively), and WNT, FGF2 and RA (somitic
mesoderm) for the spinal cord (Murielle et al., 2002). At the end of neural tube closure
(E8.5 in the mouse, PCD22‐24 in human), the prosencephalon, mesencephalon, and
rhombencephalic segments each form visible brain vesicles. The walls of the forebrain
evaginate to generate the neural folds comprising the telencephalic (anterior) and
diencephalic (posterior) vesicles (at E9‐E10 in mouse, PCW5 in human) (Figure 1.11).
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Figure 1.11: Schematic of a PCW5 human fetal brain in sagittal section showing the major CNS
segments. The telencephalon and diencephalon together comprise the prosencephalon, while the
metencephalon and myelencephalon together comprise the rhombencephalon.

As the neural plate undergoes folding to generate the neural tube, the mediolateral axis
of the neural plate axis is converted into the dorsal‐ventral (D‐V) axis (Figure 1.12). The
leading edges of the neuroectoderm‐epithelial boundary from either end will fuse
together in the midline to form the roof plate dorsally. The roof plate becomes a source
of BMP signals to pattern the dorsal neural tube (Murielle et al., 2002). The floor plate
will form ventrally under the influence of Sonic Hedgehog (SHH) signaling from the
notochord (located below the neural plate) by homeotic induction; SHH secreted from
the floor plate will in turn pattern the ventral neural tube (Murielle et al., 2002). In the
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midbrain, hindbrain, and spinal cord, BMP signals will specify populations of ascending
interneurons dorsally; SHH will specify motor neurons ventrally. A population of
interneurons will also arise close to center, where both BMP and SHH gradients are low.
Hence, following DV specification the embryo will have strips of motor, intermediate, and
sensory neuron progenitors running parallel to the midline posteriorly from the midbrain.
In the forebrain however, BMP and SHH specify different populations. Dorsally, BMP
signaling in the midline (called cortical hem) will specify the choroid plexus (Hébert et al.,
2002; Fernandes et al., 2007). On the ventral side, gradients of SHH from the notochord
will establish a ventral territory and specify various classes of neurons depending on the
concentrations of SHH the progenitors are exposed to (Murielle et al., 2002). The entire
cortex is derived from the dorsal telencephalon, while the ventral telencephalon will give
rise to the striatum, the septal area and hypothalamus, as well as nearly all interneurons
in the cortex.
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Figure 1.12: Schematic of neural tube formation in a human embryo at A) 18 days, B) 20 days, C)
22 days, and D) 24 days post conception showing folding of the neural plate and neural tube
closure. Modified from Purves et al. (Purves, 2012).

Organization of the cerebral cortex
There are three different modules that comprise the cerebral cortex, named based on
their phylogenetic origins: the archicortex, paleocortex, and neocortex (Figure 1.13). The
archicortex is evolutionarily the most ancient structure of the cerebral cortex, while the
neocortex is the most recent and the largest contributor in the mammalian brain.
Histologically, both the archi‐ and paleo‐cortices are comprised of three to four discrete
layers of neurons, while the neocortex is comprised of six layers and is exclusively present
in mammals (Cheung et al., 2010). Two major neuronal types are found in these layers:
about 80% of the cells are pyramidal neurons, which are the primary processing unit of
the cortex, while the rest are interneurons. While there is an enormous diversity in the
types of pyramidal cells, they are all excitatory in nature, share glutamate as their primary
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neurotransmitter, and project over long distances either to other parts of the cortex or to
subcortical structures (Kumamoto and Hanashima, 2014).

Figure 1.13: The three modules of the cortex – the archicortex, paleocortex, and neocortex.
Modified from Purves et al. (Purves, 2012).

Unlike pyramidal cells, which arise locally in the dorsal telencephalon, interneurons are
generated in the ventral telencephalon and migrate tangentially into the dorsal
telencephalon. They are inhibitory in nature, secrete GABA (γ‐aminobutyric acid) as their
primary neurotransmitter, and are intimately associated with pyramidal neurons to
regulate their activity and influence local circuitry (Hansen et al., 2013; Ma et al., 2013).
Most interneurons in the cortex are generated in three areas of the fetal telencephalon,
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all located ventrally: the medial, lateral, caudal ganglionic eminences (Kepecs and Fishell,
2014). It has been proposed that interneurons may be formed dorsally specifically in the
NHP and human neocortex; however this remains the subject of debate as human cases
of ventral forebrain hypoplasia lack most major classes of interneurons in the cortex
(Fertuzinhos et al., 2009; Molnar and Butt, 2013; Whalley, 2013; Radonjic et al., 2014). A
specific type of interneuron, called Cajal‐Retzius (CR) cells are found exclusively during
development and are glutamatergic in nature, unlike other interneurons (Soriano and Del
Rio, 2005). CR cells are generated in three locations in the cortex: the cortical hem, the
septal area, and the pallial‐subpallial boundary, from which they migrate to Layer I of the
cortex. During corticogenesis, CR cells are essential for secretion of the extracellular
glycoprotein reelin, which enables migration of pyramidal neurons destined for the
superficial layers (Soriano and Del Rio, 2005).
The six layers of the neocortex are morphologically, molecularly, functionally, and
electrophysiologically distinguishable (Figure 1.14). It is believed that the hodological
properties of the laminae‐specific neurons are encoded in the progenitors that generate
them (Dehay et al., 2015). The subplate and cortical layer VI neurons connect the cortex
to the thalamus, hence their designation as corticothalamic projection neurons (CThPN).
Layer V consists of large pyramidal cells that connect the cortex to various subcortical
structures such as the spinal cord, brainstem, and striatum. They are henceforth referred
to as subcortical projection neurons (SCPNs). Layer IV contains stellate shaped neurons
and send projections within cortical structures and across the corpus callosum; it is the
largest recipient of thalamocortical afferents. Layers II‐III are comprised of small
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pyramidal neurons that mainly send projections intra‐cortically. Together, I will refer to
layers II‐IV henceforth as callosal projection neurons (CPN). Some neurons in layers II‐IV
do not send axonal tracts cross the corpus callosum but rather project into other areas of
the cortex ‐ hence they are also referred to as intracortical projection neurons.

Figure 1.14: Coronal section through an adult human brain showing the neocortex in dark brown.
The six layers of neocortex are shown on the left, together with relevant molecular markers
expressed in these layers. Markers shaded green (SATB2, CUX1/2, BRN2, MEF2C) are specific for
CPNs, red (CTIP2, FEZF2, ER81) for SCPNs, while blue (TBR1, ZFPM2, TLE4) are for CThPNs. The
typical projections of each of these classes of neurons is shown on the right. The markers labeled
in red, green, and blue are enriched in their respective layers. NCX: neocortex, WM: white matter,
BG: basal ganglia, SP: subplate, Thal: thalamus.

The progenitors underlying corticogenesis
Neuroepithelial cells generated during gastrulation initially form a pseudostratified
columnar epithelium. Following neural tube closure, they progressively become
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elongated and acquire bipolar projections, which are classical features of radial glial cells
(RGs; Figure 1.15) (Kriegstein and Alvarez‐Buylla, 2009). RGs have their cell bodies located
close to the ventricular cavity in an area called the ventricular zone (VZ). As the master
progenitors of the entire CNS (Anthony et al., 2004), they can divide both symmetrically
to generate two daughter RGs as well as asymmetrically to generate a daughter RG and a
migratory neuron (Noctor et al., 2004). The former mode of cell division predominates
immediately after neural tube closure, while the latter mode predominates during the
neurogenic phase of corticogenesis. Asymmetric cell division of RGs – and hence
neurogenesis ‐ occurs around E12.5 in mouse embryos (PCW6 in humans). RGs express
molecular markers of: 1) neural identity (such as PAX6, SOX2, PLZF, BLBP), 2) apico‐basal
polarity (e.g. ZO1, aPKC, PAR3/6, N‐CAD, prominin, β‐catenin), 3) Notch signaling (e.g.
CBF1, Notch1, Hes1/3/5), and 4) cortical and areal identity (e.g. FOXG1, LHX2, EMX1/2,
OTX2, NR2F1) (Figure 1.15). In addition to generating all the neurons in the nervous
system, they also give rise to all macroglia, such as astrocytes and oligodendrocytes at
later stages of corticogenesis (Kriegstein and Alvarez‐Buylla, 2009).
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Figure 1.15: Schematic of the progenitor compartments in the human fetal cortex at PCW14
showing the ventricular zone, inner and outer subventricular zone, and the cortical plate. The
superficial layer neurons have to migrate past the deep layer neurons in the cortical plate.

The Notch signaling pathway is essential for the maintenance of RG fate both at early later
stages of corticogenesis by inhibition of pro‐neural bHLH factors (Figure 1.16) (Lui et al.,
2011; Taverna et al., 2014). Indeed, all components of the Notch pathway are enriched in
RGs except for notch ligands, which are provided by their differentiating progeny.
Deletion of CBF1 (also known as RBPJ), a DNA binding cofactor of the Notch Intracellular
Domain (NICD) results in premature neurogenesis, exhaustion of the RG pool, and severe
thinning of the cortical wall (Imayoshi et al., 2010). Similar phenotypes are observed with
deletion of MIB1 (Mindbomb 1), an E3 ubiquitin ligase required for endocytosis of Notch
ligands in signal‐sending cells to promote NICD generation in signal receiving cells (Yoon
et al., 2008), or with triple knockout of the bHLH factors Hes1/3/5, all Notch effector
genes (Hatakeyama et al., 2004). Conversely, mouse mutants of Numb and Numblike –
which are asymmetrically inherited by RGC daughter cells and inhibit Notch signaling in
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one of the daughter cells – display striking defects in neuronal differentiation and laminar
formation (Li et al., 2003). This is accompanied by a sharp increase in RG proliferation and
a delayed cell cycle exit. Together, these studies firmly establish a requirement for Notch
in the maintenance of the early neuroepithelium and RGs (Lui et al., 2011), a role that is
conserved from Drosophila neuroblasts (Gaiano and Fishell, 2002). How Notch maintains
the cells in an RG state is less well understood. It is known that Notch represses proneural
bHLH genes such as Ascl1 and Neurog1/2 in RGs in an oscillatory manner (Imayoshi and
Kageyama, 2014). Current models propose that upon asymmetric division of RGs, Notch
signaling remains active in only of the daughter cells because of two factors. First, there
is an asymmetric inheritance of the basal process by one of the daughters, and with it,
the ability to respond to Notch ligands presented by differentiated cells in the SVZ.
Second, the unbound Numb is inherited by the non‐basal process bearing daughter cell.
Numb can functionally inhibit Notch and permit expression of the proneural bHLH factors,
thus allowing neuronal differentiation to proceed (Lui et al., 2011). However, in the
daughter cell that inherits the basal process, Numb is sequestered by the apical junctional
complexes and rendered inactive. This permits active Notch signaling and maintenance
of RG fate.
In addition to RGs, which lie in the VZ, there are two other proliferative cell types that
have been described in mammals: intermediate progenitor cells (IPs), and basal radial glia
(bRG). Both these progenitor types arise by asymmetric division of RGs and occupy a
compartment called the subventricular zone (SVZ) which lies above the VZ in the radial
plane (Figure 1.15). The SVZ is itself divided into inner and outer compartments, with IPs
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being the main cellular composition of the inner SVZ. The outer SVZ (OSVZ) has a much
more diverse composition of progenitors which include IPs, bRGs, and other transit
amplifying progenitors (Lui et al., 2011). The OSVZ is a prominent zone in carnivores and
has undergone massive expansion in NHPs relative to both the VZ and inner SVZ (Figure
1.17) (Reillo et al., 2011). There is a strong correlation between the size of the OSVZ and
the extent of gyrencephaly in the various mammalian species, suggesting that progenitor
expansion has a direct consequence on the cortical surface area and hence, cognitive
function.

Figure 1.16: The Notch signaling pathway.

Asymmetric division of RGs can generate neurons directly, but a large number of RGs also
generate neurons indirectly through IPs. IPs are found in all eutherians and are
characteristic feature of a six layered cortex. They are multipolar cells that lack both apical
and basal processes and are identified by their expression of TBR2 (also called EOMES)
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(Figure 1.15). This TxF is both necessary and sufficient to give rise to this cell type
(Sebastian et al., 2008; Sessa et al., 2008). IPs are thought to be transit amplifying
progenitors that contribute cells to all layers of the cortex (Vasistha et al., 2014), even
though originally they were believed to largely contribute to the superficial cortical layers
(Arnold et al., 2008). It is thought that up to two‐thirds of all pyramidal cells in the mouse
cortex arise indirectly from RGs via IPs (Vasistha et al., 2014). Consistent with this
observation, an artificial increase in the proliferative rate of the IPs in mice via
overexpression of cyclin D/CDK4 results in an increased thickness of a normal six layered
cortex (Nonaka‐Kinoshita et al., 2013). The importance of IP’s to human corticogenesis is
provided by the observation that TBR2 silencing on both alleles due to a balanced
translocation is associated with severe brain defects in children including microcephaly,
polymicrogyria, agenesis of the corpus callosum, mental disability, motor delay, and early
lethality (Baala et al., 2007). Recent studies also suggest that IPs also have an areal
identity, and that they relay the positional information of the VZ RGs to the cortical plate.
In Tbr2 knockout mice, the areal map of the SVZ is altered, and this is reflected in cortical
plate arealization (Elsen et al., 2013).
Unlike RGs, IPs are exclusively neurogenic (Ken‐ichi et al., 2007) and also provide Notch
ligands (such as Dll) for the maintenance of RGs and presumably bRGs (Campos et al.,
2001; Ken‐ichi et al., 2007; Yoon et al., 2008). The behavior of IPs differs between mice
and NHPs, as mouse IPs mostly undergo terminal symmetric differentiation into neurons,
while NHP IPs have the potential to asymmetrically self‐renew for a few divisions prior to
terminal neuronal differentiation (Kriegstein et al., 2006; Lui et al., 2011; Betizeau et al.,
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2013). This property contributes to the overall theme of progenitor amplification in the
NHP cortex and allows for the increase in the size, number, and diversity of neurons in
the neocortex. IPs have been shown to require thyroid hormone for self‐renewal that act
via αvβ3 integrin receptors (Denise et al., 2014).
The third progenitor type, bRG cells, have been described only recently (Figure 1.15) (Fietz
et al., 2010; Hansen et al., 2010). bRGs are found in most mammalian species studied,
though they are present in significant numbers only in species with a prominent OSVZ
(Reillo et al., 2011). bRGs are the predominant progenitor during mid‐ to late‐
corticogenesis in NHPs and humans (Hansen et al., 2011; Marion et al., 2013). They share
most characteristics of RGs, including marker expression, reliance on notch signaling for
self‐renewal, ability to divide both symmetrically and asymmetrically, as well as the ability
to give rise to IPs neurons (Lui et al., 2011; Elena et al., 2013; Borrell and Gotz, 2014; Sun
and Hevner, 2014). bRGs differ from RGs in three ways: first, they do not contact the
ventricular surface and only possess a basal process; second, they are located in the OSVZ
rather than the VZ; and third, they appear much later in development compared to RGs,
about PCW12 in humans. Since bRG cells do not contact the ventricles, they do not
express markers of apico‐basal polarity (Fietz et al., 2010). Though initially thought to be
specific to gyrencephalic species due to the enormous expansion of the OSVZ in this
group, it is now known that lissencephalic NHPs such as marmosets and rodents also
possess bRGs that divide infrequently (Garcia‐Moreno et al., 2012; Hevner and Haydar,
2012; Kelava et al., 2012). Intriguingly, an artificial localized increase in the number of
bRGs in mice – which normally only have rare bRG cells – by gene knockdown of a DNA
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binding protein TRNP1 results in localized gyrification of a normally smooth cortex (Stahl
et al., 2013). Furthermore, overexpression of cyclin D/CDK4 in the OSVZ of ferrets – which
are gyrencephalic species – results in an increased surface area of the cortex accompanied
by additional cortical folds (Nonaka‐Kinoshita et al., 2013). However, this treatment does
not induce folding in mice despite increasing the cortical thickness and marginally
increasing the cortical surface area. Hence, it is the frequency of bRG cells (and other
basal progenitors) as well as their cell cycle characteristics (such as a shortened G1‐phase
as discussed below) rather than their presence per se that contributes to gyrencephaly.
Regardless, bRGs are well positioned to contribute to the increasing diversity and number
of CPNs over evolution due to their appearance during the developmental timeframe of
this neuronal class. Together with their suspected role in gyrencephaly, it is likely that
their presence has contributed to improved cognitive abilities in humans, itself thought
to be due to expansion of the superficial cortical layers (Figure 1.16) (Hill and Walsh, 2005;
Lui et al., 2011; Reillo et al., 2011; Dehay et al., 2015).
Other progenitors have also been reported in the VZ and SVZ of mammals (such as
subapical progenitors and short neural precursors) (Pilz et al., 2013) but it is unclear if
they are bonafide class of progenitors or an intermediate state of transition between RGs
to IPs or between various bRGs (Betizeau et al., 2013; Greig et al., 2013). With this
introduction of the various progenitors populating the developing brain, I will now turn
to our current understanding of the establishment of cortical layers during corticogenesis.

52

Figure 1.17: Primate specific aspects of corticogenesis. A) There is a progressive increase in the
relative thickness of the superficial cortical layers (that contain CPNs) during mammalian
evolution. B) This increase is manifested during development as an increase in size of OSVZ, the
major site of neurogenesis of superficial layers. C) Nissl stained cross‐sections of the cerebral
cortex from different species at identical developmental stages showing an increase in OSVZ
thickness from mouse to humans. Panel A adapted from (Hutsler et al., 2005), panels B and C
adapted from (Reillo et al., 2011). Scale bars: 100μm.
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Establishment of the six‐layers during corticogenesis
From classic birth‐dating studies in NHPs, it is known that the neocortex is generated in
an inside‐out manner, with waves of neuronal migration from the proliferative zone into
the cortical plate to form layers VI, V, IV, and II‐III, in that order (Figure 1.18) (Pasko, 1974).
This mass migration splits the early cortical plate (called preplate) into subplate and Layer
I neurons, which will have an important role later in migration, axonal pathfinding, and
synaptogenesis of neurons in the other layers (Kwan et al., 2012). The inside‐out manner
of neuronal generation has been shown to be conserved in all mammalian species studied
including mice, ferrets, and NHPs (Angevine and Sidman, 1961; Pasko, 1974; Jackson et
al., 1989), though the timing varies considerably between species (Figure 1.19). Hence,
CThPN are formed first (along with Layer I CR cells), followed by SCPNs, while CPNs are
formed last. In reeler mutant mice, there is a severe disorganization of the normally
continuous laminae and a complete inversion of the layers in some areas (Boyle et al.,
2011). The reeler phenotype is due to a mutation in reelin, a large glycoprotein involved
in migration of superficial neurons (mostly CPNs) through its interaction with three
receptors: ApoER2, VLDLR and EphrinB (Bouche et al., 2013). This mouse mutant
highlights the importance of Layer I CR cells in establishing the laminar pattern observed
in the neocortex and provides strong evidence that the connectivity of all classes of
cortical projection neurons is dependent on their birth date rather than their final position
in the cortical plate. Thus, the molecular identity of projection neurons and their neuronal
connectivity is determined by the intrinsic properties of the neurons and their progenitors
rather than their position in the cortical plate (Rakic, 1988; Han and Sestan, 2013).

54

Figure 1.18: Inside‐out pattern of neuronal migration in a developing NHP cortex. The proliferating
cells were labeled with tritiated [3H] thymidine and the label retaining cells followed in the
postnatal cortex (3 months). Image adapted from Purves et al. (Purves, 2012); original experiment
detailed in (Pasko, 1974).

During the course of development, the symmetric and asymmetric cell divisions of a given
RG form a clonal proliferative unit. The daughter neurons resulting from the asymmetric
divisions migrate towards the cortical plate using the parental RG as scaffolding, and
maintain a spatial register with it throughout (Torii et al., 2009). Collectively, the clonal
proliferative unit and the daughter neurons stacked above them form an ontogenetic
column. This is principle idea behind the Radial Unit hypothesis originally proposed by
Rakic (Rakic, 1988). Daughter neurons from the same parental RGs are more likely to form
functional electrical connections with each other, and are functionally similar (Li et al.,
2012; Yu et al., 2012). Thus the neocortex can be viewed as a parallel array of overlapping
ontogenetic columns, with the number of symmetric proliferative divisions of parental
RGs in these columns determining the size of a cytoarchitectonic area. On the other hand,
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the number of asymmetric divisions underwent by RGs (and their daughter progenitors)
determines the thickness of the cortex in a given area. These columns are then refined on
the basis of incoming cortical inputs from subcortical structures such as the thalamus as
discussed below. In the adult cortex, the ontogenetic columns of development are
represented as cortical columns, which are the basic computational unit of the cerebral
cortex.

Figure 1.19: The timing of corticogenesis in mice and NHPs. In mice, corticogenesis takes place
over a 5 day period, while in NHPs, it takes about 50 days. The peaks of corticogenesis are an
approximate and the rate of birth is not shown to scale. Modified from Rakic and Greig et al.
(Rakic, 1974; Greig et al., 2013).

While there is strong experimental support of the Radial Unit model, recent findings have
mandated several revisions to it. First, most interneurons – which are also essential
contributors to the cortical columns, arise in the ventral telencephalon and migrate
tangentially to populate the various layers in these columns. Second, in NHPs there is an
expanded proliferative compartment of progenitors derived from RGs, which are the
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predominant contributors to the superficial cortical layers. Due to the presence of this
compartment, there is a logarithmic amplification of neurons in an ontogenetic column,
resulting in a lateral expansion of the area occupied by RG clones from the ventricular to
the pial surface. Hence, in NHPs the ontogenetic column is shaped like an inverted cone,
with the apex at the ventricular surface and the cortical layers forming the base. In mice,
the columns are more cylindrical due to the absence of this secondary proliferative zone
(Lui et al., 2011; Taverna et al., 2014).
It has been shown that formation of a six‐layered cortex in mice requires the presence of
two TxFs in particular: FOXG1 and LHX2. In the absence of either factor, the neocortex
fails to be specified and is replaced either by archicortex (FOXG1) or by paleocortex (LHX2)
(Molyneaux et al., 2007; Kumamoto and Hanashima, 2014). While LHX2 is only required
in the early stages of neocortical specification, the requirement for FOXG1 continues even
during corticogenesis, where it represses CR cell fate, sets the schedule of corticogenesis,
and coordinates neuronal migration (Hanashima et al., 2004; Chou et al., 2009; Miyoshi
and Fishell, 2012; Toma et al., 2014). BMPs and FGF8 are known to modulate FOXG1 levels
after neural tube closure and formation of the telencephalon. However, the signaling
pathway(s) that modulate FOXG1 and LHX2 at earlier stages of development are currently
unknown. Since the requirement for TGFβ inhibition in cortical development is conserved
in vertebrates, and among this group, only mammals have a six‐layered cortex, such a
pathway would be a candidate selector pathway for archicortical versus neocortical fate
specification downstream of TGFβ inhibition. It should be noted that both LHX2 and
FOXG1 are involved in telencephalic development in vertebrates that lack a six‐layered
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cortex, so it is likely that they have evolved a new function in the mammalian dorsal
telencephalon (Hardcastle and Papalopulu, 2000; Hideki et al., 2005).

Areal specification of the neocortex
In addition to the laminar patterning in the radial axis described above, the neocortex also
undergoes areal patterning in the rostro‐caudal and M‐L axis, which will enable
subdivisions of the cortex into functional regions such as motor, sensory, auditory, etc.
Each area in turn displays differences in gene expression patterns, connectivity, and
functionality (O'Leary et al., 2007; Sansom and Livesey, 2009). Whether a neuron ends up
in the frontal or the occipital cortex is predetermined by the location of its VZ precursor
in the telencephalic neural tube (Figure 1.19). This is the basis for the “Protomap
Hypothesis” (Rakic, 1988). The implication this model is that the areal blueprint of the
cortex is established before the commencement of corticogenesis in response to signaling
centers that pattern the progenitors rather than the post‐mitotic neurons. Several studies
have subsequently lent support to this model (O'Leary et al., 2007; Sansom and Livesey,
2009). The positional protomap contained within RGs is transmitted to the daughter
neurons through IPs (Elsen et al., 2013). Later during corticogenesis, once the various
layers have been populated with neurons, extrinsic influences such as those from the
thalamus refine the molecular regionalization. This forms the foundation of the
“Protocortex theory” (O'Leary, 1989). It is now appreciated that the two theories operate
in developmental continuum, with signaling centers establishing the protomap and
thalamocortical afferents refining this map and enabling molecular and functional sub‐
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regionalization (Lopez‐Bendito and Molnar, 2003; Dehay and Kennedy, 2007; O'Leary et
al., 2007).

Figure 1.20: Schematic of TxF gradients thought to underlie rostrocaudal areal patterning in the
cortex. A) SP, FOXG1, and FGF8 are enriched rostrally, while NR2F1 (COUP‐TF1), EMX2 and DMRT3
are enriched caudally. Gradients of signaling establish TxF gradients with FGF8 acting as a
rostralizing morphogen. The identity of the caudalizing morphogen has not been established,
although BMPs and WNTs are candidates expressed in this region, B) The rostral and caudal TxFs
and their morphogens form a cross‐repressive regulatory network to maintain areal identity.

The expression gradients of various TxFs demarcate the embryonic areal ‘protomaps’.
These TxFs include PAX6, EMX2, FOXG1, NR2F1, and SP8 (Figure 1.20). The former three
are enriched rostrally, while EMX2 and NR2F1 are enriched caudally. Conditional loss‐ and
gain‐ of function studies have demonstrated that EMX2 specifies caudal areal identity in
a concentration dependent manner while NR2F1 predominantly represses rostral fate
(Sansom and Livesey, 2009). Conversely, SP8 specifies identities associated with rostral
areas. Together, these TxFs impose an areal blueprint by cross‐regulation of each other
and of signaling molecules (Figure 1.20). Therefore, a given neocortical region is not
defined by the expression of a single gene but rather by a set of genes operating at
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different levels of activity (O'Leary et al., 2007). It is worth noting that our knowledge of
areal patterning is based on studies in mice and there are some notable differences that
have been observed in human fetuses. So while gradient patterns of NR2F1 and EMX2
can be demonstrated, PAX6 does not appear to have a gradient (Bayatti et al., 2008; Ip et
al., 2010). Recent studies have shown enrichment of FGFR3 in the caudal cortex of the
human fetal brain; this appears to be conserved from mice (Miller et al., 2014).
The signaling factors proposed to be involved in areal patterning include a) FGF8/15 from
the anterior neural ridge, b) BMPs and WNTs from the cortical hem and lateral ridges, and
c) SFRP2 (a Wnt antagonist) and neuroregulins from the antihem. Of these, only FGF8 has
been shown to be a true determinant of areal patterning; evidence for other pathways is
currently lacking. In utero electroporation of FGF8 greatly expands the rostral cortical
boundary (Fukuchi‐Shimogori and Grove, 2001). Strikingly, an ectopic source of FGF8 in
the caudal cortex results in partial duplication of the somatosensory cortex, which
normally lies in the frontal lobe. This supports an instructive role for FGF8 in rostral fate.
Conversely, mice which are hypomorphic for FGF8 (i.e. express FGF8 at low levels) have
an enlarged caudal cortex at the expense of the rostral cortex (Garel et al., 2003);
overexpression of soluble dominant negative FGFR3C (which inhibits FGF8 signaling) has
a similar effect (Thomson et al., 2009). FGF8 promotes the expression of rostral TxF (SP8
and FOXG1) while simultaneously repressing EMX2 and NR2F1 (Figure 1.20) (O'Leary et
al., 2007; Hebert and Fishell, 2008; Sansom and Livesey, 2009).
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Figure 1.21: Schematic of a PCW5 human fetal brain in the sagittal section. The rostral and caudal
cortex represent two different domains, and the signaling responsible to establishing caudal
cortical identity has not been identified yet.

Apart from FGF signaling, it is not known if any other signaling pathways can affect TxF
gradients to a similar extent or if there are any pathways acting upstream of FGF. While
both BMPs and WNTs can regulate EMX2 expression, whether they affect areal patterning
more globally remains to be determined (Theil et al., 2002). Importantly, genetic and
lineage‐tracing analyses suggest that the rostral and caudal cortical domains established
by the signaling pathways have distinct fates (Kimura et al., 2005). While the rostral cortex
is confined to a neocortical fate, the caudal cortex can contribute to the caudal neocortex,
hippocampus (archicortex) as well as cortical hem, choroid plexus and thalamic structures
(Figure 1.21) (Kimura et al., 2005; Kumamoto and Hanashima, 2014). The implication here
is that a signaling pathway that modulates areal patterning of the cortex – specifically of
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the caudal cortex – can also modulate selector activity between archicortex and
neocortex as discussed in the previous section.

Figure 1.22: The relative sizes and extent of gyrencephaly observed in various eutherian mammals.
Modified from Javier, 2011 (Defelipe, 2011). Scale bar: 5cm.

Primate specific aspects of neocortical development
Concurrent with the massive enlargement of the neocortex in NHPs (Figure 1.22), several
NHP‐specific adaptions can be observed during development (Geschwind and Rakic,
2013). These include an expansion of the OSVZ progenitor compartment to enable
increased production of the superficial layer neurons, as mentioned in the previous
section (Lui et al., 2011). Quantitatively, humans have a 1000‐fold increase in the number
of neurons compared to mice, however it takes only 20‐fold the amount of time to
generate these neurons (Geschwind and Rakic, 2013). This is achieved by multiple
developmental adaptations: 1) an increase in the fraction of symmetric cell divisions in
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the various progenitor compartments described above, 2) an increase in the total number
of asymmetric cell divisions individual progenitors can undergo, and 3) a prolonged (3‐4X)
cell cycle followed by acceleration during genesis of the superficial layers (Figure 1.23)
(Kornack and Rakic, 1998; Hill and Walsh, 2005; Lui et al., 2011). It is estimated that while
mouse cortical progenitors undergo about 11 cell divisions, NHP cortical progenitors
undergo about 28 ‐ in humans this number is probably still higher (Hill and Walsh, 2005).
Moreover, within a NHP brain, relative differences in progenitor proliferation underlie
parcellation of specific brain areas as postulated by the protomap hypothesis
(Lukaszewicz et al., 2005; Geschwind and Rakic, 2013).
Given the essential role of the cell cycle during evolutionary expansion and corticogenesis,
not surprisingly, many NHP specific adaptations target the cell cycle related organelles or
genes (Bae et al., 2015). For instance, several human‐specific amino acid substitutions are
found in genes that are targeted to the mitotic spindle or the kinetochore and present in
the human mid‐fetal germinal zones (e.g. CASC5, KIF18A, SPAG5). Additionally, the
evolution of two centromere‐specific genes, ASPM and CDK5RAP2, is strongly correlated
with brain size. More recently, it was shown that a hominid‐specific gene ARHGAP11B is
enriched in human RGs and bRGs compared to mice (Florio et al., 2015). This gene arose
after divergence from chimpanzees by gene duplication of a conserved gene
(ARHGAP11A), and when overexpressed in mice, it increases the size of the SVZ by
promoting symmetric differentiation of RGs into basal progenitors such as IPs and bRGs.
Remarkably, overexpression of ARHGAP11B can induce gyrification of the normally
lissencephalic mouse cortex in a fraction of injected mice.
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Mutations in many genes that result in severe brain disorders in humans do not have a
severe phenotype when introduced in mice, suggesting human‐specific requirements of
such genes (Geschwind and Rakic, 2013; Bae et al., 2015). The NHP genome also has about
100 novel microRNAs, many of which are enriched in the OSVZ and target several cell
cycle and differentiation genes (Dehay et al., 2015). These genes – while more ancient
than the microRNAs– have also co‐evolved with their target miRNAs allowing them to
exert a regulatory influence over proliferation (Arcila et al., 2014).
In addition to changes to the coding region of the genome, recent studies also emphasize
the role of noncoding regions during evolutionary expansion and corticogenesis (Bae et
al., 2015). In many cases, these changes lie in enhancer regions that influence the
expression of genes directly or indirectly involved in progenitor cell cycle. Indeed, the
human genome has a large number of enhancers that serve as developmental enhancers
during corticogenesis, and which have no known homologues in mice (Capra et al., 2013).
For instance, an enhancer of FZD8 – a WNT receptor – lies in a human accelerated region
(HAR) of the genome and targets expression of FZD8 to the neocortex. Compared to the
corresponding chimpanzee enhancer, the human FZD8‐HAR enhancer can drive robust
expression of reporters and FZD8 in the mouse neocortex. Intriguingly, expression of FZD8
in the mouse neocortex driven by the human, but not chimp HAR enhancer can accelerate
RG cell cycle reentry and increase neocortical size (Boyd et al., 2015). Other studies have
shown expression of a long non‐coding RNA from a HAR specifically in CR cells specifically
during development (Pollard et al., 2006). Since CR cells play important roles in migration
and placement of neurons as discussed above, it is possible that noncoding HARs exert
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influence on laminae and circuit formation. Human‐specific noncoding promoter regions
have also been shown to play a role in corticogenesis. For instance, several human genes
display multiple promoters (Bae et al., 2015). One such gene, GPR56, encodes a receptor
that binds to extracellular matrix proteins and regulates progenitor proliferation. There
are 17 alternative promoters for GPR56 in humans compared to 5 in mice. A human‐
specific promoter enables GPR56 expression specifically in the perisylvian sulcus, the area
of the brain involved in language and vocalization. Patients with mutations in this
promoter region develop perisylvian polymicrogyria associated with language difficulties
and intellectual disability, presumably due to impaired progenitor proliferation in this
area (Bae et al., 2014).
Strong transcriptional differences are also observed across cortical areas between mice,
NHPs, and humans at equivalent stages of development (Geschwind and Rakic, 2013;
Miller et al., 2014; Bae et al., 2015). These differences are enriched in the progenitor and
laminar compartments and are attributable to gene expression patterns and/or multiple
splice variants. For instance, human RGs – but not mouse RGs – express the ligand PDGFD
and its cognate receptor PDGFRβ; together they promote proliferation and cell cycle
progression of human RGs in slice cultures (Lui et al., 2014). Another example of species‐
specific expression are certain TxFs (TFAP2C, FOS and EGR1) which are expressed in
human, but not mouse RGs during superficial layer corticogenesis (Pollen et al., 2014).
While the functions of these TxFs in human RGs are unknown, they are candidate Notch
targets and hence may also be involved in maintenance of progenitor fate and/or regulate
cell cycle. Another example is Trnp1, a DNA binding protein of unknown function that
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promotes symmetric RG self‐renewal in mice. Intriguingly, the human fetal cortex shows
regional differences in TRNP1 expression in the VZ, with low expression in areas
anticipating high gyrification such as the occipital cortex. Indeed, knockdown of Trnp1 in
mice promotes gyrification of the cortex by promoting the transition of RGs to bRGs (Stahl
et al., 2013). Thus in this instance, the dynamic changes in TRNP1 expression in human
fetal brains result in a predetermined pattern of cortical folding compared to mice, which
show high levels of expression during corticogenesis. Lastly, human SVZ (inner and outer)
displays high level of extracellular matrix components and cell adhesion molecules; this is
thought to contribute to the higher self‐renewal ability of human IPs compared to mouse
IPs as well as the self‐renewal of bRGs, which lack an apical process (Simone et al., 2012).
Together, these various genetic and cellular changes contribute to the increased number
of cytoarchitectonic areas, more types and numbers of neurons, increased diversity and
size of the subplate, as well as increased complexity of the frontal cortex, all of which
define human corticogenesis (Geschwind and Rakic, 2013). Importantly, this highlights
the differences between mouse and human corticogenesis and emphasizes the need to
study human corticogenesis in a relevant cellular and developmental context (Bae et al.,
2015). Due to the ethical considerations involving primate fetal research and the
limitations in availability of fetal tissue, embryonic stem cells can provide a useful
platform for modeling corticogenesis and serve as a hypothesis‐generating tool.
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Figure 1.23: Differences between rodent and primate corticogenesis at equivalent stages of
development. In mice, corticogenesis takes place over 6 days, while in monkeys it take places over
60 days. The OSVZ becomes the major site of neurogenesis in the monkey cortex after E65, while
the VZ declines over time. This is in contrast to mice, where VZ is the predominant site of
neurogenesis throughout. Multiple genetic and cell cycle differences between the two species are
thought to underlie this pattern of development as described in the text. CP: cortical plate, ISVZ:
inner subventricular zone, IZ: intermediate zone, MZ: marginal zone, OSVZ: outer subventricular
zone, SP: subplate, VZ: ventricular zone. Adapted from Dehay and Kennedy, 2007 (Dehay and
Kennedy, 2007). Scale bar: 100µm.
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THE CELLULAR BASIS OF CORTICAL LAYER FORMATION
The classical ‘Progressive Restriction’ model of corticogenesis
The earliest studies to determine the cellular basis of cortical layer formation were carried
out in mice using tritiated (3H) thymidine injections into pregnant mice followed by
autoradiography of the embryonic brain (Angevine and Sidman, 1961). The labeled
thymidine is incorporated into actively dividing cells, and retained in the daughter cells
upon asymmetric division that can be detected in the cortical plate. This established that
corticogenesis occurs in an inside‐out fashion as mentioned above. More detailed
experiments involving 3H‐thymidine injections into pregnant macaques at multiple
gestational time points followed by immunohistochemical detection in the postnatal
visual cortex have confirmed this principle in NHPs (Rakic, 1974).
More sophisticated lineage‐tracing analyses were subsequently carried out using
replication defective retroviruses expressing β‐galactosidase (a lineage tracer), which
labels only actively proliferating cells, in this case RGs (Luskin et al., 1988; Walsh and
Cepko, 1988; Reid et al., 1995). This work has demonstrated that the progeny of RGs
during early – but not late corticogenesis – are able to contribute to all layers of the
cortex; the later born neurons are restricted to a superficial laminar fate. This is referred
to as the “Progressive Restriction Model” (Figure 1.24A). Progressive restriction is also
supported by studies in transgenic and chimeric mice in which in only a fraction of RGs
express β‐gal (Tan and Breen, 1993; Soriano et al., 1995; Kuan et al., 1997; Tan et al.,
1998). In these mice, local dispersion of labeled neurons spanning the CP is observed, in
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addition to a separate origin and migratory route for interneurons. There are also other
lines of experimental evidence. For instance, transplantation of 3H‐thymidine labeled
early stage VZ progenitors from ferrets into early stage ferret VZ can form both superficial
and deep layer neurons, whereas transplantation into late stage VZ predominantly gives
rise to superficial layer neurons (McConnell, 1988; McConnell and Kaznowski, 1991). Late
stage progenitors however, are only able to contribute to superficial layer neurons, both
in the early or late transplants (McConnell and Kaznowski, 1991; Frantz and McConnell,
1996).
Other groups have followed the fate of clonal lineages generated by individual
progenitors in vitro (Shen et al., 2006). Using molecular markers to stain for cortical layers,
the timing of deep versus superficial layer neurogenesis was determined to be an
intrinsically determined property i.e. the progenitors become more restricted in their
ability to generate various layers over time. Thus while early stage progenitors could give
rise to neurons expressing markers of various layers, late stage progenitors were more
restricted in their potential. It is worth noting that there are major caveats to interpreting
this study. First, the authors consistently saw a large number of Layer I CR cells from the
individual progenitors. Since CR cells are formed from a different source as described
above, this suggests a contamination in their cultures from extra‐dorsal cortical sources.
Second, the neurons derived from these progenitors showed minimal differentiation into
superficial cortical neurons in their culture conditions, suggesting that the protocols
utilized were suboptimal. Third, the presence of both superficial and deep layer markers
in the same clonally derived lineage was not actually demonstrated.

70

Further support for the progressive restriction model comes from Cre recombinase based
lineage‐tracing studies, which allow for fate mapping of progenitors without experimental
manipulation of the embryo. The method involves expression of the bacterial enzyme Cre
recombinase expressed from a tissue‐specific gene locus, which itself is either
endogenous or part of a bacterial artificial chromosome. When crossed to reporter mice,
Cre can recognize loxP sites that are positioned around a fluorescent protein reporter to
make it conditionally dependent on Cre for its expression. By adding an estrogen receptor
domain (ERT2) to Cre, the activity of Cre can be controlled with a small molecule agonist
or ERT2, tamoxifen. Hence fate mapping during embryogenesis can be controlled both
spatially (via a tissue‐specific promoter) as well as temporally (via ER and tamoxifen
administration).
Using this strategy, Chao et al. labeled the progeny of cells expressing the TxF Fezf2 at
various time points during development (Guo et al., 2013). Fezf2 is expressed in the VZ
starting at E8.5 and is maintained only during corticogenesis of deep layers, after which it
cannot be detected (Hirata et al., 2004). Congruently, its expression is maintained in post‐
mitotic neurons of the deep layers, but not in superficial layer neurons. It has been
proposed that Fezf2 may mark deep layer restricted progenitors during corticogenesis
(Greig et al., 2013). When crossed to reporter mice, early induction of Fezf2‐CreERT2
(E12.5) resulted in reporter expression in neurons in multiple layers as well as glial cells,
suggesting that Fezf2 is not predominantly expressed in lineage‐restricted cells.
Moreover, later induction of Fezf2 (E14.5) could also label neurons in the superficial layers
(together with glia), even though Fezf2 is below the detection threshold at the mRNA level
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at later stages. Clonal analysis of the fate‐mapped cells by low dose tamoxifen induction
strongly suggested progressive restriction of progenitors. Lastly, the authors fate‐mapped
RGs expressing the TxF Cux2 (see below) and showed that the majority of lineage traced
neurons contributed to both superficial and deep layers and expressed markers
representative of both at P0.
More recently, Gao et al. utilized MADM (Mosaic Analysis of Double Markers) to fate map
rare individual progenitors in the Emx1 lineage and carried out clonal analysis of the
progeny (Gao et al., 2014). Emx1 is a TxF that is specifically expressed in the dorsal
neocortical progenitors that will give rise to glutamatergic neurons starting at E8.5. The
study of Gao et al. shows that the vast majority of single progenitors labeled in the G2
phase of the cell cycle from E11.5‐E13.5 give rise to progeny that contribute to all layers
of the cortex at P21 and express markers appropriate for CPNs and SCPNs. Progenitors
labeled at later stages (E15.5) are restricted in their potential and can only contribute to
the superficial layers, consistent with progenitor restriction. Moreover, a significant
fraction of individual RGs (1 in 6) also give rise to astrocytes, establishing them as truly
multipotent. Importantly, the authors did not observe any clones containing only glial
cells, suggesting that in the Emx1+ lineage, glial cells and neurons share parental
progenitors. Finally, through a series of elegant modeling experiments, they have also
demonstrated that the neuronal output of RGs is very deterministic, with each RG
contributing to about 8 neurons prior to terminal cell division.
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Figure 1.24: The two models of cortical layer formation in mammals: A) Progressive Restriction
Model. B) Multiple Progenitors Model. The color code of the progenitors is meant to highlight the
differences in the two models.

The Multiple Progenitor model of corticogenesis
More recently, an alternative model of cortical layer generation has been proposed.
Known as the “Multiple Progenitor” model, it postulates the existence of lineage
restricted progenitors that are predestined to give rise to only one lineage or a set of
related lineages (Figure 1.24B) (Franco et al., 2012; Franco and Müller, 2013). Hence
according to this model, an early multipotent progenitor diverges into separate
progenitors for CPNs, SCPNs, CThPNs, and possibly glial cells at an early stage of
corticogenesis. The model also allows for nested lineages so that multipotent and fate
restricted can coexist in the same compartment, but are lineally related (Greig et al.,
2013; Costa and Muller, 2014). Direct experimental evidence for this model relies largely
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on fate mapping based on one TxF – Cux2 (also known as Cutl2) – in RGs. Cux2 is known
to be the most specifically expressed gene in superficial layer neurons (CPNs) in mice,
monkeys, and humans (Céline et al., 2004; Nieto et al., 2004; Arion et al., 2007; Bernard
et al., 2012; Zeng et al., 2012). Studies in mice have shown that Cux2 is also enriched in
the SVZ, where it is co‐expressed in IPs thought to give rise to the superficial layer neurons
(Céline et al., 2004; Nieto et al., 2004). However, migrating interneurons also express
Cux2 and make up a large contingent of Cux2+ cells in the mouse SVZ (Guo et al., 2013).
Notwithstanding the non‐pyramidal expression of Cux2, Franco et al. demonstrated using
an array of genetic tools that Cux2 can be used to lineage trace a fraction of RGs at E10.5
in the mouse, before corticogenesis has commenced (Franco et al., 2012). Remarkably,
these RGs give rise to daughter neurons that are restricted in their potential to CPNs
expressing Satb2, which is a necessary and sufficient TxF to generate this population of
neurons. Intriguingly, the minority of Cux2‐lineage traced pyramidal cells that settled in
the deeper layers also express Satb2, suggesting that the Cux2+ RG lineage is already
committed to a CPN fate as early at E10.5. Enforced cell cycle exit of the Cux2+ RGs does
not change their fate and they still take on a CPN fate, albeit prematurely. Moreover,
Cux2+ RGs mostly divide symmetrically during formation of the deep layer neurons (SCPN
and CThPNs), and only during later stages coinciding with superficial layer corticogenesis
do they divide asymmetrically. Hence, according to the Multiple Progenitor model, the
progenitors destined to give rise to superficial and deep layers are already fundamentally
different at the earliest stages of corticogenesis in terms of their relative frequency, mode
of cell division, and neuronal fate. The Cux2+ RGs do however seem to share the
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requirement for Notch and WNT/β‐catenin signaling for self‐renewal with non‐lineage
traced RGs.
Previous studies that support progenitor restriction model can also be reinterpreted to
support the multiple progenitor model (Franco and Muller, 2013; Greig et al., 2013; Han
and Sestan, 2013). For instance, in addition to showing neuronal progeny populating
multiple layers, retroviral lineage tracing also reveals a large number of clones that exist
in a restricted laminar distribution. This suggests the presence of lineage restriction in
some fraction of labeled progenitors. Furthermore, the transplantation of early stage
progenitors could potentially contain a mixture of lineage‐restricted cells that respond to
temporally restricted cues for differentiation. Hence the deep layer specified progenitors
only differentiate into deep layer neurons when transplanted at an early stage; at this
time the transplanted superficial layer progenitors are largely proliferative. The latter can
only respond to the differentiation signals at an advanced stage of corticogenesis.
Transplantation of late stage progenitors into the cortex only gives rise to superficial layer
neurons only in a stage appropriate manner, because the deep layer progenitors have
been depleted by then.
The strongest support of the Progressive Restriction model to date comes from the
studies of Gao et al. (Gao et al., 2014) using the MADM strategy. MADM preferentially
labels dividing cells due to its dependence on recombination during the G2 phase, where
4n chromosomes are present. The authors used the CreERT2 system under the control of
the Emx1 promoter to induce recombination; thus, their fate mapping is dependent on
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the fidelity of the MADM strategy. It is conceivable that recombination of the MADM
alleles is biased towards a progenitor class that is slowly dividing i.e. spends more time in
the G2‐phase and has not yet transitioned to the fast dividing Cux2+ lineage restricted
radial glia. This might explain why the majority of the MADM labeled clones were found
in both the superficial and deep layers of the cortex. Support for this comes from the
observation that most RGs labeled with MADM give rise to 8‐9 neurons. This is in contrast
with lineage tracing studies of IPs (which are derived from RGs) using Tbr2‐Cre, which
show that the majority of IPs labeled at early stages give rise to 16 and above neurons
(Vasistha et al., 2014). Since a single RG can give rise to one or two IPs by asymmetric or
symmetric division respectively, the number of neurons generated by RGs comes out to
be higher when estimated with this strategy. Hence MADM might be labeling progenitors
in an unbiased manner and hence not detecting lineage‐restricted progenitors (Gil‐Sanz
et al., 2015).
The experiments of Guo et al. with Fezf2‐CreERT2 lineage tracing conclusively establish
that Fezf2 is not a good marker of the various lineage‐restricted progenitors, if they exist
(Guo et al., 2013). However, their assertion that the progeny of Cux2+ RGs contribute to
pyramidal neurons to all layers of the cortex has been called into question recently (Gil‐
Sanz et al., 2015) for two reasons. First, the Cux2‐Cre and Cux2‐CreERT2 mouse line used
by Guo et al. did not recapitulate the endogenous Cux2 mRNA expression faithfully
because of their breeding strategy, since the Cux2 locus seems to be strongly dependent
on the genetic background. Indeed, crossing these mice to outbred mice could recover
the original pattern of Cux2 expression seen by Franco et al. (Gil‐Sanz et al., 2015).
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Second, it is unclear if Guo et al. were analyzing the progeny of single clones (Gil‐Sanz et
al., 2015).
Due to the increased complexity of the NHP proliferative zone – from an increase in the
types and numbers of progenitors, to their distinctive behaviors, and the larger number
of CPN required – it remains an open possibility that the Multiple Progenitor model may
apply to NHP corticogenesis. Moreover, the inherent limitations of the techniques applied
so far in mouse models preclude a definitive conclusion on the validity of this model even
in mice. It is a common consensus that single cell studies of progenitors and their lineages
is required at the level of lineage‐tracing and RNA‐seq in order to definitively resolve
these issues (Costa and Muller, 2014; Bae et al., 2015).

The molecular basis of laminar patterning
An understanding of the molecular mechanism of how RGs switch from generation of
deep layers to superficial layers is lacking at present. Inhibition of β–catenin/WNT
signaling, RA signaling from the meninges and CSF to the RG end feet, and feedback
signaling of post‐mitotic neurons to the RGs via neurotrophins (NT3) have all been
suggested as possible mechanisms for progenitor restriction and the laminar switch
(Mutch et al., 2009; Siegenthaler et al., 2009; Lehtinen et al., 2011; Parthasarathy et al.,
2014). The extent to which these pathways play a role in promoting the restriction, the
nature of the underlying restriction itself, and whether these pathways are acting
downstream of a primary event remain unclear and are a subject of debate (Zhou et al.,

77

2006; Chatzi et al., 2011; Munji et al., 2011). Regardless of the model of corticogenesis
considered, there is considerable evidence for feedback signaling from the post‐mitotic
neurons to the RGs both in generation of subsequent cortical layers, as well as gliogenesis
from RGs (Barnabe‐Heider et al., 2005; Namihira et al., 2009; Seuntjens et al., 2009; Toma
et al., 2014).
Altering the G1‐length of the cell cycle of progenitors can also change the laminar fate of
neurons (Pilaz et al., 2009). An enforced reduction of the G1‐phase in mice by
overexpression of cyclins promotes cell‐cycle reentry of progenitors at the cost of
neuronal differentiation. This applies both VZ RGs and SVZ TBR2+ progenitors and results
in an overall increase in the size of the progenitor pool as well as an increase in the surface
area of the cortex, as is the case in primates. Interestingly, the delayed exit of progenitors
eventually leads to an increase in the number of neurons being generated at the new
birthdate, in this case superficial layer neurons. This would suggest that the laminar fate
of neurons is intrinsically encoded in RGs, as reducing the G1‐phase decreases the
timespan (and likelihood) of RGs and IPs to respond to external signals, if such signals
exist. Alternatively, external signals may be responsible for setting this intrinsic program
of laminar formation in the first place, but at a much earlier time during development.
The expansion of both progenitor pools upon Cyclin D/CDK4 overexpression and surface
area of the cortex has been reported by other groups as well (Lange et al., 2009).
Additionally, modulating the G1‐phase by overexpression of cyclin E or the cell cycle
inhibitor p27Kip1 can also alter the increase or decrease the rate of progenitor cell‐cycle
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reentry in primates, respectively (Lukaszewicz et al., 2005). Mathematical modeling
indicate that regional differences in the expression of such cell cycle modulators may
contribute to regulation of the size of the superficial layers between the different cortical
areas. Together, current studies suggest that a decrease in G1‐phase of progenitors, as is
observed at later stages in primates (Kornack and Rakic, 1998), promotes an expansion of
the superficial cortical layers and CPNs. The signal(s) that orchestrate a decrease in the
G1‐phase of primate progenitors are not known at present, although the ligand PDGFD
and its cognate receptor PDGFRβ, expressed specifically in human RGs, may contribute
(Lui et al., 2014).

PSCs AS MODELS FOR NEOCORTICAL INDUCTION AND PATTERNING
Most of our understanding of the molecular basis of corticogenesis comes from studies
in mice. However, many differences between human, NHP, and mouse corticogenesis are
already appreciated at the cellular, genetic, and clinical level, as described above. Due to
the genetic intractability of NHPs, ethical issues surrounding experimentation, as well as
limited availability of fetal tissue, there is a paucity of molecular studies in this system. To
study unique traits of the primate cortex, specifically homo sapiens cortex in terms of its
progenitors, developmental trajectory, diversity of neurons, and function requires a
detailed study in a relevant developmental and cellular context. As neural plate formation
starts at PCW3 and corticogenesis at PCW5‐6 in humans, direct studies in embryos are
prohibitive. However, as I will discuss in this section hPSCs have been used to model early
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human development and provide a viable alternative to study human‐specific features of
corticogenesis.
To what extent does the artificial nature of in vitro corticogenesis correspond to in vivo
development? A number of studies have established that PSCs respond to appropriate
signaling cues, follow the same developmental trajectories, and even faithfully
recapitulate organogenesis in three‐dimensions when provided with appropriate culture
conditions. As discussed above, the requirement for BMP inhibition for neuroepithelial
induction is conserved in vitro in mESCs from in vivo forebrain development (Bachiller et
al., 2000; Di‐Gregorio et al., 2007; Kamiya et al., 2011). Moreover, the temporal hierarchy
of development from PSC derived neural progenitors follows the in vivo tempo closely.
For instance, neuronal fate precedes astroglial fate specification in vivo (Kriegstein and
Alvarez‐Buylla, 2009). Similarly, neurons are generated before glial cells over the same
time period as embryonic development in vitro in both human and mouse PSCs (Gaspard
et al., 2008; Naka et al., 2008; Okada et al., 2008; Yichen et al., 2012). Similarly, in neural
progenitors derived from both mouse and human PSCs, the temporal emergence of
laminar neurons in vitro corresponds to their in vivo timing (Eiraku et al., 2008; Gaspard
et al., 2008; Shi et al., 2012; Taisuke et al., 2013). This also true for mouse and human
PSCs that have been caudalized to generate spinal cord progenitors (Wichterle et al.,
2002; Li et al., 2005) or ventralized to generate interneurons (Maroof et al., 2010; Maroof
et al., 2013; Nicholas et al., 2013). Cortical‐specified PSCs also mimic the molecular
progression of markers from progenitors to neurons. When grafted into the cerebral
cortex of newborn mice, they possess an area‐specific identity and can develop patterns
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of axonal projections and contribute to the local circuitry (Eiraku et al., 2008; Gaspard et
al., 2008). Furthermore, hESC‐derived cortical neurons and interneurons maintain their
intrinsic developmental and maturation programs, even when transplanted into mouse
brains (Espuny‐Camacho et al., 2013; Maroof et al., 2013; Nicholas et al., 2013).
Recently, human and mouse PSCs have also been shown to mimic in vivo nervous system
development in three dimensions. Provided the right environmental signals (such as TGFβ
inhibition) and extracellular matrix components, PSCs can self‐organize in vitro into
telencephalic, cerebellar, retinal, pituitary or otic placodes (Eiraku et al., 2011; Suga et al.,
2011; Nakano et al., 2012; Kadoshima et al., 2013; Koehler et al., 2013; Muguruma et al.,
2015). Strikingly, the hPSC‐derived cortical ‘embryoid bodies’ or ‘organoids’ also
demonstrate human‐specific characteristics of corticogenesis, such as the longer
timescale of development, the presence of bRGs at later stages, as well as features of
microcephaly when derived from patient IPSCs (Kadoshima et al., 2013; Lancaster et al.,
2013). The three‐dimensional cortex can also be patterned appropriately into different
cortical areas using known developmental cues (Eiraku et al., 2008; Kadoshima et al.,
2013). These observations suggest that the program for corticogenesis is intrinsically
encoded in the neural progenitors, from tissue‐level morphogenesis to patterning and
laminar formation. Indeed, these human‐specific features of corticogenesis are also
observed in two dimensional, monolayer cultures (Shi et al., 2012).
Together, these studies establish that hPSCs faithfully recapitulate in vivo development
spatially, temporally, and by extension, mechanistically. Hence, hPSCs can be used to
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generate specific predictions on the molecular aspects of laminar and areal specification
during corticogenesis. These predictions can be very meaningful if combined with
endpoint readouts in human fetal material.
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CHAPTER 2: MATERIALS AND METHODS
CELL CULTURE OF HUMAN EMBRYONIC STEM CELLS
The RUES1 and RUES2 hESCs lines were derived in our lab and have been described
previously (James et al., 2006; Lacoste et al., 2009). Both lines were maintained in feeder‐
free conditions on Matrigel‐coated dishes and cultured in conditioned medium (CM) or
mTESR (Stem Cell Technologies) with daily media changes. Whenever mTESR was used,
hESC cultures were adapted to the medium for at least 2‐3 passages prior to experiments.
For the preparation of CM, mitotically inactivated MEFs were seeded at a density of 1.0 ×
107 cells per 150 mm dish and incubated in HUESM for 24hrs. CM was collected and
supplemented with 20ng/mL bFGF prior to feeding the hESCs. For expansion, hESCs were
grown as colonies and enzymatically passaged with 1 mg/mL dispase by incubating at 37
for 7min. followed by three washes with DMEM/F12. In some instances, ReLeSR (Stem
Cell Technologies) was used for dissociation and passaging per manufacturer’s
instructions. The composition of HUESM and other media is given in Table 6.1.

NEURAL INDUCTION OF EGFP‐T2A‐SMAD7 CELLS
Clonal RUES1 TRE::EGFP‐T2A‐SMAD7 cells were generated as described in the section
below and maintained in CM like regular hESCs. Two to three days before the start of the
experiments, the cells were pre‐treated for 1hr with 10μM ROCK‐inhibitor (Y‐27632) and
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passaged as single cells with Accutase (Stem Cell Technologies). ROCK‐inhibitor strongly
diminishes dissociation‐induced apoptosis and increases cloning efficiency (Watanabe et
al., 2007). The cells were subsequently plated onto Matrigel‐coated wells at a density of
15,000‐30,000cells/cm2 in CM supplemented with ROCK‐inhibitor and hygromycin for
three days. At this point, the wells were >95% confluent and DOX (2μg/mL) was added to
the medium. This was considered Day 0 of induction. Media was replaced every day with
DOX for the duration of the experiment; DOX was excluded for the control wells. For the
MEK‐inhibitor experiments, the cells were seeded onto Matrigel‐coated wells as before,
and MEK‐inhibitor was added at various time points depending on the experiment. For
BMP4/TGFβ1‐challenge experiments, the cells were passaged in dispase and seeded as
colonies. Where applicable, the TGFβ inhibitor SB431542, the BMP inhibitor LDN193189,
and MEK‐inhibitor PD0325901 (Tocris) were used at concentrations of 10μM, 100nM and
1μM, respectively. BMP4 and TGFβ1 were used at concentrations of 50ng/ml and
25ng/ml, respectively. Media was replenished daily in all conditions.

NEURAL INDUCTION AND CORTICAL DIFFERENTIATION OF hESCs WITH SMALL
MOLECULE INHIBITORS
Before the start of the experiment, Matrigel was plated onto 12‐well plates or 10cm
dishes at a dilution of 1:35 in DMEM/F12 overnight. Human ESC lines were grown on
Matrigel with CM containing 20ng/mL bFGF. Once the colonies were to be passaged, they
were pre‐incubated in 10µM ROCK‐I for 1hr and incubated with Accutase (Stem Cell
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Technologies) at 37°C for 20min. Cells were triturated with a pipet to ensure single cells.
Accutase was diluted with 4X media and the cells were counted. About 50,000cells/cm2
were spun down and plated onto the Matrigel plates. Media was replaced every day with
CM/bFGF/ROCK‐I until the cells were confluent. At this point cells were washed with PBS
once and then 3N media with 10µM SB431542 and 100nM LDN193189 (SB/LDN
henceforth) was added per well/dish. This was considered Day 0 of differentiation.
SB/LDN media was changed every day for 12 days. The composition of 3N is provided in
Table 6.2.
On days 9‐10, cells with primitive neuroepithelial morphology (small nuclei, tightly
packed) become apparent. At this point, the neuroepithelium was passage onto laminin
(LAM) coated plates to form rosettes. On day 11, dispase was added directly to the
medium at 1:10 v/v, and cultures incubated for 3min. at 37°C. After three washes with
DMEM/F12 to get rid of excess dispase, media was replaced with SB/LDN and the
neuroepithelial sheets were gently broken into clumps by scraping with a 2mL pipette.
The clumps were seed onto LAM‐coated dishes at high density. The procedure for making
LAM‐coated plates is described below. Beyond day 15, media was replaced with 3N every
other day. Rosettes started appearing around day 16‐20. At this point, 20ng/mL FGF2 was
added for 4 days. Between days 24‐26, the rosette structures were dissociated with
Accutase at 37°C for 10min. Accutase was neutralized with 4X media and the cells
suspension spun down for 5min at 300g. Single cell suspension of neural progenitor cells
was ensured by incubating the pellet with DNAse I (200U/mL) for 15 min. at room
temperature and passing the cells through a cell strainer. Neural progenitors were then
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plated at a density of 200,000cells/cm2 onto polyornithine/laminin/collagen /fibronectin
(PLCF) dishes in 3N medium. From this point on, LAM was added to 3N media at a 1:500
dilution (final conc. 2µg/mL) at every other media change to prevent clumping and
detachment of neurons. Appearance of anterior neural markers was confirmed by
antibodies to PAX6, OTX2, SOX2, PLZF, TBR2, and FOXG1. The progenitors typically
differentiated into various cortical layers over several weeks and cultures became
predominantly neuronal around Day 35. Cultures were maintained for 90‐100 days. An
identical protocol was followed for monkey ESCs, except that the cells were passaged at
day 7 to form rosettes, and then at day 20 to form neurons.
For Bromodeoxyuridine (BrdU) incorporation studies, 10µg/mL of BrDU stock (BD
Biosciences; 1:1,000 dilution) was added to the culture medium for one day at days 45,
70, and 95.
PCLF coated plates were prepared as follows: poly‐ornithine (Sigma) was diluted in water
to 100µg/mL, added to the wells/dishes and incubated at 37°C for 4hrs. Following the
incubation, the solution was aspirated and the wells rinsed with distilled water twice. For
collagen coating, collagen I solution (advanced Biomatrix) was diluted 1:100 in PBS, added
to wells and incubated at 37°C for 2 hours. For LAM coating, laminin (Life Technologies)
was diluted in PBS to 20µg/mL (1:50) together with 2µg/mL Fibronectin, mixed thoroughly
and added to the wells/dish. The plates were incubated at 37°C overnight. The next day,
the solution was aspirated, and the plates washed with PBS once before use.
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Where required, the following small molecules and growth factors were used: IWP2
(2.5µM), Ascorbic acid (200µM), BDNF (10ng/mL), NT3 (10ng/mL), 4‐hydroxy tamoxifen
(2µM), CHIR99021 (0.5‐3µM), DAPT (20µM).

CELL CULTURE OF MOUSE AND MONKEY EMBRYONIC STEM CELLS
Two monkey ESC lines were used in this study: Macaca Nemestrina, and Macaca Mulatta.
They ESCs were cultured and passaged in CM + bFGF and maintained on Matrigel similar
to as described above for hESCs. For the mouse studies, two mouse ESC lines were used:
46C SOX1‐EGFP reporter (made by Austin Smith, kindly provided by Laura Grabel), and
SOX2‐EGFP V6 (kindly provided by Konrad Hochedlinger). Mouse ESCs were maintained
in defined medium in LIF + 2i conditions; the composition of the base medium is given in
Table 6.3. The two inhibitors in this cocktail (“2i”) are CHIR99021 (GSK3β inhibitor) and
PD0325901 (MEK inhibitor). LIF + 2i was used at the following concentrations: LIF,
1000U/mL, CHIR99021, 3μM and PD0325901, 10μM. The mESCs were plated on gelatin
coated plates made as follows: 0.1% gelatin solution (Millipore) was added to tissue
culture dishes for 20min. at room temperature, after which the gelatin was aspirated and
the plates allowed to dry for another 20min. Mouse ESCs were typically split every 5 days
with 0.25% trypsin (Life Technologies) added for 10min. and incubated at 37°C. After this
incubation, 10% fetal bovine serum (FBS) containing DMEM was added at 4X amount to
neutralize the trypsin. Typically, the cells were split at a ratio of 1:1,000 added directly to
LIF+2i medium without centrifugation.
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NEURAL INDUCTION OF MOUSE PSCs
For mouse ESCs, we modified existing protocols to convert them first into EpiSCs. Mouse
ESCs were seeded at high density (100,000 cells/cm2) on LAM‐ and fibronectin‐ coated
plates, made as described above. The next day, medium was switched to CM + 10ng/mL
bFGF + 2.5μM IWP2 for three days. At this point, the mESCs took on the flat, circular
morphology of hESC colonies. Like hESCs, EpiSCs rely on Activin and FGF (present in CM)
to self‐renew. EpiSC colonies were confirmed to express pluripotency markers such as
OCT4, SOX2, and NANOG. Neural differentiation was initiated with base medium +
SB/LDN at similar concentrations to that used for hESCs. This was considered day 0 of
induction. SB/LDN was maintained for three days, with media change only the first day.
Neural differentiation was monitored with the SOX1‐EGFP reporter line. EGFP was seen
within 4 days of induction and coincided with rosette formation. Subsequent
differentiation was carried out on PCLF plates by dissociating the rosettes with trypsin for
10min. at 37°C followed by neutralization with FBS containing medium. The cells were
plated in 3N medium at a density of 150,000cells/cm2. Media was changed every other
day henceforth. IWP2 was added for some experiments at a concentration of 0.5µM
between days 0‐5.
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CLONING AND MOLECULAR BIOLOGY
Plasmids for cloning as well as Gibson assembly were designed and archived in Lasergene
Seqbuilder (DNAStar). In all instances, PCR of inserts or backbone was carried out with Q5
polymerase (New England Biolabs) or GC‐rich PCR system (Roche). Typical parameters for
Q5 polymerase were: denaturation at 98°C for 1min., followed by 25‐35 cycles of
denaturation 98°C for 10s, annealing at 50‐72°C for 30s, and extension at 72°C for 30s/kb;
the final extension was at 72°C for 2min. For the GC‐rich PCR system, amplification was
carried out in two steps: in the first step, denaturation was carried out at 95°C for 3min.,
followed by 10 cycles of denaturation 95°C for 30s, annealing at 45‐65°C for 30s, and
extension at 72°C for 45s/kb. The second step comprised of 25 cycles of denaturation
95°C for 30s, annealing at 45‐65°C for 30s, and extension at 72°C for 45s/kb; the final
extension was at 72°C for 7min. The annealing temperature used for the GC‐rich PCR kit
was 3°C less than the lower melting temperature of the two primers, while for Q5
polymerase the annealing temperature was calculated using an online tool
(http://www.neb.com/). Betaine (1M) was added to Q5 polymerase kit in cases of GC‐rich
templates, while 0.5M resolution solution was used with the GC‐rich PCR system. Primers
were synthesized by Integrated DNA Technologies and are listed in Table 6.8. Ultramers
were used where the primer size exceeded 50bp. For regular cloning, plasmids, PCR
products, or synthesize fragments were digested with restriction enzymes in the
appropriate 1X buffer in a 40µL reaction at 37 or 55°C for 4‐8hrs. When required, blunting
and phosphorylation of the digested ends was carried out with the Quick Blunting kit or
if blunting was not desired, with T4 polynucleotide kinase by incubation at 37°C for 30min.
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in T4 ligase buffer. Removal of nucleotides and buffers was achieved with the PCR
purification kit or the MinElute PCR purification kit (Qiagen). DNA digests were typically
run on a 0.7% agarose gel at 125V for 45min. and purified with Qiaquick gel extraction kit
(Qiagen). Plasmid backbones were dephosphorylated in all instances with Antarctic
Phosphatase in a 50µL reaction at 37°C for 20min. and inactivated at 65°C for 10min. In
some cases, fragments of double stranded DNA (~500bp) were synthesized commercially
(Integrated DNA Technologies) and digested for assembly. Up to three‐fragment ligation
was carried out with the Quick ligation kit for 10min. at room temperature using a vector
to insert ratio of 1:3. Stbl3 bacteria (Life Technologies) were used for routine cloning of
inserts and were left to grow overnight at 37°C. Bacterial cultures were inoculated for
mini or midi preps and incubated at 37°C with shaking at 260rpm for 16‐20hrs. Mini or
midi preps were carried out with QIAprep spin miniprep or Plasmid plus midi kits (Qiagen),
respectively. Bacterial colonies were screened with Clonechecker (Life Technologies)
followed by sequencing (Genewiz). Sequences were assembled in Lasergene Seqman
(DNAStar). Restriction enzymes, Antarctic phosphatase, Quick ligation kit, T4
polynucleotide kinase, T4 ligase, and Quick blunting kit were all purchased from New
England Biolabs.
When constructing ePiggybac vectors, BamHI/NotI sites were used for cloning coding
sequences downstream of the promoter and were introduced by PCR. BglII, BclI, or BBsI
sites were utilized when BamHI sites were unavailable in the coding sequence, while
PspOMI or BBsI sites were utilized when NotI was unavailable. Six base pairs of random
non‐palindromic sequences were introduced at the 5’ end of each primer to distance the
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restriction enzyme sites from the end of the DNA fragment. The following Kozak
consensus sequence was added right before the initiation codon of all open reading
frames (initiation codon underlined): CGCCACCATG. Where required, XhoI/BamHI sites
were used to replace the upstream promoter in ePiggybac backbone. Lastly, AscI sites
were utilized for cloning the ePiggyBac cassettes (with inverted terminal repeats) into the
AAVS1 homology donor.
For creation of the FUCCI triple reporter lines, three constructs were generated: ePB‐
CAG::Venus‐Gem(1‐110)/PURO, ePB‐CAG::mCherry‐CDT1/BSD and ePB‐CAG::mCerulean‐
H2B/NEO. ePB‐CAG::Venus‐Gem(1‐110)/PURO was made by PCR cloning of Venus,
followed by digestion with BamHI/BsrGI. Human geminin (Gem) fragment (1‐110AA) was
synthesized and digested with BsrGI/NotI. Three way ligation of Venus and Gem was then
carried out into the BamHI/NotI site of ePB‐CAG::MCS/PURO. An identical procedure was
followed for ePB‐CAG::mCherry‐CDT1(30‐120)/BSD, except that the synthesized fragment
was CDT1 (30‐120AA), and an ePB‐CAG::mCherry/BSD vector was digested with BsrGI and
NotI and used for ligation. mCerulean‐H2B was PCR cloned, digested with BamHI/NotI,
and ligated into the BamHI/NotI site of ePB‐CAG::MCS/NEO to create ePB‐
CAG::mCerulean‐H2B/NEO.
Oligomer annealing was carried out to introduce new restriction sites into vector
backbones or to introduce FEZF2 CRISPR guides into the Cas9 X335 vector backbone. The
following components were mixed together in a 10µL reaction: 1µL of forward and
reverse oligos (100µM each), 1µL 10X T4 ligation buffer, 6.5µL of nuclease‐free water, and
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0.5µL of T4 polynucleotide kinase. The mixture was annealed in a thermocycler using the
following parameters: 37°C for 30min., 95°C for 5min., 90°C for 1min., followed by a ramp
down of ‐5°C/min for 13 cycles. The resulting annealed double‐stranded DNA with
overhangs was stored at ‐20°C and diluted 1:200 before being used for ligation.

CONSTRUCTION OF TALENS, CRISPRS AND HOMOLOGY DONORS
Gene specific TALEN plasmids were constructed for the SOX2 and CUX2 loci using
published protocols utilizing the Golden Gate strategy (Sanjana et al., 2012). The TALEN
targeter tool (https://tale‐nt.cac.cornell.edu/) was used to design locus specific TALENs
with a high percentage (>50%) of CG binding TALEs, 19 repeat variable dinucleotides
(RVDs) for both left and right TALENs, and spacers of 15‐19 nucleotides. For the FEZF2
CRISPR, a nickase mutant (D10A) of the Streptococcus pyogenes Cas9 that cleaves only
one strand of DNA was utilized because of its higher specificity (Cong et al., 2013). The
appropriate CRISPR site was selected using an online resource (http://crispr.mit.edu/)
and cloned into the pX335 Cas9‐nickase backbone (Ran et al., 2013) by digesting with BBsI
restriction sites and oligomer annealing. The final sequences of TALENs and CRISPRs used
for subsequent experiments are provided in Chapter 6: Appendix. The homology donor
typically had five components: the 5’ homology arm, a reporter or Cre recombinase, a
selection cassette flanked by Frt or VloxP sites, a 3’ homology arm, and a vector backbone.
About 1kb of each homology arm was amplified by PCR from genomic DNA of hESCs.
pBlueScript was used as the vector backbone. In all cases, PCR was carried out with Q5
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polymerase (New England Biolabs) or the GC‐rich PCR system (Roche) using the protocol
described above. Betaine (1M) was added to Q5 polymerase kit in cases of GC‐rich
templates, while 0.5M resolution solution was used with the GC‐rich PCR system. Primers
were designed with the NEB Builder tool (http://nebuilder.neb.com/) and synthesized by
Integrated DNA Technologies. Ultramers were used where the primer size exceeded
50bp. The list of primers and ultramers are provided in Table 6.9. In some cases, small
fragments of double stranded DNA (~500‐750bp) were synthesized commercially
(Integrated DNA Technologies).
For creation of the homology donor plasmids, five fragment Gibson assembly was carried
out with the Gibson Assembly Mastermix (New England Biolabs) using a vector to insert
ratio of 1:3:3:3:3. The insert amount was calculated using the following formula: (3 x
amount of vector backbone x size of insert/size of vector backbone). Typical parameters
for Gibson Assembly incubation were 50°C for 1hr, followed by digestion of template DNA
with DpnI for 30min. at 37°C. DpnI was inactivated by incubating at 80°C for another
30min. DH10‐beta bacteria (New England Biolabs) were used for transformation of
plasmids assembled by this method. Bacterial colonies were screened with Clonechecker
(Life Technologies) followed by sequencing (Genewiz). Using these strategies, two
homology

donors

were

constructed:

CUX2::CreERT2/PURO

(flp)

and

FEZF2::NeonGreenV5/NEO (vflox). For the CUX2 homology donor, a PGK::TK‐polyA
(thymidine kinase) cassette was also added after the 3’ homology arm at the KpnI site. In
all cases, circular rather than linear DNA was used for nucleofection of hESCs. Unless
otherwise specified, the manufacturer’s instructions were followed for all kits.

93

For targeting the AAVS1 (also known as PPP1R2C) locus, a previously published TALEN
pair and homology donor was used (Hockemeyer et al., 2011). The AAVS1 SA‐2A‐puro‐pA
homology donor (Addgene) was modified as follows: the SA‐2A‐puro‐pA cassette was
release by digestion with HindIII and replaced with annealed oligos with complementary
overhangs containing an internal AscI site. This modification permitted direct cloning of
all ePiggyBac based vectors, as both the 5’ and 3’ inverted terminal repeats of ePiggyBac
are flanked by AscI sites.
For creation of an knock‐in reporter line, an inverted tdTomato flanked by dual loxP sites
was PCR cloned from the pAAV‐FLEX‐tdTomato construct (Addgene) and introduced into
the BamHI/NotI site in the ePB‐CAG::MCS/BSD. The FLEX‐tdTomato/BSD cassette with
ITRs was released from the vector backbone by digestion with AscI. This cassette was then
introduced into the AAVS1 homology donor to generate AAVS1‐HD CAG::FLEX‐
tdTomato/BSD.

CONSTRUCTION OF THE DRAGONBOW VECTORS
The DRAGONBOW (Doxycycline Regulated Auto‐excisable Genetic Labeling of Neurons
Based On brainboW) system is comprised of two constructs, one that stochastically labels
the nuclei, while the other stochastically labels the cell membranes. For construction of
the DRAGONbow constructs, we obtained the Nucbow and Palmbow constructs from
Jean Livet (Loulier et al., 2014). Palmbow was digested with NdeI/NotI and the resulting
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cassette ligated into ePB‐CAG::MCS/NEO digested with the same enzymes. This plasmid
was in turn digested with XmaI/EcoRV to remove the H2B‐EBFP2 and replaced with
cytoplasmic TagBFP2. TagBFP2 was designed have an AgeI restriction site (compatible
with XmaI) and a blunt end (compatible with EcoRV) and were introduced by PCR. The
final construct was named ePB‐CAG::Membow/NEO. Two modifications were introduced
into the Nucbow construct: it was first digested with XmaI/EcoRV to remove the H2B‐
EBFP2 and replaced with TetOn‐T2A‐PURO using AgeI/EcoRV. T2A is a post‐translational
self‐cleaving peptide that allows for 1:1 stoichiometric expression of proteins on either
side of it. This modified construct was subsequently digested with NsiI/AscI to release the
vector backbone from the modified Nucbow cassette. An ePiggyBac backbone containing
the 5’ and 3’ piggybac inverted terminal repeats was PCR cloned and ligated to the
NsiI/AscI fragment using Gibson assembly. The final construct in ePiggyBac was named
ePB‐CAG::DRAGONbow/PURO. To induce recombination of the DRAGONbow constructs,
a DOX inducible Cre construct was made for targeting to the endogenous AAVS1 locus.
Two Lox5171 sites were introduced at either end of Cre recombinase by PCR to make it
auto‐excisable. This PCR product was digested with BBsI/NotI – sites also introduced by
PCR – and cloned into the ePB‐TRE::MCS/BSD vector digested with BamHI/NotI. The
resulting construct was digested with ClaI/MfeI to introduce a synthesized SV40 intron
into the Cre coding sequence; this was found to be critical to prevent auto‐excision of Cre
in bacteria after transformation. The final construct, ePB‐TRE::CRE(lox5171ae)/BSD was
then digested with AscI and cloned into the AAVS1 homology donor to generate AAVS1‐
HD TRE::CRE(lox5171ae)/BSD.

95

GENERATION OF TRANSGENIC CELL LINES
Nucleofection was used to introduce the plasmids into hESCs to generate ePiggyBac,
CRISPR, or TALEN modified cell lines (Lacoste et al., 2009). Cultures were pretreated for
1hr with 10μM ROCK‐inhibitor and dissociated with Accutase (Stem Cell Technologies) for
20min. Cells were then triturated with a pipet to ensure single cell suspension and the
Accutase diluted out with 4X medium. Cells were counted and desired amount
resuspended in nucleofection solution L (Amaxa) and the needed cocktail of constructs.
For ePiggyBac insertions, typically 200,000 cells were used, while for TALEN and CRISPR
modifications, about 2,000,000 cells. Nucleofection was performed with program setting
B‐016 on an Amaxa Nucleofector II (Lonza). The transfected cells were then plated drop‐
wise onto Matrigel plates containing CM supplemented with 10μM ROCK‐inhibitor. The
inhibitor was removed after 48hrs and colonies allowed to form over the next several
days. Antibiotic selection was typically started at day 4 after nucleofection. When needed,
the following concentrations of antibiotics were used: 2µg/mL of puromycin, 10µg/mL
blasticidin, 200µg/mL hygromycin, or 500µg/mL G418. Selected colonies could be seen
within 2‐5 days after antibiotic initiation. Media was changed for 8‐10 days in the
presence of selection to allow the colonies to grow. Individual colonies were then picked
under an IVF hood with a 10µL pipette tip and dropped into 10µM ROCK‐I containing
medium with a P20 pipette. Colonies were broken down by vigorous pipetting and plated
on Matrigel or feeder cells. Once the various clones had been successfully established,

96

they were assayed by either PCR of the locus for TALEN or CRISPR clones using primers
listed in Table, and/or subjected to functional analysis based on the nature of the plasmid
inserted (e.g. expression of fluorescent protein, live imaging, or differentiation). All clones
were karyotyped after expansion to ensure chromosomal stability after genetic
modification(s).
For generation of the RUES1 TRE::EGFP‐T2A‐SMAD7 line, 1μg of transposase, 2μg of ePB‐
CAG::rTA‐M2/HYGRO,

and

2μg

of

ePB‐TRE::SMAD7‐T2A‐EGFP

plasmids

were

nucleofected into the cells. After 3 days of recovery, hygromycin selection was started
and maintained for about 10 days when large resistant colonies became visible. For
selection of a clonal RUES1 TRE::EGFP‐T2A‐SMAD7 line, 10 hygromycin resistant colonies
were picked manually and grown on feeder layers in CM. Each clone was subsequently
split into two 24‐well plates. One plate was induced with 2μg/ml doxycyline (DOX) while
the other was maintained without DOX. The line displaying homogenous and brightest
EGFP expression in the induced plates was chosen for subsequent experiments. This clone
was expanded from the uninduced plate and frozen down. Similar protocols were
followed for derivation of the RUES2 TRE::EGFP‐T2A‐SMAD7 line, except that clonal
selection was not carried out.
FUCCI triple transgenic lines were made in the RUES2 background following the above
protocol with 1μg of transposase, 1μg of ePB‐CAG::Venus‐hGeminin/PURO, and 1μg ePB‐
CAG::mCherry‐CDT1/BSD and 1μg of ePB‐CAG::mCerulean‐H2B/NEO plasmids. Following
expansion and triple antibiotic selection with puromycin, blasticidin, and neomycin, 16
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clones were expanded and assayed for triple expression of fluorescent proteins by
confocal analysis of live cultures. The clone with brightest and most homogenous
expression of all three fluorescent proteins was selected and grown for further
experiments.
The CAG::Citrine and CAG::H2B‐Citrine lines were made on an RUES2 background by
nucleofection of 0.5μg of transposase together with 1μg of either ePB‐CAG::Citrine/NEO
or ePB‐CAG::H2B‐Citrine/NEO plasmids. The cells were then cultured and selected with
either neomycin or puromycin for 10 days. After this period, expression of fluorescent
proteins in the cytoplasmic or nuclear compartments was visualized in live cultures. One
clone displaying the most homogenous signal was selected for each line, expanded for
use, and karyotyped.
The triple transgenic CUX2::CreERT2 || FEZF2::NeonGreenV5 || AAVS1‐CAG::FLEX
tdTomato line was also created in the RUES2 background by three sequential
nucleofection and selection cycles. In the first round, 2μg of CUX2::CreERT2/PURO(flox)‐
TK homology donor was nucleofected into 2,000,000 early passage hESCs together with
0.5μg each of CUX2 right and left TALENs. The cells were grown and selected with
puromycin as described above, except that 2μM ganciclovir was also added for negative
selection of random integrations. After 2.5 weeks of growth, 22 clones were selected for
further characterization by PCR genotyping, sequencing and karyotyping. One clone,
which satisfied all criteria, was expanded and subjected a second round of nucleofection
with 2μg of AAVS1‐HD CAG::FLEX tdTomato/BSD homology donor and 0.5μg each of
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AAVS1 right and left TALENs. These cells were selected with blasticidin and expanded for
10 days. Finally, the resulting non‐clonal cells were nucleofected a third time with 5μg of
the FEZF2::NeonGreenV5/NEO(vflox) homology donor and 10μg of the nickase FEZF2
CRISPR vector (X335). The nucleofected cells were grown and selected in neomycin for 14
days and 12 clones were expanded for PCR genotyping. Out of the clones that were found
to be suitable, one clone was chosen for further experiments, expanded, and frozen
down. A list of primers used for genotyping is provided in Table 6.10.
The DRAGONbow lines were also created sequentially in the RUES1 hESC background.
Two million cells were nucleofected with of 0.5μg of transposase together with 2.5μg
each of ePB‐CAG::DRAGONbow/PURO and ePB‐CAG::Membow/NEO. After four days, the
transgenic cells were dual‐selected with neomycin and puromycin for 10 days. Since ePB‐
CAG::Membow/NEO has TagBFP2 in the first position, these colonies could be visualized
under epifluorescence with the cyan filter. A second round of nucleofection was carried
out on this clone to introduce DOX‐inducible CRE into the endogenous AAVS1 locus. In
order to do this, 2μg of the AAVS1‐HD TRE::CRE(lox5171ae)/BSD homology donor and
0.5μg each of AAVS1 right and left TALENs were introduced into the cells as before. The
resulting cells were allowed to grow for 4 days and selected with blasticidin for 10 days.
Twelve clones were then picked based on high TagBFP2 brightness and expanded. Each
clone was assayed for expression of various combinations of fluorescent proteins by
addition of 0.5μg/mL of DOX for 8hrs and subsequent analysis after 48hrs. The clone
displaying the broadest color palette of lineages at this time was expanded, frozen down,
and used for subsequent experiments.
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LIVE IMAGING
For live imaging of fluorescent proteins, ESCs or neural rosettes were seeded onto 35mm
µ‐dishes (ibidi) and cultured in the appropriate growth medium. At the start of the
experiment, the dish lids were replaced with the transparent adapter lid and the dishes
loaded into the 37°C incubation chamber of LCV110 VivaView Microscope (Olympus) or
CV1000 Spinning disc confocal (Olympus). Images were typically acquired every 15‐
20min. for varying periods depending on the experiment. Where triple fluorescence was
required, the preferred fluorescent proteins were mCerulean (cyan), mCitrine (yellow),
and mCherry (red). The exposure settings were usually between 200‐400ms. Acquisition
parameters were set on a custom interface on Metamorph software (Molecular Devices)
for the LCV110. Data analysis was carried out on Fiji (Schindelin et al., 2012) and using
custom scripts made in MatLab (MathWorks). The graphs resulting from the analysis were
plotted in Mathematica (Wolfram).

EMBRYONIC BRAIN CRYOSECTIONING AND PROCESSING
Fetal brains were obtained from either mouse embryos (E12.5‐E18.5) or human aborted
fetuses (5‐20 PCW). For extraction of brain tissue from mouse embryos, timed pregnant
female mice were euthanized at the required stage following institutional guidelines.
Surgery was then performed to remove the uterus and extract the embryos into PBS. The
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amniotic sac and placenta were then separated and the embryonic head dissected out
with a scalpel. For E18.5 and P0‐10 pups, the brains were removed from the skull. The
tissues were then fixed overnight in 4% PFA and washed in PBS three times. Subsequently,
they were cryoprotected with 30% sucrose solution overnight, equilibrated in OCT for
2hrs, and mounted onto a mold. The mold was snap frozen in a mixture of dry ice and
isopropanol for 5min. and stored at ‐80°C. For sectioning, the samples were brought down
to ‐20°C for two to three hours. The cryostat (Leica CM3050 S) was set to a chamber
temperature of ‐18°C and an object temperature of ‐16°C during this incubation phase.
The brains were sectioned at a thickness of 12μm and mounted onto superfrost slides,
which were stored at ‐80°C.
Human fetal brain tissue was obtained from the Human Developmental Biology Resource
(http://www.hdbr.org/). The brains were fixed in 4% PFA and washed multiple times in
PBS. The fetal brains were then serially cryoprotected in 5%, 15%, and 30% sucrose (in
PBS‐/‐) at 4°C for overnight at each concentration. For more advanced fetal stages (15‐20
PCW), the brains were left in 30% for two days to allow them to sink completely. The
meninges were subsequently dissected, and the larger brains were dissected further into
three parts (Appendix) to allow OCT to permeate into the ventricles. The brains were then
allowed to equilibrate in OCT as follows: tissues were swirled in a weighing boat to ensure
OCT entry into the ventricles, the air bubbles were removed, and the weighing boat left
at 4°C overnight in OCT. Custom molds were made for each brain tissue using 123Design
(Autodesk) and 3D printed using the high quality setting in Replicator 2 (Makerbot). The
next day, tissues were mounted into the molds (Appendix) and overlaid with OCT. The
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mold was snap frozen as above and stored at ‐80°C until sectioning. For sectioning, the
same protocol was followed as for mouse brain sections, except that the tissues were
sectioned at 12‐20μm thickness. Thinner sections were cut for 10PCW brains while thicker
settings were used for the 15PCW brains.

IMMUNOFLUORESCENCE STAINING
Monolayer cultures of hESCs or neural progenitors were fixed in 4% paraformaldehyde
(PFA) for 20min. To avoid detachment of neurons, a stock solution of PFA was diluted in
culture medium and pre‐warmed to 37°C. After two washes in PBS, the plates were
blocked and permeabilized in blocking buffer (3% normal donkey serum in 0.2% Triton‐
X100) for 1hr. Primary antibodies were diluted in block buffer and the cultures incubated
in them at 4°C overnight. The list of primary and secondary antibodies used in the study
and their respective dilutions are given in Tables 6.4 to 6.6. The plates were subsequently
washed in wash buffer (0.1% Tween20 in PBS) three times for 30min. each and incubated
in appropriate Alexafluor‐conjugated secondary antibodies (Life Technologies) for 1hr at
room temperature. The secondary antibodies were also diluted to 1:1,000 in block buffer.
After three further washes for 15min. each in wash buffer, DAPI (dilution 1:5,000) was
added to the plates in PBS for 15min. Imaging was performed on a LSM 550 Pascal
confocal microscope (Zeiss). Immunofluorescent (IF) staining for SMAD C‐terminal
phosphorylation and BMP4/TGFβ‐challenge experiments were carried out using the same
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protocol except that the epitopes were demasked and permeabilized with 1% SDS in PBS
at 37°C for 30min. prior to blocking.
For fixation of neurons in monolayer cultures, several modifications were made to the
protocol. The fixative comprised of PFA resuspended to 4% in 3N medium with 10% (w/v)
sucrose to allow the PFA to sink rapidly. The fixative was warmed to 37°C before being
applied to the cultured cells. After three washes in PBS for 10min. each, the cultures were
blocked and permeabilized in 3% normal donkey serum and 0.2% Triton‐X100/PBS for
30min. at room temperature. Primary antibodies (Chapter 6: Appendix) were diluted in
block buffer and added to the cultures for 1.5 hours at room temperature. This was
followed by three washes with PBS for 5min. each. The appropriate Alexafluor conjugated
secondary antibodies (all from Life Technologies; Chapter 6: Appendix) were diluted
1:1,000 in block buffer along with Hoescht33342 nuclear counterstain (1:10,000 dilution)
and added to the cultures for 30min. at room temperature. The cultures were
subsequently washed twice with PBS for 10min. each. Where required, cover slips were
mounted onto the slides with 65µL of Fluoromount G or ProLong Diamond Antifade
reagent (Life Technologies) if the cells were expressing fluorescent proteins. If using ibidi
µ‐plates, aqueous ibidi mounting medium was added to the wells. For larger wells, use
PVA mounting medium with DABCO (Sigma) was used for mounting. Four to six color
imaging was performed on either LSM 710 confocal microscope (Zeiss) or ImageXpress
Micro (Molecular Devices). The channels utilized have been indicated in Chapter 6:
Appendix. Data analysis was carried out on Fiji (Schindelin et al., 2012) and using custom
scripts made in MatLab (MathWorks).

103

For staining of human and mouse brain sections, the protocol was modified to include a
4 hour incubation at 60°C in HIER buffer. HIER is comprised of 10mM Tris Base and 1mM
EDTA solution adjusted to pH 9. Following incubation, the glass slides were placed in a
humidifying chamber and blocked, permeabilized and stained essentially as described for
monolayer cultures, using identical dilutions of primary and secondary antibodies. The
sections were mounted in ProLong Diamond Antifade reagent and allowed to air dry
overnight. The sections were imaged on a confocal at an optical section of 10µm using
405, 488, 568, 594 and 647nm lasers at 12‐bit resolution.
For BrdU staining, 2N HCl (diluted in water) was added to the fixed neuronal cultures and
incubated at 37°C for 20min. to break open the DNA. HCl was aspirated and the cultures
washed with PBS three times before proceeding with primary antibody incubation as
described above.

IMAGE QUANTIFICATION
Quantification of cells was carried out on immunofluorescent images or movies using
custom code written by Christoph Kirst or Aryeh Warmflash. Images were acquired at 12‐
bit resolution for quantification purposes and stitched in Zen software 2012 or ImageJ.
Nuclear proteins were used as far as possible for quantification. In cases where
cytoplasmic markers were used, either flow cytometry or automated counting of images
was carried out. The intensity of staining was normalized to DAPI stains for
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immunofluorescent images. For analysis of the DRAGONbow lineage tracing, a custom
pipeline was designed by Christoph Kirst for analysis. This involved collaborative filtering
of the raw images, followed by SLIC for background removal, and lastly superpixel
detection and segmentation. The software was programmed to generate color clusters,
which were quantified.

MICROARRAY ANALYSIS
Samples were lysed on ice with the mirVana miRNA isolation kit (Ambion) at the following
timepoints: 6, 12, and 24hrs and days 2, 3, 5 and 7 post‐DOX induction. Each time‐point
was represented by 2‐4 replicates. The extracted RNA was treated with Turbo DNA‐free
kit (Ambion) and 5μg of RNA was used for microarray analysis. Microarray hybridization
was carried out by Rockefeller University Genomics Resource Center on the Illumina
platform and data normalization and analysis was carried out with GeneSpring v11.5
software (Agilent Technologies) and Matlab (MathWorks Inc). For microarray analysis, we
first obtained lists of genes associated with fates and signaling pathways. Those
associated with pathways were from the KEGG pathway database and were downloaded
from the Molecular Signatures Database (Subramanian et al., 2005). For neural fate, we
used all genes associated with gene ontology keywords: "Nervous System Development",
"Generation of neurons", "Brain Development", and "Regulation of nervous system
development." Gene lists were downloaded from http://amigo.geneontology.org/. For
pluripotency genes, we used the list published by (Suarez‐Farinas et al., 2005)
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supplemented with the following genes: TDGF1, NANOG, DNMT3B, FOXD3, OTX2,
MYOSINX, HEY2, FGF4, REX, and NODAL. These genes are known to be upregulated in
hESCs but were excluded from that study for technical reasons. For each list of genes,
custom software written in MATLAB was used to find all genes on the list that were up or
down regulated by at least 1.5 folds at any time point during SMAD7 mediated neural
induction, perform hierarchal clustering of the resulting genes, and generate heatmaps
for visualization. Gene ontology analysis was carried out with the DAVID bioinformatics
tool using the biological processes option (Huang da et al., 2009b, a).

RT‐PCR AND QUANTITATIVE PCR
A hybrid protocol was utilized for RNA extraction in which samples were lyzed with Trizol
and RNA was extracted with RNeasy Mini kit (Qiagen). Briefly, cell were lysed at room
temperature, homogenized thoroughly, and incubated at room temperature for 5 min.
Chloroform was added to the homogenate (0.2 ml chloroform per mL Trizol used) and the
mixture vortexed vigorously. After 3min., the sample was spun at 12,000xg for 15min. at
4°C. The aqueous phase was then extracted and an equal volume of 100% RNA‐free
ethanol was added. After mixing, the sample was passed through an RNeasy column
(Qiagen) seated on a vacuum manifold. Between washes, an on‐column DNase digestion
was carried out Dnase I (Qiagen) at room temperature for 15min. After further washes to
remove salt, the column was spun in a centrifuge for 2min. at max speed to remove the
remaining buffer in the column. Next, the RNA was eluted from the column membrane in
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RNase‐free water by incubating at room temperature for 1‐2min., and then spun down at
max speed. About 1µg of total RNA was reverse transcribed with Transcriptor First strand
synthesis kit (Roche) and quantitative real‐time PCR reactions were performed with a
LightCycler 480 SYBR Green I Master Kit (Roche), both following manufacturer’s
instructions. Typical reactions for reverse transcription were carried out in a 20μL volume
using these parameters: denaturation of RNA with anchored‐oligodT(18) primer at 65°C
for 10min., followed by incubation with a mixture of dNTPs, RNase inhibitor, reverse
transcriptase, and enzyme buffer at 50°C for 1hr. cDNA was subsequently diluted 10‐folds
and stored at ‐80°C before being used for used for qPCR or RT‐PCR. qPCR was carried out
in a LightCycler480 (Roche) with 384‐well blocks in a 10μL reaction per well with SYBR
green I. The following parameters were used: pre‐incubation at 95°C for 5min. (ramp rate
4.8°C/s), followed by 45 cycles of denaturation 95°C for 10s (ramp rate 4.8°C/s), annealing
at 55°C for 10s (ramp rate 2°C/s), and extension at 72°C for 12s (acquisition mode: single,
ramp rate 4.8°C/s). The melting curve was plotted using standard parameters. For RT‐
PCR, GoTaq polymerase (Promega) was used; the parameters were: denaturation at 95°C
for 2min., followed by 35 cycles of denaturation 95°C for 30s, annealing at 55°C for 30s,
and extension at 72°C for 20s; the final extension was at 72°C for 5min. Primers used for
the qPCR experiments are listed in Table 6.7. Results for RT‐PCR and qPCR were
normalized to the house keeping gene ATP5O and from 3‐4 technical replicates for each
time point. Statistical significance and RNA quantitation relative to un‐induced hESCs was
determined with REST using the Pair‐Wise Fixed Reallocation Randomization Test (Pfaffl
et al., 2002) and data was plotted in Office Excel (Microsoft).
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FLOW CYTOMETRY
Human ESCs or neural progenitors at time points indicated in the text were detached with
Accutase (Stemgent) at 37°C for 15min. They were then washed in PBS and fixed in 2%
paraformaldehyde (PFA) for 10min. at 37°C. For staining of intracellular antigens, samples
were permeabilized in 90% methanol in PBS for 30min. on ice. Samples were blocked in
incubation buffer (0.5% BSA in PBS) at room temperature for 10min. and subsequently
incubated in primary antibodies in incubation buffer at room temperature for 1hr
(Chapter 6: Appendix). For conjugated antibodies, the samples were washed three times
in incubation buffer and analyzed directly. For unconjugated antibodies, samples were
washed three times again as before and incubated in Alexafluor‐conjugated secondary
antibodies in incubation buffer for 30min. at room temperature. Samples were washed
again as before and then analyzed. Controls included untreated cells, isotype‐only and
secondary antibody‐only samples. Analysis was carried out in BD‐LSRII and FCS data was
imported into DiVa (v5; Becton Dickinson) or FlowJo Software (v9; Treestar Inc.) for
statistical analysis and visualization. In instances where RNA needed to be extracted from
reporter lines, the cells were detached as described and sorted as live cells directly into
Trizol (Life Technologies) for cell lysis and RNA extraction. The sorting in this case was
carried out by the flow cytometry core facility using BD FACSAriaII (BD Biosciences).
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WESTERN BLOT
To detect C‐terminal phosphorylation of SMAD1 and SMAD2 after SMAD7‐induction, cells
were grown in CM for 3 or 7 days, after which they were trypsinized, washed twice in PBS
and transferred to SDS‐sample buffer for lysis. Protein lysate (40μg) was boiled for 5min.
in SDS‐sample buffer then subjected to SDS‐PAGE and subsequently transferred into
nitrocellulose membrane. The membranes were blocked in 5% milk in TBS‐T at room
temperature for 1hr, incubated with primary antibodies overnight at 4°C, and washed
with TBS‐T four times (for 10min. each). The samples were subsequently incubated with
HRP‐conjugated secondary antibodies at room temperature for 1hr and washed in TBS‐T
again four times (for 10min. each). Detection was performed using the enhanced
chemiluminescence reagent (Amersham Pharmacia Biotech). Western blot was
performed with the following primary antibodies: total‐ and phospho‐SMAD1 and
SMAD2, α‐tubulin, and SMAD7. The details of these antibodies are provided in Chapter 6:
Appendix.
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CHAPTER 3: HUMAN EMBRYONIC STEM CELLS CAN ACQUIRE AN
ANTERIOR NEURAL FATE BY A DEFAULT MECHANISM
As described in Chapter 1, inhibition of ongoing TGFβ signaling is sufficient to establish
neural fate in amphibian embryos as posited by the “default model” of neural induction
(Hemmati‐Brivanlou and Melton, 1992, 1994). However, the Activin/Nodal branch can
signal through both canonical and non‐canonical pathways, and it is unclear if inhibition
of both these pathways is required for neural induction, and if the default model applies
to hESCs if only the canonical branch of TGFβ signaling is inhibited. In this chapter, I will
establish the sufficiency canonical Activin/Nodal and BMP pathway inhibition in anterior
neural fate specification of hESCs.
Threshold‐specific activation of R‐SMADs has been shown to regulate cell fate decisions
in all embryonic cells. For example, intermediate R‐SMAD2/3 and low R‐SMAD1/5/8
signaling are necessary for the maintenance of the hESC pluripotency. Higher input of
SMAD2/3 signaling results in induction of mesoderm and endoderm, while higher
threshold of SMAD1/5/8 signaling results in trophectodermal differentiation (Xu et al.,
2005; Yu et al., 2011). The default state of neural fate represents maximal inhibition of
TGFβ activity. This inhibition can occur by secreted inhibitors, such as noggin, chordin,
follistatin, and cerberus, as well as intracellular inhibitors of signal transduction such as
SMAD6 and SMAD7. Both secreted and the known small molecule inhibitors of TGFβ
inhibit both canonical and non‐canonical branches of the pathway, as can SMAD6. While
there is ample evidence demonstrating that early frog and mammalian embryonic cells
default directly to neural fate of telencephalic character in the absence of TGFβ signaling
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(Ozair et al., 2013), it is unknown if inhibition of non‐canonical components of the TGFβ
signaling pathway are also involved. Also, as discussed in the introduction, there is also
controversy about the involvement of the FGF‐MEK signaling in neural induction.
Several protocols have been developed for neural induction in mammalian ESCs, with
most utilizing small molecule inhibitors of the TGFβ pathway (Watanabe et al., 2005;
Smith et al., 2008; Chambers et al., 2009; Li et al., 2011) or simply FGF (Ying et al., 2003;
Pankratz et al., 2007). However the interpretation of the early events leading to neural
induction in these studies has been complicated by several factors: a) usage of small
molecule inhibitors that block both canonical and non‐canonical branches, b)
neuralization has not been shown unequivocally to be a result of direct conversion, c) the
character of generated neural tissue is heterogeneous, and d) in some studies, anterior
neural fates are not generated. These limitations have precluded a definitive conclusion
on the requirement for canonical TGFβ inhibition in mammalian neural induction.
Among the many inhibitors of TGFβ signaling, SMAD7 is known to be a potent, cell
autonomous inhibitory SMAD that functions downstream of receptor activation, and is a
specific inhibitor of both R‐SMADs, but not the non‐canonical branch of signaling (Su
Myung et al., 2013). During development, activation of either Activin/Nodal or BMP
pathways can induce SMAD7 transcription in most cells, where it acts as a negative
feedback regulator of both these branches (Yan et al., 2009).
To test rigorously whether the default model of neural induction applies in humans, and
to establish if inhibition of the canonical TGFβ pathway is sufficient for this activity, we
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over‐expressed SMAD7 in an inducible manner in hESCs. In this chapter, I demonstrate
that SMAD7 overexpression is sufficient to directly convert hESCs from pluripotency to
telencephalic fate, just as in frog embryonic cells (Casellas and Brivanlou, 1998). Global
and time‐course transcriptome analysis allowed evaluation of transcriptional response
elicited by other signaling pathways in response to SMAD7 expression and TGFβ
inhibition, specifically indicating down‐regulation of FGF‐MAPK signaling components in
human neural induction. MEK inhibition significantly accelerated telencephalic neural
conversion under pluripotency conditions, suggesting that FGF‐MAPK has no role in
neural induction in the presence of TGFβ inhibition.

SMAD7 INHIBITS TGFβ SIGNALING AND INDUCES NEURAL FATE IN hESCs
SMAD7 mRNA injections are sufficient to directly induce telencephalic fate in Xenopus
pluripotent embryonic cells (Casellas and Brivanlou, 1998). In order to address whether
increasing SMAD7 levels could also completely inhibit TGFβ signaling and convert hESCs
to neuroepithelia, we used the ePiggyBac transposon system (Lacoste et al., 2009) to
generate a Tet‐inducible bicistronic expression cassette encoding EGFP (used as lineage
tracer), attached to human SMAD7 via self‐cleaving peptide sequence (Figure 3.1A). A
second construct constitutively expressing Hygromycin (Hyg) resistance and reverse
transactivator (rTA‐M2) was also generated. These constructs, along with a plasmid
encoding the transposase, were transfected into an hESC line, RUES1 (James et al., 2006),
and grown in Hyg selection. A Hyg‐resistant clonal line called RUES1 TRE::EGFP‐T2A‐
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SMAD7 was isolated and further expanded (Figure 3.1B). Addition of Doxycycline (DOX)
led to the EGFP expression (Figures 3.1C and 3.2A) as well as strong induction of SMAD7
compared to endogenous SMAD7 as determined by Western blot (Figure 3.2B).
After 48 hours of induction, the cells displayed marker changes consistent with exit from
pluripotency as observed by the decreases in OCT4 (see below) and undetectable NANOG
expression (Figure 3.2C). Since the SMAD2 branch of the TGFβ pathway has been shown
to be necessary for the maintenance of hESC pluripotency (James et al., 2005; Vallier et
al., 2005), exit from pluripotency was consistent with SMAD7‐inhibition of Activin/Nodal
signaling. Activation of R‐SMADs occurs by C‐terminal phosphorylation of serine residues
and nuclear translocation. Functional analysis confirmed that SMAD7 was indeed
inhibiting R‐SMADs by preventing C‐terminal phosphorylation as determined by Western
blot (Figure 3.1B). IF confirmed that SMAD7‐induced hESCs were resistant to R‐SMAD C‐
terminal phosphorylation in the presence of TGFβ1 and BMP4 ligands (Figure 3.2A). In
addition, SMAD7‐induced cells failed to upregulate the trophectodermal marker CDX2 in
response to BMP4 after 48 hours of DOX induction and did not show morphological
changes of trophectodermal differentiation, whereas it could be readily detected in un‐
induced BMP4 treated cells (Figure 3.2C). These results establish that in hESCs SMAD7
expression inhibits TGFβ signaling biochemically and functionally.
Examination of the induced cells by cell type‐specific markers demonstrated induction of
neural markers at day 11 such as PAX6, OTX2, SOX1, and NFH (Figure 3.1C). A marker of
migratory neuronal progenitors, DCX was also demonstrable at this time point. Flow
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cytometric quantification of PAX6 demonstrated that at day 11 about 97% of the EGFP
positive RUES1 TRE::EGFP‐T2A‐SMAD7 cells had adopted a neural fate (Figure 3.5A). We
were able to confirm expression of these markers and efficient induction of PAX6 in an
independent RUES1 TRE::EGFP‐T2A‐SMAD7 clone, as well as another SMAD7 expressing
hESC line, RUES2 TRE::EGFP‐T2A‐SMAD7 (data not shown). As induction of neural fate
occurred by simple addition of DOX to the pluripotency culture medium, without the
requirement of any other changes in extrinsic factors, this initial experiment establishes
that SMAD7‐induction was sufficient for neural conversion under these conditions.
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Figure 3.1: SMAD7‐induction promotes homogeneous neural conversion of hESCs.
A. Schematic of the ePiggyBac constructs used to create the SMAD7 cell line from RUES1 hESCs.
The ePB‐HYGRO‐CAG‐rTA/M2 codes for a tetracycline transactivator that binds to the TRE
promoter sequence in ePB‐TRE::EGFP‐T2A‐SMAD7 only in the presence of DOX and permits
inducible SMAD7 expression. The T2A peptide enables post‐translational cleavage of SMAD7
from EGFP.
B. Experimental setup for time‐course immunocytochemical and qPCR/microarray analysis.
C. IF microscopy reveals extensive expression of the neural determinant PAX6 on day 11 under
pluripotency conditions. Strong co‐localization of PAX6 with another neural‐specific gene
SOX1 is also observed, while near‐complete overlap is seen with the forebrain‐midbrain
marker OTX2. Clusters of PAX6+ cells are surrounded by migratory DCX+ neurons. NFH+ cells
with features of mature neurons are also seen in areas of DCX+ cells.
Scale bars: 200μm.
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Figure 3.2: SMAD7 inhibits canonical Activin/Nodal and BMP signaling in hESCs and prevents
alternative fates.
A. Immunocytochemistry confirms attenuation of SMAD2/3 and SMAD1 C‐terminal
phosphorylation in SMAD7‐induced cultures on exposure to high doses of BMP4 and TGFβ1.
RUES1 TRE::EGFP‐T2A‐SMAD7 cultures were induced with DOX for 24hrs, challenged with
25ng/ml TGFβ1 and 50ng/ml BMP4 for 1.5hrs and subsequently fixed. Sytox is used here as a
nuclear counterstain.
B. Western blot demonstrating loss of C‐terminal phosphorylation (and hence activity) of SMAD1
and SMAD2 in RUES1 TRE::EGFP‐T2A‐SMAD7 cultures on DOX induction on Days 3 and 7.
C. Uninduced

TRE::EGFP‐T2A‐SMAD7

cells

respond

to

BMP4

by

upregulating

the

trophectodermal marker CDX2, whereas DOX‐induced cells are resistant to trophectodermal
differentiation. In addition, induced cells downregulate NANOG as it is a direct downstream
target of Activin/Nodal signaling. Induction of CDX2 coincided with nuclear localization of P‐
SMAD1/5. Cultures were induced with DOX for 24hrs, challenged with 50ng/ml BMP4 for 48hrs
and subsequently fixed. Sytox is used here as a nuclear counterstain.
Scale bars: 200μm.
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TIMING OF SMAD7‐MEDIATED NEURAL INDUCTION
To determine the exact timing of conversion from pluripotency to neural fate, time‐
course microarray studies at discrete time points following SMAD7‐induction were
performed in parallel with IF of cell type‐specific molecular markers (Figure 3.1B).
Transcriptome analysis of induced RUES1 TRE::EGFP‐T2A‐SMAD7 transgenic cells was
done every day for 7 days, and at 3 time points during the first day (6, 12, and 24 hours),
and analyzed relative to un‐induced controls. Parallel confocal IF was extended to day 11.
Time‐course heatmaps showed that at the transcriptional level the expression of a panel
of molecular markers of pluripotency (Suarez‐Farinas et al., 2005) including NANOG,
OCT4, DMNT3B, ETS1, BAMBI, GDF3, ZFP42, and LEFTY2, were down‐regulated by day 1‐
2, and were lost after one week of Dox induction (Figure 3.3A; see also Table 6.11). This
was independently confirmed by qPCR for OCT4 and NANOG (Figure 3.3C), and by IF for
OCT4 (Figure 3.3D). Interestingly, we also observed transient up‐regulation of the epiblast
marker ZIC2 (day 3), and a sustained up‐regulation of the epiblast and anterior neural fold
marker POU3F1 (data not shown), as has been reported for mouse embryos in vivo, and
mESCs in vitro (Kamiya et al., 2011; Zhu et al., 2014). This suggests that even though hESCs
share defining characteristics with mouse epiblast stem cells (mEpiSCs) (Hanna et al.,
2010), they still pass through an epiblast‐like phase during neural conversion. The decline
of pluripotency gene expression coincided with the gradual expression of early neural
markers, including OTX2, PAX6, NR2F2, POU3F1, HES5, HESX1, SIX3, DACH1, ZNF521, and
SIP1, which were induced at days 2‐5 (Broad Molecular Signature Database; Figure 3.3B
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and Table 6.11). Induction of more mature neuronal markers was also observed in this
time window. Expression of PAX6 and SOX1 was confirmed independently by qPCR and IF
(Figure 3.3C‐D). No expression of the neural crest determinant TxF SOX10 was observed
by IF or qPCR (Figures 3.3C and 3.4). It has been shown that neural crest induction require
high levels of WNT signaling (Menendez et al., 2011); this finding points to low to
moderate levels of WNT in our culture system. Flow cytometry for PAX6 and the pan‐
neural marker NCAM supported the gradual acquisition of neural fate by the SMAD7
expressing cells (Figure 3.5A‐C). NCAM is known to be expressed by both Xenopus
neuroepithelial cells as well as hPSC‐derived PAX6+ neuroepithelial cells (Kintner, 1988;
Lee et al., 2015). Flow cytometric quantification of PAX6 demonstrated that at day 11 the
majority (97%) of the EGFP positive cells had adopted a neural fate (Figure 3.5A). In
addition, expression of markers of more differentiated neuronal cells was readily
detectable by IF at day 5 for NCAM and days 7 for DCX and NFH (Figure 3.5C‐E). Taken
together, the results from time‐course microarray, qPCR, and IF demonstrate that
SMAD7‐mediated neural induction in TRE::EGFP‐T2A‐SMAD7 cells starts after 3 days post‐
DOX induction in feeder‐free pluripotency conditions.
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FIigure 3.3: SMAD7 is sufficient for neural conversion of hESCs under conditions favoring
pluripotency without contamination by non‐neural lineages.
A. Heatmap of pluripotency genes changing by more than or equal to 2‐fold on SMAD7‐
induction under pluripotency conditions. The complete list of genes is provided in Table
6.11.
B. Time‐course heatmap from global transcriptome analysis of SMAD7‐induced cultures
showing gradual acquisition of a neural fate. Genes up‐ or down‐ regulated by more than
or equal to 2‐fold are shown. The complete list of genes is provided in Table 6.11.
C. qPCR of lineage‐specific genes between Days 1‐13 of DOX induction. A decrease in
transcripts of pluripotency genes (OCT4, NANOG) and absence of ectodermal (KRT14),
neural crest (SOX10), endodermal (SOX17), or mesodermal (BRA, MIXL1) lineage
transcripts is observed. The small upregulation of BRA between days 2‐5 was not
accompanied by nuclear localization of the protein on IF (see also Figure 3.6A‐B).
Upregulation of PAX6 is also seen.
Time‐course expression of neural and pluripotency markers between days 1‐17 in SMAD7‐induced
cultures are shown in D‐F.
D. The pluripotency marker OCT4 is strongly down‐regulated Day 3 onwards.
E. Upregulation of PAX6 is first seen at Day 5 and stays up till Day 17.
F. PAX6 expression is paralleled by expression of another early neuroepithelial gene SOX1,
which disappears entirely by Day 17. Between days 3‐11, there is a strong overlap between
domains of PAX6 and SOX1 expression.
qPCR data is presented as LOG2‐fold change over uninduced hESCs. ATP5O was used for internal
normalization at each time point. Bars represent n = 3‐4 ± SEM. Scale bars: 200μm.
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The dynamics of expression of neural TxFs support the neural inducing activity of SMAD7
via inhibition of the Activin/Nodal‐SMAD2/3 and BMP‐SMAD1/5/8 branches. For
example, it is known that Activin/Nodal‐SMAD2/3 signaling maintains pluripotency in
hESCs by directly maintaining expression of NANOG, a core pluripotency gene (Vallier et
al., 2009a). Together, NANOG SOX2 and OCT4 act in a feed‐forward loop to promote
expression of each other and repress many differentiation specific genes in ESCs (Boyer
et al., 2005). Inhibition of Activin/Nodal‐SMAD2/3 by SMAD7 down‐regulates NANOG and
promotes expression of the zinc finger homeodomain TxF ZEB2, as shown here by qPCR
and microarray data (Figure 3.7A and E). ZEB2 has previously been shown to promote
neuroectodermal differentiation and prevent mesendodermal of hESCs (Chng et al.,
2010). In addition, SMAD7 induction promoted induction of OTX2 and NR2F2 (Figure 3.7B
and E), which are among the earliest TxFs expressed during neural differentiation of hESCs
(Greber et al., 2011; Rosa and Brivanlou, 2011). OTX2 in turn can directly activate
transcription of the neural determinant PAX6 in hESCs (Greber et al., 2011). NR2F2 on the
other hand represses OCT4 expression directly and promotes expression of other neural‐
specific markers, as shown previously (Rosa and Brivanlou, 2011).
Inhibition of BMP‐SMAD1/5/8 branch during neural induction is also known to trigger
characteristic patterns of gene expression that our recapitulated in our SMAD7 induction
dataset. For instance, Inhibition of BMP signaling is known to stabilize the neural program
by maintaining expression of SOX2 (Greber et al., 2011). Maintenance of SOX2 is observed
in our microarray (data not shown). Absence of BMP signaling is also known to promote
expression of cell‐intrinsic neural determinants, such as the zinc finger TxF ZNF521, which
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is necessary and sufficient for neural induction in hESCs (Kamiya et al., 2011). ZNF521 was
also strongly induced under SMAD7 induction at Day 11 (data not shown). Lastly, BMP
inhibition prevents induction of non‐neural germ layers (trophectoderm and
mesendoderm) as shown below (Figure 3.3C and 3.6). Indeed, previous studies have
shown that low BMP signaling together with down‐regulation of OCT4 is a prerequisite
for neuroectodermal specification in hESCs (Wang et al., 2012b).

Figure 3.4: SMAD7‐induced cells do not express the neural crest marker SOX10. A) EGFP expression
in induced cultures. B) Absence of the neural crest lineage TxF SOX10 by IF analysis. Scale bars:
200μm.
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Figure 3.5: Efficient neuralization in SMAD7‐induced hESCs under conditions favoring pluripotency.
A. Flow cytometry of EGFP+ cells showing that majority of SMAD7‐induced cells become
PAX6+ by Day 12 of induction under pluripotency conditions.
B. Dynamics of NCAM expression on DOX induction as determined by flow cytometry. About
85% of EGFP+ cells are also NCAM+ by Day 7, and this correlates with PAX6 expression
observed by IF (See Figure 3F). NCAM+ cells comprise about 90% of EGFP+ cells on Day 11.
C. IF of SMAD7‐induced cultures selectively expressing the surface marker neural cell
adhesion molecule (NCAM; CD56) on Day 11 of DOX (lower panels). Almost complete co‐
localization with EGFP+ cells is seen. A few NCAM+ cells are also seen in uninduced cultures
(upper panels).
D. Time‐course analysis of differentiating SMAD7‐induced cells shows that the migrating
neuronal marker doublecortin (DCX), a marker of early neuronal differentiation, is
observed at later time points (Days 11‐17) in cells with clear neuronal morphology.
E. The post‐mitotic neuronal marker NFH is also observed in these cultures at these time
points. While co‐localization of DCX and NFH as well as PAX6 and DCX was seen in some
areas, they are largely mutually exclusive. EGFP fluorescence is not displayed here for
clarity.
Scale bars: 200μm.
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Figure 3.6: SMAD7‐mediated neural induction is direct and does not take place through
mesodermal intermediates. A) EGFP expression in induced cultures. B) Absence of the mesodermal
lineage TxF BRA (brachyury) by IF. Scale bars: 200μm.

SMAD7‐MEDIATED NEURAL INDUCTION IS DIRECT
Pluripotent cells can adopt a neural fate by either direct or secondary/concomitant
induction of other embryonic germ layers such as mesoderm, organizer/node, endoderm,
or extra‐embryonic tissue. To address whether SMAD7 mediated neural conversion was
direct, we analyzed the microarray data set, which indicated that DOX‐induced RUES1
TRE::EGFP‐T2A‐SMAD7 cells did not express markers of other embryonic germ layers.
These included Brachyury (BRA), MIXL1, HAND1, for mesoderm; SOX17, GATA4 or GATA6,
for endoderm; CDX2, EOMES, β‐HCG, KLF5, for trophectoderm; and KRT14 for non‐neural
ectoderm, at any time point (data not shown). This conclusion was independently
confirmed by qPCR for BRA and MIXL1 for mesoderm and SOX17 for endoderm (Figure
3.3C) and by IF for BRA and SOX17 (Figure 3.6 and data not shown). This was also true for
the non‐neural ectoderm marker KRT14 and the neural crest progenitor marker SOX10
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(Figures 3.3C and 3.4). Importantly, SMAD7 did not induce expression of organizer/node
specific markers such as GSC, MIXL1, FOXD3, or FOXA2 (also demarcating the floor plate
at later time points) (Tamplin et al., 2008), demonstrating that neural fate induction was
not following or concomitant with the formation of the organizer/node. These results
provide evidence for direct induction of neural fate from pluripotent RUES1 cells and
support the validity of the second attribute of the default model: direct conversion from
pluripotency to neural fate.
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Figure 3.7: SMAD7 imposes an anterior identity in neuralized hESCs.
A. qPCR of neural lineage genes between Days 1‐13 of DOX induction. A robust increase in neural
lineage transcripts such as SIP1, SOX1, and BRN2 as well as anterior neural transcripts such as
OTX2, SIX3, LHX2, and FOXG1 is seen. Primers specific to the anterior neural specific isoform
of OTX2 were used. No change in the hindbrain marker HOXB4 is observed.
Time‐course expression of dorsal and ventral forebrain markers between Days 1‐17 in SMAD7‐
induced cultures are shown in 4B‐4D. Human ESCs were induced in conditions favoring
pluripotency as before.
B. The first marker up‐regulated is the anterior marker OTX2. Near complete co‐localization of
OTX2 is seen with PAX6 D5 onwards, suggesting a neural, rather than anterior visceral
endodermal source of expression of OTX2.
C. The dorsal neural tube marker PAX3 is also seen in the cultures between D5‐17. Patchy
expression of PAX3 was noticeable at these time‐points. During mouse development, PAX3 is
expressed in some parts of the dorsal forebrain early on.
D. Clusters of cells expressing the ventral telencephalic (medial ganglionic eminence) marker
NKX2.1 are also observed in the cultures in a mutually exclusive manner to PAX6.
E. Time‐course heatmap from global transcriptome analysis showing expression of genes
associated with forebrain signature. Genes up‐ or down‐ regulated by more than or equal to
2‐fold are shown. The list of genes is also provided in Table 6.12.
qPCR data is presented as LOG2‐fold change over uninduced hESCs. ATP5O was used for internal
normalization at each time point. Bars represent n = 3‐4 ± SEM. Scale bars: 200μm.
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NEURAL TISSUE INDUCED BY SMAD7 IS TELENCEPHALIC IN IDENTITY
Finally, we addressed the character of SMAD7‐induced neural fate globally in function of
time followed by independent confirmation with qPCR and IFs. We first looked at the
antero‐posterior identity. Microarray data indicated the presence of the most anterior
neuronal fate in SMAD7‐induced cells, as evidenced by expression of the anterior‐specific
neural genes such as OTX1/2, SIX3, LHX2, ZNF521, LHX5, SP8, LIX1, LMO4, RAX, SIX6, and
GLI3 (Figure 3.7A and E; see also Table 6.12). This was also confirmed by Gene Ontology
analysis of enriched genes on Day 7 (Figure 3.8). Induction followed a temporal hierarchy.
For example, genes induced by at least five‐fold by DOX included OTX2 and ZEB2, first
induced at Day 2, PAX6 and SIX3 at Day 3, LHX2 and FOXG1 at day 7, and BRN2 (POU3F2)
at later time points. Early expression of OTX2 was confirmed by IF (Figure 3.7B). However,
markers of midbrain (EN2), hindbrain, or spinal cord (HOXB4) were not detected at any
time point, suggesting specific induction of human telencephalic fate. Examination of
dorsal‐ventral markers established the presence of dorsal and ventral cell types within
the forebrain territory, as demonstrated by the expression of NKX2‐1 and PAX3 (Figure
3.7C). NKX2‐1 is a marker of ventro‐lateral fate (medial ganglionic eminence), and was
detected in rare clusters, but the most ventral fate (floor plate) did not seem to be
induced, as FOXA2 expression was not detected (data not shown). This suggests the
absence of the most ventral fate. Together, these results establish that the third attribute
of the default model – i.e., anterior neural conversion – is also valid in hESCs, as in frogs,
and supports the notion that the molecular circuitry underlying early neural induction is
evolutionarily conserved in humans.
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Figure 3.8: DAVID gene ontology of D7 SMAD7‐induced cultures. GO shows enrichment for genes
involved in forebrain fate and neuroepithelial identity.

INHIBITION OF FGF‐MEK SIGNALING PROMOTES SMAD7‐MEDIATED NEURAL FATE
FGF‐MEK signaling is required for the maintenance of pluripotency through NANOG
expression in hESCs (Chen et al., 2011), but not mESCs. Additionally, the FGF‐MEK
signaling pathway has been proposed to be required for mammalian neural induction
(Stavridis et al., 2007; LaVaute et al., 2009). Due to the requirement of FGF and
Activin/Nodal signaling for maintenance of the pluripotent state of hESCs, it has been

132

suggested that hESCs represent an epiblast‐like state rather than the ICM state of mESCs.
A brief exposure of FGF‐MEK signaling is required for mESCs to become epiblast cells,
which can then be grown in the presence of Activin, like their hESC counterparts (Hanna
et al., 2010). For mESCs neural induction, FGF might be required initially simply to allow
the transition of mESCs to an epiblast fate, but not later for neural induction (Kunath et
al., 2007; Sterneckert et al., 2010).
In order to obtain high‐resolution views of the secondary signaling events operating
downstream of SMAD7‐mediated neuralization, we analyzed genes pertaining to the
developmentally relevant signaling pathways in our time‐course microarray.
Interestingly, we found an overall down‐regulation in many components of FGF/MAPK
signaling and upregulation of several cell‐intrinsic inhibitors of MAPK signaling in our
analysis (Figure 3.9A and Table 6.13). These inhibitors included the dual‐specificity
phosphatase inhibitor (DUSP4), the cell intrinsic FGF and WNT inhibitors of the SHISA
family (SHISA2 and SHISA3), as well as a FGF/EGF cell intrinsic inhibitor of the SPROUTY
family (SPRY1). We followed up on these observations to address the relevance of FGF‐
MEK signaling in hESC neural induction. FGF‐MEK signaling was inhibited using the specific
MEK1/2‐inhibitor PD0325891 to block the pathway downstream of the receptor under
pluripotency conditions. MEK‐inhibitor was added to RUES1 TRE::EGFP‐T2A‐SMAD7
cultures at 0, 12, 24 and 48hrs after DOX‐induction, and cells were cultured in the
presence of the inhibitor until day 7 of DOX‐induction. No discernible differences in neural
conversion were detected between these conditions as determined by PAX6 and OCT4 IF
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on day 7 (Figure 3.9C), excluding the possibility of MEK1/2 signaling involvement in the
epiblast‐like transition or neural conversion during this period of hESC differentiation.
The dynamics of neural induction were then determined by combined MEK‐inhibition and
SMAD7‐induction in hESCs. We used the highly specific MEK‐inhibitor PD326901 at a
concentration that can eliminate MEK/ERK phosphorylation in hESCs as determined by
Western blot and protein arrays (data not shown). RUES1 TRE::EGFP‐T2A‐SMAD7 cells
were cultured in pluripotency conditions and subsequently treated with MEK‐inhibitor,
DOX, and MEK‐inhibitor/DOX combinations. cDNA was generated from cells after 0, 1, 3,
5, and 7 days of treatment. qPCR demonstrated that PAX6, ZNF521, SIP1, and POU3F2
expression increased to significantly higher levels in the MEK‐inhibitor/SMAD7 condition
compared to SMAD7 only and MEK‐inhibitor only conditions (Figure 3.9B and 3.9E). While
low levels of PAX6 transcripts were induced by MEK‐inhibitor alone (data not shown), the
other neural determinants SIP1, ZNF521 and POU3F2 were not induced in this condition
(Figure 3.9E). Furthermore, while down‐regulation of the pluripotency transcripts OCT4
and NANOG was also seen in MEK‐inhibitor alone, SMAD7 and MEK‐inhibitor/SMAD7
conditions demonstrated a more robust down‐regulation of these transcripts (Figure
3.9E). Compared to SMAD7 only, MEK‐inhibitor/SMAD7 condition showed higher levels
of PAX6 (3‐fold), the intrinsic neural determinant ZNF521 (25‐fold), and the neural POU‐
domain TxF POU3F2 (6‐fold) on Day 5, comparable levels of the neural fate determinant
SIP1, and an almost complete loss of NANOG and OCT4 expression during this time.
Intracellular flow cytometry on Day 7 of the MEK‐inhibitor/SMAD7 combination for the
neural genes PAX6 and SOX2 confirmed expression of these factors in >90% of EGFP+ cells
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compared to 67% of PAX6 cells in the SMAD7‐only condition (Figure 3.9D). Together,
these results demonstrate that FGF‐MEK‐ERK signaling has an inhibitory, rather than an
instructive, role in hESC neural induction, and points to TGFβ inhibition as sufficient for
neural conversion. Since inhibition of MEK alone can directly up‐regulate some neural
genes and down regulate pluripotency genes, this suggests that FGF‐MEK signaling may
be directly repressing neural genes in hESCs, as has be shown in mEpiSCs (Greber et al.,
2010). The combination of SMAD7‐induction and early MEK inhibition strongly promotes
expression of neural genes, coupled with down‐regulation of pluripotency genes and
results in robust neural conversion of hESCs.
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Figure 3.9: MEK‐inhibition promotes SMAD7‐mediated neural conversion under conditions
favoring pluripotency.
A. Time‐course heatmap of the MAPK pathway in induced hESCs showing down‐regulation
of several MAPK related genes and upregulation of cell‐intrinsic MAPK inhibitors. Genes
changing by more than or equal to 1.5‐fold are shown on this heatmap. The complete list
of genes is provided in Table 6.13.
B. Quantitative RT‐PCR for PAX6 transcripts in MEK‐inhibitor (blue), SMAD7 (green), and
MEK‐inhibitor/SMAD7

(red)

combinations

in

pluripotency

conditions.

MEK‐

inhibitor/SMAD7 and SMAD7 result in significantly higher increase in PAX6 expression
relative to MEK‐inhibitor alone, with the MEK‐inhibitor/SMAD7 combination leading to a
>3‐fold increase in PAX6 on D5 compared to SMAD7. qPCR data is presented as relative
fold‐change over MEK‐inhibitor treated hESCs.
C. MEK‐inhibition before epiblast‐like transition does not prevent neural conversion in
SMAD7‐induced cultures. Addition of MEK‐inhibitor at 0, 12, 24 and 48hrs after SMAD7‐
induction did not result in observable differences in PAX6 expression or down‐regulation
of OCT4 on D7 of induction. The time labels above the figures represent the time of
addition of MEK‐inhibitor after DOX‐induction.
D. Flow cytometry for EGFP, PAX6, and SOX2 in the MEK‐inhibitor/SMAD7 combination
shows that >90% of the cells are positive for these markers by D7 of induction in conditions
favoring pluripotency. SOX2 is expressed in both pluripotent cells as well as neuroepithelial
cells.
E. qPCR of anterior neural genes between Days 1‐7 of MEK‐inhibitor (blue), SMAD7 (red),
and MEK‐inhibitor/SMAD7 (green) combinations. Transcripts for anterior neural genes
FOXG1, LHX2, OTX2, and ZNF521 BRN2 (POU3F2) and SIP1 are all significantly higher in
the MEK‐inhibitor/SMAD7 combination compared to SMAD7 alone. Down‐regulation of
the pluripotency genes OCT4 and NANOG is also more robust in this combination than
MEK‐inhibitor alone.
qPCR data is presented as LOG2‐fold change over uninduced hESCs. ATP5O was used for internal
normalization at each time point. Bars represent n = 3‐4 ± SEM. Scale bars: 200μm.
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Figure 3.10: Time‐course comparison of lineage‐specific genes expressed in MEK‐inhibitor+SMAD7
induced cultures versus SMAD7‐only controls. A) Addition of MEK‐inhibition accelerates an
anterior neural fate without changing expression of other germ layer lineage genes as compared
to B) SMAD7 induction alone.
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COMBINED SMAD7 INDUCTION AND MEK INHIBITION PROMOTES ANTERIOR NEURAL
FATE
MEK‐inhibition was then tested to ascertain whether it alters the anterior neural profile
imposed by SMAD7 induction alone. In addition to promoting neural fate, qPCR confirmed
that combined MEK and TGFβ inhibition also enhanced acquisition of an anterior fate. The
MEK‐inhibitor/SMAD7 combination accelerated the expression of the forebrain TxF
FOXG1, as compared to SMAD7‐induction alone (Figure 3.9E) and resulted in ~10 fold
greater expression of FOXG1 transcripts at Day 7, the last time point tested. Like SMAD7
alone, these changes were also direct and did not significantly induce non‐neural lineage
genes, as evidenced by absence of expression of mesoderm, endoderm, non‐neural
ectoderm, and trophectoderm lineage markers (see Figure 3.10A‐B). Importantly, the
neural crest marker SOX10 was also not induced in the MEK‐inhibitor/SMAD7
combination. Interestingly, MEK‐inhibitor alone could also up‐regulate FOXG1 to a
greater extent than the SMAD7‐only condition, although to a considerably lesser extent
than that of the MEK‐inhibitor/SMAD7 combination, suggesting that MEK1/2‐ERK and
TGFβ‐SMAD signaling might be regulating FOXG1 expression. In addition, higher
expression levels were seen for the forebrain determinant LHX2 at Day 7 (3‐fold), as well
as the rostral neural gene ZNF521 (25‐fold) between Days 5‐7 in the MEK‐
inhibitor/SMAD7 combination compared to SMAD7‐only conditions. Comparable
expression of OTX2 was observed until Day 3, after which slightly lower levels were
observed (Figure 3.9E). Based on these results, we can conclude that combined inhibition
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of FGF‐MEK and TGFβ‐SMAD signaling significantly accelerates the acquisition of neural
fate in hESCs without changing the anterior character of the cells.

Figure 3.11: Proposed model of the ‘default’ neural differentiation of hPSCs. The pathways
mediating pluripotency such as FGF‐MEK and ACTIVIN/NODAL‐SMAD2/3 repress neural fate
directly and indirectly through pluripotency TxFs. Our data suggests that maintenance of
pluripotency requires inhibition of the default state of differentiation, i.e. the neural fate. Arrows
represent activation while hatches represent inhibition. The dashed line represents aDirect
evidence for
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SUMMARY
We demonstrate here that SMAD7, a cell‐intrinsic inhibitor of canonical TGFβ signaling, is
sufficient to directly convert pluripotent hESCs to an anterior telencephalic fate while
preventing induction of non‐neural and posterior neural fates. Time‐course gene
expression revealed down‐regulation of MAPK components, and combining MEK1/2
inhibition with SMAD7‐mediated TGFβ inhibition promoted telencephalic conversion.
FGF‐MEK and TGFβ‐SMAD signaling maintain hESCs by promoting pluripotency genes and
repressing neural genes. Our findings suggest that in the absence of these cues,
pluripotent cells revert to an intrinsic program of neural fate. Hence the “primed” state
of hESCs requires inhibition of the “default” state of neural fate acquisition (Figure 3.11).
This suggests an evolutionarily conserved mechanism of forebrain specification from
amphibians.
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CHAPTER 4: IN VITRO CORTICOGENESIS REVEALS EXISTENCE OF
MULTIPOTENT PROGENITORS AND NEURONAL RESTRICTION IN VIVO
Human embryonic stem cells can recapitulate many early developmental events
faithfully, including germ layer differentiation, developmental timing, and even
organogenesis (Kadoshima et al., 2013; Nicholas et al., 2013; Warmflash et al., 2014).
There is a strong interest in utilizing hPSC‐derived tissues for disease modeling and cell
replacement therapies. However, in many instances the cell types being generated in the
various differentiation protocols are poorly defined and not relevant to the disease
context. This is partly due to our incomplete understanding of the events underlying
corticogenesis and neuronal diversity, especially in humans. While mouse models have
been greatly informative with respect to human development and diseases, many
diseases of the human cortex cannot be adequately modeled in mice, such as
microcephaly, autism, many psychiatric illnesses, and neurodegenerative diseases
(Geschwind and Rakic, 2013; Bae et al., 2015). Hence the ability to make defined neuronal
types for any application requires a better understanding of human neural development.
In this chapter, I will discuss my efforts in this direction to establish hPSCs as a model for
studying early corticogenesis using TGFβ inhibition as a starting point. By harnessing the
strength of in vitro manipulations and combining them with single cell and population
level quantitative analysis, we show that in vitro corticogenesis recapitulates many
aspects of human corticogenesis. We also provide evidence for “progressive restriction”
of human neural progenitors at the level of individual progenitors as has been suggested
in mice. Intriguingly, our parallel analysis of human fetal brains shows a heretofore‐
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unappreciated pattern of laminar marker restriction over the course of development.
Based on our findings, we propose a neuronal restriction model of cortical lamination
where restriction at the level of progenitors manifests in patterns of expression of fate
determinant in neurons. This has implications for understanding diseases where
abnormalities in laminar cytoarchitecture and neuronal differentiation are observed, such
as autism (Stoner et al., 2014). Lastly, the transgenic approaches, reporters, lineage‐
tracing tools, and the novel analytical approaches we use here are broadly applicable for
studies of various aspects of hPSC differentiation and organogenesis.

SMALL MOLECULE INHIBITION OF TGFβ SIGNALING IS SUFFICIENT TO INITIATE A
PROGRAM OF CORTICAL DIFFERENTIATION FROM MAMMALIAN PSCs
We first sought to optimize our protocol of cortical differentiation using recently available
and specific small molecule inhibitors of Activin/Nodal and BMP signaling (referred to as
SB/LDN). We also switched to serum free conditions as albumin in serum has intrinsic
signaling activity as was observed by others and us (Blauwkamp et al., 2012; Nakano et
al., 2012) (data not shown). Under these conditions, hESCs could be readily differentiated
into primitive neuroepithelium at near purity. Upon replating the neuroepithelium on
laminin, the cultures developed into a rosette‐like morphology as has been described
before (Figure 4.1D). The neuroepithelium and rosettes were found to homogeneously
co‐express markers of dorsal telencephalic and neocortical identity including OTX2
(97.5%), FOXG1 (93.5%), and LHX2 (93.9%) (Figure 4.1A‐C). Moreover, the rosette
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structures recapitulated the radial organization of the early ventricular zone, with a
central cavity with N‐CAD+ margins (comparable to ventricles) and PAX6+ neural
progenitors lining the central cavity. Subventricular zone IPs, which express the TxF TBR2
were found outside the PAX6+ domain (Figure 4.1D). This organization was observed in
the majority (91.7%) of rosettes on day 25. At this point the cells were dissociated into
single cells and allowed to differentiate into neurons for a prolonged period of time. At
late stages of cultures (>day 70), we observed the emergence of PAX6+ progenitors with
only one long process. The timing of emergence, morphology, and marker expression of
these progenitors is consistent with bRG cells, which have also been observed by other
groups (Shi et al., 2012; Kadoshima et al., 2013; Lancaster et al., 2013). Importantly, no
markers of interneurons or their progenitors (NKX2‐1, DLX2) were observed at any point
during the differentiation process, suggesting that our cultures were uniformly of dorsal
telencephalic identity (data not shown).
We also tested for expression of cortical markers at different time points. On day 55, we
were able to observe expression of deep layer markers such as TBR1 and CTIP2, which are
initially uniformly expressed in the cortical plate (Figure 4.1F) (Onorati et al., 2014). Using
a CRISPR transgenic knock‐in reporter line (see Figure 6.3 for details), we were also able
to demonstrate expression of FEZF2 at this time point, and its co‐expression with CTIP2.
FEZF2 is known to be expressed in SCPNs as well as the progenitors. At late time points in
culture, we were able to observe expression of several known CPN markers such as
SATB2, BRN2, and MEF2C (Figure 4.1F). Together, this suggests that in our in vitro culture
conditions Activin/Nodal and BMP inhibition drives acquisition of neocortical fate by
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hESCs, and that the neural progenitors derived from this transition are competent to
generate SCPNs and CPNs.
Additionally, we also wanted to test if TGFβ inhibition was sufficient for conversion of
other hPSCs and PSCs derived from other mammalian species into a neural fate. We used
two mouse ESC lines (46C SOX1‐EGFP and V6 SOX2‐EGFP), two monkey ESC lines (M.
Mulatta and M. Nemestrina) and two human ESC lines (RUES1 and RUES2) for our
experiments. The mouse ESCs were first differentiated into EpiSCs as it has been shown
that EpiSCs are competent for germ differentiation and resemble hESCs more closely. To
this end, mouse ESCs were cultured in hESC medium (CM + FGF) for three days with a
WNT inhibitor IWP2. EpiSC conversion was manifested by appearance of flat colonies
similar to hESCs rather than dome‐shaped colonies typical of mESCs. Presence of
pluripotent markers such as OCT4, SOX2, and NANOG were demonstrated by IF (Figure
4.2A).
The two mouse EpiSCs, together with monkey and human ESCs were subjected to SB/LDN
conditions for varying periods of time. The cultures were fixed at the following days after
induction: 6 days for mouse EpiSCs, 11 days for monkey ESCs, and 17 days for human
ESCs. The number of cells that have underwent neural conversion was assessed by SOX1+
cells for mouse PSCs and PAX6 for monkey and human PSCs. This was because SOX1 is the
first marker of neural fate in mouse, compared to primates, where PAX6 is the earliest
marker (Zhang et al., 2010). Quantification of these results showed that all six PSCs were
able to undergo neuralization in the presence of SB/LDN, with human cells showing the
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highest efficiencies (>90%) and monkey and mouse PSCs showing efficiencies of 75‐85%
(Figure 4.2B).
We conclude that TGFβ inhibition is sufficient for neural induction and an evolutionarily
conserved property of mammalian PSCs.

Figure 4.1: hPSCs can recapitulate early corticogenesis in vitro downstream of TGFβ inhibition. A)
Schematic overview of the protocol used for cortical differentiation. B) Neuroepithelium generated
using this protocol uniformly express markers of telecephalic and neocortical fate such as PAX6,
LHX2, FOXG1, OTX2, PLZF and EMX1 C) Quantification of co‐expression of LHX2, FOXG1, and OTX2
with PAX6. The schematic shows a sagittal section of the PCW5 fetal brain while the colored areas
are expected domains of expression of LHX2, FOXG1, and OTX2. Dorsal forebrain progenitors
should express all three together with PAX6. D) Upon passaging, the neuroepithelium self‐
organizes into rosettes expressing characteristic markers of embryonic germinal layers including
a central cavity lined by PAX6+, NCAD+ cells and another layer of TBR2+ IPs. E) At late stages in
culture, monopolar progenitors expressing PAX6 and p‐Vimentin appear which are properties of
OSVZ bRG cells. F) The neural progenitors can also be differentiated into SCPNs expressing deep
layer markers such as BRN2, CTIP2, and FEZF2, as well as CPNs expressing superficial layer markers
such as SATB2, BRN2, and MEF2C. Scale bars: 100µm.
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Figure 4.2: Pluripotent cells from various species can be converted into neural fate on TGFβ
inhibition with small molecules. A) Top panels: Mouse EpiSCs, monkey and human ESCs all
expressing the pluripotency marker OCT4. On application of SB/LDN, all three PSCs differentiate
into neural fate as indicated by SOX1 reporter expression in mouse EpiSCs and PAX6, OTX2, and N‐
cadherin expression in NHP and human ESCs. The bottom panels show neural rosettes from each
species. PAX6 is a neocortical marker in mouse. The timescale of differentiation varied between
the three species. B) Quantification of neural markers in two different lines of each species. Sox1
is the first neural marker expressed in differentiation of mESCs while PAX6 is the first neural marker
expressed in hPSC differentiation (Zhang et al., 2010). n=3 experiments per PSC line. Scale bars:
100µm.

hPSC‐DERIVED NEURAL PROGENITORS DISPLAY DYNAMIC RADIAL GLIAL PROPERTIES
In the next set of experiments, we wanted to test if neural progenitors derived in vitro
display the dynamic cell cycle behavior that has been shown in mouse and human RG cells
in ex vivo cultures (Noctor et al., 2001; LaMonica et al., 2013). These behaviors include
interkinetic nuclear migration (INM) and positioning of the nuclei at the ventricular
surface during M‐phase of the cell cycle (Figure 4.3E). In order to monitor the cell cycle

149

behavior and movements of in vitro derived neural progenitors, we derived a transgenic
hESC line expressing FUCCI markers and a Histone‐H2B tagged cerulean fluorescent
protein using the ePiggyBac system (Figure 4.3A‐C) (Lacoste et al., 2009). FUCCI markers
are comprised of Venus and mCherry fluorescent proteins fused to the ubiquitinated
domains of GEMININ (amino acids 1‐110) and CDT1 (amino acids 30‐120), respectively.
GEMININ normally accumulates during the S→M‐phase of the cell cycle, after which it is
degraded; conversely, CDT1 accumulates in the G0/G1‐phase and is actively degraded in
the S→M phases (Figure 4.3B). Hence in FUCCI cells, Venus expression is seen in the
nucleus in the S to M‐phase of the cell cycle, while mCherry is observed in the nucleus
either in the G1‐phase or upon cell cycle exit (i.e. G0 phase). We added an H2B‐tagged
cerulean fluorescent protein (CFP) to enable visualization of the cells in the M‐phase,
wherein there is a brief period when cells are no longer expressing Venus‐GEM(1‐110),
and have not yet accumulated mCherry‐CDT1(30‐120) (Figure 4.3B). H2B‐CFP shows a
spike in intensity during the M‐phase due to chromatin condensation and accumulation
of the chromosomes on the spindle axis (Figure 4.3C and D).
Upon selection with Puromycin, Blasticidin, and Neomycin, we generated clonal hESC
triple reporter lines stably expressing high levels of the FUCCI markers and H2B‐CFP
(Figure 4.3C). Live imaging and single cell analysis of FUCCI/H2B‐CFP line confirmed the
accumulation of Venus in the S→M phase, of mCherry in the G1‐phase, as well as the M‐
phase spike of H2B‐CFP (Figure 4.3D). We next differentiated the FUCCI/H2B‐CFP hESCs
into neuroepithelium with SB/LDN, and subsequently replated them to allow rosette
formation. Based on RG movement in the ventricular zone, it would be expected that
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green cells (i.e. progenitors in S→M phase) move inwards and accumulate close to the VZ
while red cells (i.e. progenitors in G1 and post‐mitotic G0 neurons) move away from it
and accumulate away from the ventricles. Indeed, this was observed in cortical slices
derived from brains of E13 transgenic FUCCI mice (Figure 4.3E) (Sakaue‐Sawano et al.,
2008; Abe et al., 2013). Remarkably, we observed identical cell cycle dynamics upon live
imaging of D25 rosettes, including INM over a three day period (Figure 4.3H). This was
confirmed upon population level analysis, where green cells accumulated close to the
center of the rosette structure, while green cells on the periphery were gradually replaced
by bright red G0/G1 cells (Figure 4.3G‐H). Interestingly, there was a decrease in the
fraction as well as the intensity of green cells over the 72‐hour period at a single cell level;
this is attributable to the lack of media change during the live‐imaging period. Self‐
renewal signals (such as insulin) are present in the culture medium and would be depleted
over time if not replaced. The decrease in green cells was accompanied by a
corresponding increase in the number and intensity of red cells at a signaling (Figure 4.3G‐
H), suggesting post‐mitotic neuronal fate due to accumulation of CDT1. These patterns of
FUCCI marker segregation was observed for 12/12 rosettes that were imaged (data not
shown). Hence we conclude from FUCCI/H2B‐CFP experiments that neural rosettes
demonstrate self‐organization similar to what is seen in vivo, and that in vitro derived
neural progenitors demonstrate INM.
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Figure 4.3: hPSC‐derived neural progenitors display dynamic radial glial properties. A) Schematic
of the three ePiggyBac cassettes and their respective antibiotic selection markers used to generate
the transgenic FUCCI/H2B‐CFP line. B) Schematic of FUCCI marker dynamics during cell‐cycle.
Green is indicates actively dividing (“GO”), while red indicates cell cycle pause or exit (“STOP”). C)
Image of a FUCCI/H2B‐CFP clone used for further experiments. Expression of all three transgenes
can be observed. D) Single cell dynamics of FUCCI/H2B‐CFP over a 36 hour period. The expected
behaviors of all three markers are observed. The arrowheads indicate M‐phase of the cell cycle,
that corresponds to a spike in H2B‐CFP fluorescence. E) Schematic of RG cell cycle dynamics and
overlay of triple marker expression corresponding to phase of RG cell cycle. F) Single cell analysis
of FUCCI dynamics over a 72‐hour period. Each dot represents a single cell, while the intensity of
the dot represent the intensity of flourescent protein expression. The y‐axis represent distance
from the center of the rosette structure (highlighted in H). The number and intensity of green can
be seen to be decreasing over time, while for red cells they are increasing. G) The density of cells
as a function of distance from the center at three time points: t=0, t=36hrs and t=72hrs. The
restriction of green cells to the center of the rosette and accumulation of red cells away from the
rosette over time can be seen. H) Montage of a single rosette from the above experiment at 6:20hr
intervals showing the pattern of FUCCI emerging over the 72 hr period. The images are
timestamped on the bottom left. The small circle indicates the center of the rosette, while the
larger circle dermarcates the rosette boundary. Scale bars: 100µm.
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hPSC‐DERIVED NEURAL PROGENITORS ALSO DISPLAY MITOTIC BEHAVIORS AND
SIGNALING PROPERTIES OF RADIAL GLIA
We next looked for periventricular mitotic events, as is also characteristic of RG cells. Live
imaging of FUCCI/H2B‐CFP rosettes demonstrated mitotic chromosomes close to the
center of the rosette (Figure 4.4A). Additionally, we tracked single progenitors as they
approached the center of the rosettes and divided next to the central cavity, with
daughter cells moving away from it. Two examples are shown in Figure 4.4A. Next, we
fixed and stained rosettes on day 24 with N‐cadherin, which is an apical polarity marker,
and phospho‐histone H3, which marks chromosomes in the M‐phase of the cell cycle
(Figure 4.4B). Upon quantification, we observed that a large majority of mitotic nuclei
(83.9%) were present next to N‐cadherin+ rosette centers (Figure 4.4C). Some mitotic
events were also observed away from the rosette center in both live imaging and pH3
staining; these were presumably dividing IP cells.
In the next set of experiments, we wanted to determine if in vitro derived progenitors
generated in our protocol also require Notch signaling for maintenance, as has been
shown for RG cells in vivo and ex vivo. Rosettes were derived from the FUCCI/H2B‐CFP
line and live imaging carried out in the presence or absence of the small molecule γ‐
secretase inhibitor, DAPT. Notch signaling requires γ‐secretase for cleavage of the
intracellular domain upon activation. DAPT strongly suppresses Notch signaling, as
determined by qRT‐PCR for the Notch target gene, HES5 (Figure 4.4D). Media was
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changed every day for both control and DAPT‐treated rosettes in this experiment to
ensure that self‐renewal signals were not depleted. Remarkably, within 14 hours of DAPT
application, we observed a dramatic increase in the number of red FUCCI cells, suggesting
that Notch inhibition was forcing cell cycle exit of the progenitors (Figure 4.4E). By the
end of the 72 hour period, virtually all green cells had disappeared, were replaced by
bright red cells, and the rosette structure had complete collapsed in 24/24 rosettes
observed. This was not simply due to migration of green cells away from the field of view,
as we were unable to find any green cells in the entire well upon fixation of cultures (data
not shown). Quantification of the fraction of cells expressing green or red FUCCI markers
confirmed the dramatic phenotype on DAPT application (Figure 4.4F). Both phase
contrast microscopy and immunostaining confirmed that the progenitors were losing
contact with the rosette and subsequently differentiating into post‐mitotic neurons
expressing the early cortical plate marker TBR1 (Figure 4.4G‐H).
We conclude from these experiments that in vitro derived neural progenitors undergo M‐
phase events next to the apical boundary they form in rosettes, and that Notch signaling
is essential for self‐renewal of TGFβ inhibition derived neural progenitors.
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Figure 4.4: hPSC‐derived neural progenitors display mitotic behaviors and signaling properties of
RGs. A) Schematic showing increase in M‐phase signal intensity of H2B‐CFP. The montage on the
right was made at intervals of 20min. and tracks two individual progenitors (red and white arrow)
as they move towards the center of the rosette, divide close to the apical surface and the daughter
cells moving away to the basal side. B) Day 24 rosettes stained with N‐CAD and phospho‐histone
H3 show clustering of pH3+ cells close to the NCAD+ apical surface. C) Quantification of the
position of pH3+ cells in rosettes. D) qRT‐PCR of Notch target gene HES5, and the progenitor
markers PAX6, SOX1, and SOX2 in the presence of DAPT and WNT signaling modulators. indicating
the specific effect of DAPT on HES5, n=4 technical replicates. E) Montage of typical control and
DAPT treated rosettes demonstrate collapse of rosette structure and disappearance of green cells.
The montage is at 7 hr intervals. F) Quantification of the fraction of red and green cells in three
control and DAPT treated cultures. G) On phase‐contrast, maintenance of rosette morphology is
seen in control cultures while conversion to a bipolar, neuronal morphology is seen in DAPT treated
cells. H) The neuronal cells in G) stain with the early cortical marker TBR1 and the neuronal marker
βIII‐tubulin. Scale bars: 100µm.
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EARLY NEUROEPITHELIUM CAN BE PATTERNED ON THE ROSTROCAUDAL
AXIS WITH WNT MODULATION
We hypothesized that WNT signaling can alter the areal pattern of the cortex based on its
expression in the zona limitans intrathalamica (ZLI) at the junction of the telencephalon
and diencephalon (Braun et al., 2003). FGF8 has a well‐established role in rostral areal
specification, but a corresponding factor for caudalization of the cortex has not been
described. We hypothesized that moderate activation of β‐catenin could generate caudal
cortical neuroepithelium. ESCs were subjected to neural induction via TGFβ inhibition,
and a small molecule WNT activator (CHIR99021; 0.5μM) or inhibitor (IWP2; 0.5μM) were
added between days 2‐10 and replenished every day. RNA was harvested at 0, 5, and 10
days of induction (Figure 4.5A).
Strikingly, inhibition of WNT signaling with IWP2 resulted in an upregulation in rostral
markers such as FOXG1 and FGF8 while decreasing posterior markers such as EMX2 and
COUP‐TF1 (Figure 4.5B). Conversely, moderate activation of WNT pathway with a GSK3β
inhibitor resulted in an increase in caudal markers (EMX2, NR2F1) and a concurrent
decrease in rostral markers (FOXG1, FGF8). Importantly, this change in rostral‐caudal axis
specification required moderate levels of WNT activation. At higher levels of WNT activity,
the neuroepithelium is switched from telencephalic to midbrain identity (data not
shown). Furthermore, changes in expression patterns of areal genes occurred in the
absence of changes to markers of general neural fate such as PAX6 and SOX2 (Figure
4.5C). It is worth noting that while PAX6 is expressed in a high rostral‐low caudal gradient
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in mouse telencephalon, it does not demonstrate this pattern in human embryos (Bayatti
et al., 2008; Ip et al., 2010).
Of interest, WNT signaling regulated the expression of LHX2 together with FOXG1 (Figure
4.5B‐C). Since LHX2 and FOXG1 are determinants of neocortical fate, intermediate levels
of WNT signaling may act as a selector pathway at the neocortex‐archicortex bifurcation,
just as FGF8 does at the paleocortex‐neocortex boundary anteriorly. In mice, LHX2 is
required to suppress hippocampal organizer fate, which is dependent on WNT signaling
(Hebert and Fishell, 2008), while loss of FOXG1 results in conversion of the neocortex into
archicortex (Muzio and Mallamaci, 2005). Hence while TGFβ inhibition by itself is
sufficient to promote cortical fate, FGF8 and WNT signaling determine the areal fate as
well as the type of cortex generated. Intriguingly, we also saw upregulation of thalamic
markers (FOXB1 and IRX3; data not shown). Since the caudal cortex is thought to be part
of the domain that also gives rise to the diencephalon (Kimura et al., 2005), our data
supports a role of intermediate WNT signaling in generation of the caudal cortex‐
diencephalic territory.
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Figure 4.5: WNT signaling modulates the cortical areal identity in hPSC‐derived neuroepithelium.
A) Timetable of differentiation and RNA collection. B) Time course RT‐PCR of FOXG1, FGF8, EMX2,
and COUP‐TF1 in control, WNT inhibited and WNT activated conditions. The schematics outline
the expected patterns of expression. C) Changes in gene expression patterns of areal genes
occurred in the absence of changes to markers of general neural fate such as PAX6 and SOX2. LHX2
was found to be regulated by WNT signaling. Hence inhibition of WNT anteriorizes cortical
neuroepithelium.
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LINEAGE‐TRACING OF SINGLE NEURAL PROGENITORS REVEALS PRESENCE OF
MULTIPOTENTIAL PROGENITORS THAT GIVE RISE TO BOTH SCPNs AND CPNs
We next wanted to establish the clonal neuronal output of individual progenitors
generated in our differentiation paradigm. To this end, two transgenic lines were
established, one expressing Citrine fluorescent protein, and other Citrine fused to H2B
(Figure 4.6A‐B). These lines were differentiated into neural rosettes using TGFβ inhibition,
and on day 30 were subjected to flow cytometry to obtain single progenitors (Figure 4.6C‐
D). The individual progenitors were then mixed and seeded at a dilution of 1:1000 each
onto isochronic unlabeled cultures that were differentiated in parallel using the same
protocol (Figure 4.6C‐D). This was done because single progenitors do not survive well as
single cells, and also to provide a more physiological environment for differentiation,
since newborn neurons interact extensively with progenitors as well as other newborn
neurons in vivo. The mixing strategy enabled us to determine whether clonal output of a
progenitor was indeed derived from a single labeled progenitor or a random probability
of two progenitors attaching to the culture plate next to each other despite the very low
density of seeding.
The cultures were maintained for a period of 110 days, which corresponds to 16 weeks of
human post‐conception development. After this period, the neuronal cultures were fixed
and stained for cortical layer makers. We chose CTIP2, which is expressed by SCPNs of
layer V, and BRN2, which is expressed by CPNs of layers II‐IV (Figure 4.6F). Only the H2B‐
citrine clones were quantified by automated imaging and analyses. We observed a small
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number of clones (<5) that cells expressing both nuclear and cytoplasmic fluorescent
proteins, and these were excluded from the analysis. We only considered clones that
were 10 cells in size and above, reflecting at least four cell divisions. Analysis of the clones
revealed that the majority of the clones ranged from 10‐30 cells in size (Figure 4.6G). The
vast majority of these clones (78%) stained for both CTIP2 and BRN2. Interestingly, a
fraction of these clones (4.6%) stained for only one marker, while significant number of
clones (11.5%) displayed a mixed pattern of staining (Figure 4.6H). Within these mixed
clones, BRN2+ cells coexisted with cells co‐expressing CTIP2/BRN2. This might reflect the
transient requirement for superficial layer transcription factors in deep layer
corticogenesis, as has been shown to be the case in the mouse (Dino et al., 2014).
Alternatively, this might reflect post‐mitotic refinement of deep layer cortical neurons,
which is also known to take place during corticogenesis (Fishell and Hanashima, 2008).
We also looked at the distribution of BRN2 and CTIP2 positive cells in the clones. On
average, nearly two‐thirds (67.5%) of all cells across all clone sizes were BRN2 positive;
the rest were either CTIP2 positive or unlabeled (Figure 4.6I). This large fraction of CPNs
likely represents the enhanced requirement of superficial layer neurons that is
characteristic of primate corticogenesis. A consistent fraction of unlabeled cells was also
seen in all clone sizes that represented 5.4% of the total number of cells counted. We
speculate these cells are either subplate neurons or progenitor cells.
Hence, based on these results, we conclude that majority of human neural progenitors
derived from hESCs can give rise to both deep and superficial layer neurons at a single cell
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level. This has been shown to be the case for mouse radial glia by independent groups
(Guo et al., 2013; Gao et al., 2014); however it has remained the subject of debate due to
recent data postulating the existence of progenitors predestined to give rise to superficial
layers (Franco et al., 2012). Our analysis also suggests considerable heterogeneity of the
progenitor populations in terms of their self‐renewal ability.
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Figure 4.6: Lineage‐tracing of individual neural progenitors in vitro. A) Clone RUES2 lines
expressing Citrine or H2B‐Citrine. B) Schematic of ePiggybac constructs used to generate hESC
lines. C) Schematic of the experiment used to identify the clonal output of single progenitors. D)
FACs plot showing isolation of single neural progenitor cells on day 30 of neural differentiation,
from left to right: control RUES2, RUES2 Citrine, and RUES2 H2B‐Citrine. The plots show that >95%
of cells were still expressing the fluorescent proteins on differentiation. E) Neural rosettes
generated by RUES2 Citrine and RUES2 H2B‐Citrine lines, close to the stage at which they were
sorted. F) Examples of individual Citrine+ progenitors giving rise to CTIP2+ and BRN2+ neurons on
day 110. G) The clonal size distribution of clones analyzed on Day 110. H) The fraction of analyzed
clones expressing various cortical layer markers. I) The ratio of laminar marker expression in
various clone sizes is constant and biased towards BRN2+ cells. Scale bars in A), E) and F) represent
100µm.
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CUX2 LINEAGE TRACED PROGENITORS REPRESENT A SMALL POPULATION OF hPSC‐
DERIVED NEURAL PROGENITORS AND ARE FATE RESTRICTED
Based on the results in the previous section, we surmised that the majority of CPNs in our
system were generated from multipotent progenitors. However, a small fraction of the
clones contained CPN layers markers only, or cells co‐expressing CPN and SCPN markers
(Figure 4.6H). Hence, there exists a possibility that either a subclass of CPNs is generated
by lineage‐restricted progenitors or that multipotent progenitors were contributing to
lineage restricted progenitors (Greig et al., 2013). It has been shown that CUX2 expression
can mark the lineage‐restricted progenitors that are destined to give rise to rise to CPNs
in mice (Franco et al., 2012). In order to establish if CUX2 was marking lineage‐restricted
progenitors in our culture system, conditional reporter hESC lines were generated using
genome‐editing tools. CreERT2 was knocked into the CUX2 locus using TALENs designed
to target the first coding exon (Figure 4.7A; see also Figure 6.1). After selection and
confirmation of clones, a FLEX‐tdTomato reporter cassette (Fenno et al., 2014) was
knocked into the AAVS1 ‘safe harbor’ locus, again using TALENs. Recombination was
confirmed by PCR of the regions on either side of the homologous arms (Figure 4.7B). In
this CUX2‐ CreERT2 reporter lines, tdTomato reporter expression is dependent on a)
expression of CUX2, and b) presence of Tamoxifen (TAM) in the culture medium allowing
for spatial and temporal control of lineage‐tracing (Figure 4.7C).
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Days 15‐30 were chosen for addition of TAM, as large numbers of deep layer cortical
neurons start emerging after day 30 in our differentiation protocol. TAM induction
resulted in detectable tdTomato expression as early as 20 days of neural induction in a
small fraction of the cells. TdTomato expression was observed in neural rosettes (Figure
4.7D) and there was a progressive increase in the size of the clones over a period of 70
days. This suggests that the reporter recombination had taken place in a progenitor
population. At day 80, the cultures were fixed and stained for BRN2 and CTIP2 as before
(Figure 4.7E). Upon quantification of marker co‐expression, we found that tdTomato+
cells induced at Days 15‐30 were more likely to express BRN2+ than unlabeled cells (74.8%
vs. 47.6%) (Figure 4.7G). A fraction of BRN2+ cells also co‐labeled with CTIP2 cells,
however it is unclear if these CTIP2+ cells were of superficial or deep layer identity (see
next section). Importantly, we were only able to label a small fraction of the cells in the
population when TAM was added between days 15‐30 in repeated experiments (0.26‐
0.49%; between 9,000‐11,000 cells counted) (Figure 4.7F), suggesting that lineage‐
restricted cells do not comprise a major population of cells in our differentiation protocol
at the time points analyzed. Since our cortical cultures are predominantly comprised of
CPNs at later stages, we conclude that CUX2 labels lineage‐restricted progenitors but
contributes only a small number of CPNs in in vitro neural differentiation. We cannot at
present rule out the possibility that CUX2+ progenitors represent a transient state during
the course of differentiation to CPNs or are specified later in these cultures.
The number of CUX2 positive cells increased considerably when TAM was added after Day
80, but these cells were not quantified because a large number of CPNs have already been
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generated by this phase and TAM would induce recombination in post‐mitotic neurons in
addition to lineage pre‐fated progenitors.

Figure 4.7: Lineage‐tracing of CUX2 neural progenitors in hPSCs. A) Double transgenic conditional
reporter RUES2 hESCs expressing Cre‐ERT2 from the CUX2 locus and the FLEX‐tdTomato conditional
reporter under a constitutive active promoter at the AAVS1 safe harbor locus. Expression of CUX2
in the presence of TAM in culture medium induces recombination at the reporter locus and
tdTomato expression. B) PCR confirmation of targeted transgenesis. Lanes 1‐2 confirm 5’ and 3’
CUX2‐CreERT2 insertions, respectively, while lanes 3‐4 confirm 5’ and 3’ CAG‐tdTomato/FLEX
insertions, respectively. Expected band sizes for lanes 1‐4: 1273, 1264, 934, and 1127 base pairs.C)
Schematic timetable of TAM induction. The time of induction is from start of neural induction.
TGFβ inhibition is maintained for the initial 12 days. D) Lineage traced tdTomato+ cells at rosette
stage (left panel), early differentiation (middle panel) and mid differentiation (right panel) stages
showing an increase in clone size. This suggests that CUX2 was labeling a progenitor population.
E) TdTomato+ CUX2+ lineage derived cells preferentially express BRN2. Low magnification view
(left panel), high magnification view (right panel). Arrows point to tdTomato positive cells
expressing BRN2, arrowheads point to tdTomato positive cells expressing CTIP2. F) CUX2‐lineage
traced cells comprise a low fraction of the total cells. G) Quantification of BRN2 and CTIP+ cells in
TdTomato+ and TdTomato– cell populations. CUX2 lineage traced cells are more likely to express
BRN2 than non‐CUX2 expressing cells . Scale bars in D) and E) represent 100µm.
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HUMAN FETAL BRAINS DEMONSTRATE CPN GENES IN SCPNs AT MID‐CORTICOGENESIS,
UNLIKE IN MICE
In order to validate marker expression for our hPSC studies, and to explore temporal
progression of SCPN and CPN marker expression in vivo, human fetal brains were
obtained at PCW10 and PCW15 (i.e. time points corresponding to our in vitro culture)
(Figure 4.8A). The brains were dissected, embedded, and sectioned onto slides (Figure
6.4A‐F). Many interesting differences were found in patterns of marker expression
between mouse and human mid‐corticogenesis brains in the VZ, SVZ as well as the cortical
plate, some of which have been reported previously (Hansen et al., 2010). We focused on
the expression of laminar markers in particular. In the mouse brain, SATB2 is expressed
in callosal projection neurons and is required for their formation (Britanova et al., 2008).
CTIP2 (or BCL11B) on the other hand, is expressed in SCPN’s and is involved in their
specification (Chen et al., 2008); while NURR1 is a marker of subplate neurons (Wang et
al., 2010). These genes have also been shown to be expressed in the expected cell
populations at later stages of human fetal development (Wang et al., 2010; Onorati et al.,
2014).
Strikingly, we observed expression of SATB2 in the entire cortical plate at PCW15 of
development (Figure 4.8B‐G). Even more surprisingly, SATB2 in the deep layers
completely co‐localized with either CTIP2 only or with both CTIP2 and NURR1 (Figure
4.8C‐G). This is unexpected when compared to mouse development, where SATB2 starts
to be expressed at mid‐corticogenesis (E13.5), and in only in a small subpopulation of
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deep cortical plate neurons at E15.5 (Figure 6.5A) (Alcamo et al., 2008; Britanova et al.,
2008). Additionally, SATB2 is known to post‐mitotically repress CTIP2 and is only rarely
expressed in the same neurons in the cortex (Baranek et al., 2012; Srinivasan et al., 2012;
Srivatsa et al., 2014) (see also Figure 6.5A).
The observations of co‐labeling held true in different areas as well as at different
rostrocaudal levels of the human PCW15 cortex (Figure 4.8C‐D and data not shown). Upon
quantification, nearly all CTIP2+ and/or NURR1+ cells were found to co‐express SATB2
(Figure 4.8H‐I). Importantly, the number of cells in the cortical plate not labeled by any of
the three markers was very low in all instances. Hence, the PCW15 cortex was divided
into three zones: a deep layer expressing all three, a middle layer co‐expressing SATB2
and CTIP2, and the most superficial layer expressing predominantly SATB2 only with a
small population of SATB2/CTIP2+ cells (Figure 4.8J‐K). There were quantitative
differences in the fraction of cells expressing the various combinations in the different
areas, even though the relative ratios were comparable (Figure 4.8L). Interestingly, a
small fraction of cells (<1%) in the deep layers expressed SATB2 only (Figure 4.8E, box
IV).These cells might be neurons in transit to the superficial cortical plate where the
majority of the cells are SATB2 positive; alternatively, they might reflect a different class
of projection neurons.
We saw similar patterns of expression when SATB2 was replaced with another superficial
layer TxF MEF2C (Layers II‐IV), or when CTIP2 was replaced with ER81 or SOX5 (Layer V
markers), as well as when NURR1 was replaced with TLE4 or TBR1, both corticothalamic
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neuronal markers (Figure 6.5B‐C). This suggests that projection neuron class‐
determinants are not rigidly locked to a layer‐specific expression initially; rather they are
broadly expressed in the deeper layers of the cortical plate along with expression in the
more superficial layers.
If neuronal restriction is taking place in the PCW15 brain, we reasoned that it should be
possible to observe superficial layer markers at an earlier stage of human cortical
development, when the superficial cortical layers have not been generated. Furthermore,
given the fidelity of our hPSC‐derived cortical cultures, co‐expression of superficial and
deep layer neurons should be observed at some stages of in vitro differentiation. We next
turned our attention to these questions.
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Figure 4.8: Human PCW15 brains demonstrate different patterns of laminar expression at mid‐
corticogenesis compared to mice. A) Gross anatomy of PCW15 brain. Sectioning and staining was
carried out on the right hemisphere. B) Coronal section through the frontal cortex show staining
for CTIP2, SATB2 and NURR1. C) Magnified view of box I in B) showing the demarcation between
superficial cortical plate (sCP) and deep cortical plate (dCP). SATB2 is expressed throughout the
cortical plate, while CTIP2 and NURR1 are restricted to the deep cortical plate. SATB2 positive,
SATB2/CTIP2 positive and SATB2/CTIP2/NURR1 positive domains can be appreciated D) Higher
magnification of box II in figure B) showing similar domains of expression as in C). E) The left panel
is a magnified view of box III in D) located in the sCP. The arrows point to SATB2/CTIP2 positive
cells in the sCP. The right panel is a magnification of box IV in D) which is located in the dCP. The
arrowheads point to SATB2/CTIP2 positive cells in the dCP while the open arrows point to SATB2
positive only cells; the rest of the cells are SATB2/CTIP2/NURR1 positive. F) Color space
representation of the image in D) after segmentation demonstrating the three domains of marker
expression clearly. The segmentation was gated to remove low expressing and background cells.
G) Segmentation results from the area under box I in B) for individual channels superimposed on
the original image. Presence of SATB2 throughout the CP can be seen. H) Quantification of marker
distribution in F). I) Quantification of marker distribution in G). J) Distribution of markers along the
cortical plate in F). K) Distribution of markers along the cortical plate in G). The distance on y‐axis
in J) and K) is relative to the lowest part of the dCP. L) Relative fraction of cells expressing the
various markers in boxes I and II. All cells are SATB2 positive. Scale bars: A) 1cm, B) 1mm, C‐E)
100μm.
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To establish if deep layer neurons in in vitro cultures expressed superficial layer markers
at comparable stages of development, the cultures were subjected to a one day pulse of
bromodeoxyuridine (BrdU) at various stages of differentiation corresponding to 45, 70
and 95 days after induction (Figure 4.9A). The cultures were maintained for a total of 100
days, which is equivalent to about 14.5 weeks of development. The neural cultures were
then fixed and stained for BrdU, together with two markers: BRN2 (CPN marker) and
CTIP2 (SCPN marker). Analysis of BrdU expressing cells showed that the majority of CTIP2
positive cells born on day 45 and 70 were also BRN2 positive (98.6% and 93.2%
respectively); the majority of neurons born on day 95 however, were not (33.6%) (Figure
4.9B). This could be because the CTIP2+ neurons born on day 95 haven not had enough
time to express BRN2 because the cultures were fixed 5 days later. Indeed, in the PCW15
fetal brain we observe CTIP2 expression earlier in the SVZ compared to BRN2 in the
cortical plate (data not shown). In contrast to CTIP2, the majority of BRN2+ neurons did
not co‐express CTIP2 at any of the three stages (Figure 4.9C), in parallel with SATB2
expression in the superficial cortical plate of PCW15 brains.
Finally, we stained a PCW10 human fetal cortex with the range of markers we used for
PCW15 brain. Gross anatomy of the PCW10 brain is shown in Figure 6.4A. As expected,
we observed expression of CPN markers throughout the cortical plate, together with
SCPN genes such CTIP2, TBR1, and NURR1. An example of SATB2 staining in the PCW10
cortical plate is shown in Figure 4.9D‐F. The cortical plate in the PCW10 brain was thus
divided into two domains, one co‐expressing SATB2/CTIP2/NURR1 and the one above it
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expressing SATB2/CTIP2 only. As expected, there was no domain of SATB2 only expressing
cells since superficial layer neurons are not yet present at this stage of development.
Taken together, our data suggests that the neurons in human fetal corticogenesis become
progressively limited in their ability to express various projection neuron determinants.
We propose that this inside‐out restriction in ability to express neuronal class‐
determinants is a reflection of the restriction occurring at the level of the progenitors that
are giving rise to the different types of projection neurons. This restriction manifests
during corticogenesis as limitations in what the neuronal progeny of these progenitors
can express after formation of each layer i.e. “progressive neuronal restriction” follows
“progressive progenitor restriction” (Figure 4.10). The expression of CPN genes in the
deep layers may be essential for generation of certain classes of SCPN’s, such as
corticostriatal neurons which project subcortically to the striatum but in the contralateral
hemisphere, and hence have to cross the corpus callosum (Azim et al., 2009). The
presence of small numbers of CTIP2 cells in the superficial cortical plate at this stage may
indicate that the progenitor switch is asynchronous and gradual in terms of its output due
to the shift from VZ to OSVZ neurogenesis. Alternatively, CTIP2 might be required for the
differentiation of a subclass of CPNs in the superficial layers. This progressive restriction
of post‐mitotic neuronal determinants has been observed in mice as within CPN subtypes
(Azim et al., 2009), suggesting that this might be a generalized property.
Over the course of development, post‐mitotic refinement of these TxF determinants
would ensure the laminar specific expression observed in adults (Johnson et al., 2009;
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Greig et al., 2013). These post‐mitotic refinements can occur by input from various
subcortical structures, especially the thalamus, but also other projection neurons (Chou
et al., 2013; Pouchelon et al., 2014). It is important to note that at PCW15 – the stage we
have analyzed here – thalamocortical afferents have not yet invaded the cortical plate in
human fetal development; these afferents only reach the cortical plate after PCW20 (Lee
et al., 2005). Hence the pattern of TxF expression we observe here is likely representative
of the raw, unrefined neuronal output of the progenitors present at this stage. This is
discussed in further detail in Chapter 5.
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Figure 4.9: hPSC‐derived SCPNs and early human fetal brains both show co‐expression of CPN and
SCPN genes. A) Schematic of BrdU labeling of in vitro derived cortical progenitors. BrdU was added
at days 45, 70, and 95 of differentiation for one day. All three groups were subsequently fixed and
stained on D100. B) Fraction of BrdU/CTIP2+ cells either co‐expressing BRN2 or CTIP2 only at days
45, 70, or 95. The majority of CTIP2+ populations born on days 45 and 70 co‐express BRN2 by day
100, while the majority of CTIP2+ cells born on day 95 do not. C) Fraction of BrdU/BRN2+ cells co‐
expressing CTIP2 or BRN2 only at the same time points. The majority of BRN2+ cells do not co‐
express CTIP2, as is observed in the PCW15 fetal brain. D) Immunocytochemistry of the PCW10
human fetal brain, a time point at which there are no CPNs and the entire cortical plate is
comprised of early born neurons destined for the deep layers. Two patterns of expression are
observed: NURR1/CTIP2/SATB2 co‐expressing cells, presumably destined to form layer VI/subplate
cells, and CTIP2/SATB2+ co‐expressing cells, likely destined to form layer V. E) Quantification of
marker distribution in D). F) Distribution of markers along the cortical plate in D). Scale bars:
100μm.
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This neuronal restriction model has important implications for not only understanding
corticogenesis, but also human diseases that are thought to arise during development
such as autism and neuropsychiatric diseases. Both these conditions demonstrate defects
in laminar gene expression and circuit formation (Geschwind and Rakic, 2013; Stoner et
al., 2014). Neuronal restriction provides a conceptual link between how defects in
progenitors could affect laminar development and neuronal hodology, which in turn
underlies cortical circuit formation. Additionally, understanding the biological basis of
neuronal restriction in hPSC‐derived cultures will facilitate an understanding of the
developmental origins of neuronal diversity, including neurons that are specifically
enriched in the primate brain (Geschwind and Rakic, 2013).

Figure 4.10: “Progressive neuronal restriction” model. Progressive limitation in the ability of the
daughters neurons of VZ/OSVZ to express various projection neuron class‐determinants over time
might be a manisfestion of the progressive restriction happening within the progenitors
themselves. Further refinement of these early patterns of expression to the adult patterns would
require input from other projection neurons or subcortical sources (e.g. the thalamus).
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SUMMARY
Here we use hESCs as a model to study human corticogenesis and show that neural
progenitors derived from hESCs recapitulate forebrain marker expression and
differentiation potential of all the major progenitor types involved in human
corticogenesis. Using FUCCI transgenic hESCs, we observe dynamic cell‐cycle properties
of RGs at a single cell and population level. We use this in vitro model of differentiation
to show that neuroepithelium derived from hESCs by TGFβ inhibition can be areal‐
patterned on the rostrocaudal axis by modulating WNT signaling. This positions WNTs as
candidates to caudalize the cerebral cortex in vivo, which has not been shown to date.
Using transgenic hPSCs, we demonstrate that individual hPSC‐derived neural progenitors
have the potential to differentiate into both SCPNs and CPNs, lending support to the
“Progressive Restriction” model of corticogenesis. CUX2‐lineage traced progenitors
represent a small pool of precursors that appear to be destined to a CPN fate. However,
given the low fraction of these cells, their contributions to CPNs in our system are likely
to be minimal. We propose that CUX2 progenitors represent a transient state on the
differentiation time‐line rather than a separate class of progenitors, at least in human
corticogenesis. Finally, we show differences in cortical marker expression in the human
fetal cortex during mid‐corticogenesis compared to mice and propose that these
differences are due to “progressive neuronal restriction”. This neuronal restriction is a
manifestation of progressive progenitor restriction and is conserved in our in vitro
differentiation model.
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CHAPTER 5: DISCUSSION
THE REQUIREMENT FOR TGFβ INHIBITION TO INDUCE NEURAL FATE IS CONSERVED
FROM XENOPUS AND WITHIN MAMMALS
It is rather remarkable that inhibiting TGFβ signaling has the same outcome over
hundreds of millions of years of evolution. This is because while the body plan is
conserved in chordates, the complexity of neural derivatives and the underlying
transcriptional circuitry have changed drastically. For instance, in the Xenopus cortex,
only two to three layers of organized cells can be appreciated, mammals can have up to
six layers that are specialized into different areas. Moreover, even within mammals, the
primate neuroepithelium generates a more complex organization of progenitors and
neurons, yet the underlying pathway that enables this to happen has remained the same.
Intriguingly, the requirement for BMP inhibition to establish a neural domain evolved
early in bilaterians, as was discussed in Chapter 1.
We have shown that cell‐intrinsic inhibition of canonical TGFβ signaling via the inhibitory
SMAD7 is sufficient to impose a neural fate in hESCs. This neuroepithelium is of anterior
character, as defined by several criteria. Significantly, this conversion can take place very
efficiently and even under pluripotency conditions. Inhibition of TGFβ by SMAD7 occurs
in both the cytoplasm and the nucleus, and SMAD7 acts at many nodes to achieve this
inhibition, including promotion of receptor degradation, disruption of receptor SMAD
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binding, inhibition of SMAD4‐DNA complex formation in the nucleus, and recruitment of
transcriptional repressors to SMAD binding sites (Yan et al., 2009).
Our results also demonstrate that FGF‐MEK has an inhibitory, rather than an instructive
role in neural induction in the presence of TGFβ inhibition. However, we cannot at this
time rule out the possibility that other branches of FGF signaling, namely, PI3K‐AKT, and
PLCɣ‐Ca2+ may have a role in neural induction. It is plausible that different branches of
FGF signaling may have contradictory roles in neural induction, and this will need to be
addressed in future studies. It is worth mentioning that other studies have reporter
similar findings, and FGF receptor inhibition (rather than MEK inhibition as we did) also
promoted neural induction in these studies (Greber et al., 2011).
As mentioned in the Chapter 1, human PSCs are thought to closely resemble the primed
pluripotent of mEpiSCs. The fact that Activin/Nodal and FGF signaling are required to
maintain the pluripotent mEpiSC and hESC state, inhibition of the “default” state of neural
differentiation can been viewed as a prerequisite for maintenance of the “primed”
pluripotent state in vitro.

SMAD7 IS A POTENT NEURAL INDUCER AND ITS LEVELS ARE TIGHTLY REGULATED
DURING DEVELOPMENT
Overexpression of SMAD7 has a potent neuralizing effect in hPSCs, as it does in animal
caps of the Xenopus embryo (Casellas and Brivanlou, 1998). Since our work on SMAD7,
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other groups have shown that in a screen of neuralizing factors, SMAD7 had among the
most potent neuralizing activity in mPSCs (Yamamizu et al., 2013). In vivo, SMAD7 is a
TGFβ inducible gene, acting in a feedback loop to regulate TGFβ signaling (Nakao et al.,
1997). Because of its strong neural inducing activity, it is essential to regulate the levels
of SMAD7 very closely to prevent its unchecked activity. This is done through two known
mechanisms. First, SMAD7 protein is targeted for degradation by the E3 ligase RNF12 in
embryos (Zhang et al., 2012). Indeed, zebrafish embryos with RNF12 morpholinos have a
larger head and anterior phenotypes, together with loss of mesoderm derivatives.
Additionally RNF12 knockout mESCs had higher levels of SMAD7 and could undergo
neural differentiation even in the presence of BMP. Second, the SMAD7 mRNA has
sequences in the 5’ and 3’ untranslated regions (UTR) that act as mRNA destabilizers and
target it for degradation via the nonsense‐mediated decay (NMD) pathway in pluripotent
cells (Lou et al., 2014). Knockdown of NMD components results in SMAD7 upregulation
and increased neural differentiation in pluripotent teratocarcinoma cells by inhibition of
TGFβ signaling.
Hence, it is unlikely that SMAD7 has a predominant role in neural induction in vivo, as the
role of TGFβ inhibition is fulfilled by the extracellular inhibitors released by the
node/organizer. It may however act redundantly with these inhibitors once the process
has started to stabilize the neural fate.
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HOW DOES TGFβ INHIBITION PROMOTE DEFAULT NEURAL INDUCTION IN hPSCs?
Gain‐ and loss‐ of function approaches have permitted scrutiny of the mechanisms
operating downstream of TGFβ inhibition by which pluripotent cells undergo neural
conversion. Inhibition of Activin/Nodal down‐regulates NANOG and promotes expression
of ZEB2 (also known as SIP1 and ZFHX1B), a SMAD binding protein (Chng et al., 2010). In
pluripotent cells, ZEB2 limits the mesoderm inducing effects of Activin/Nodal signaling
and is repressed directly by the pluripotency factors NANOG and OCT4. On Activin/Nodal
inhibition, ZEB2 promotes neuroectodermal differentiation of EpiSCs and hESCs. Neural
induction of hESCs also promotes expression of NR2F2 (also known as COUP‐TFII), which
is among the earliest TxFs expressed during neural differentiation of hESCs as shown by
our group and others (Rosa and Brivanlou, 2009; Greber et al., 2011). In pluripotent
hESCs, OCT4 and the OCT4‐induced microRNA mir‐302 regulate expression of NR2F2 by
transcriptional and post‐transcription mechanisms, respectively, whereas in the
differentiating neuroectoderm, NR2F2 directly represses OCT4 expression and promotes
expression of other neural specific markers such as PAX6.
BMP inhibition also contributes to neuroectodermal differentiation through various
mechanisms. First, it promotes the specificity of neural induction by inhibiting induction
of non‐neural germ layers such as trophectoderm, mesoderm, and non‐neural ectoderm
(Greber et al., 2011). Indeed, inhibition of BMP signaling together with down‐regulation
of OCT4 is a prerequisite for neuroectodermal specification in hESCs (Wang et al., 2012a).
Second, inhibition of BMP signaling may serve to stabilize the neural fate by maintaining
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expression of neural genes such as SOX2 (Greber et al., 2011). Third, inhibition of BMP
signaling permits expression of cell‐intrinsic neural determinants, such as the zinc finger
TxF, ZNF521, which is necessary and sufficient for neural induction in hESCs as well as
EpiSCs (Kamiya et al., 2011). Znf521 acts by directly transactivating neural promoters such
as such as Sox3, Sox1, N‐cad, and Pax6 in concert with the co‐activator p300. Importantly,
Znf521 can only promote a neural fate in EpiSCs and hESCs, but not in mESCs, suggesting
a conservation of downstream wiring between the primed state of EpiSCs and hESCs.
Znf521 is potently inhibited by BMP signaling at this stage. Lastly, BMP inhibition also
promotes acquisition of anterior neural fate, as neural induction in the absence of BMP
inhibitors appears to generate neuroepithelium of posterior identity in both EpiSCs and
hESCs (Patani et al., 2009; Chng et al., 2010; Lupo et al., 2013).
FGF signaling maintains pluripotency in EpiSCs and hESCs; in hESCs but not EpiSCs, the
FGF‐MEK‐ERK cascade directly regulates NANOG expression (Greber et al., 2010; Chen et
al., 2012). Hence one way removal of FGF supports neural induction is by promoting
down‐regulation of pluripotency TxFs and thereby permitting expression of the default
neural program. In addition, FGF‐MEK‐ERK signaling directly represses expression of the
neural determinant paired box TxF PAX6 in hESCs as well as EpiSCs. Indeed, small
molecule inhibition of either the FGF receptor or deletion of MEK itself causes
upregulation of PAX6 expression (Greber et al., 2010; Greber et al., 2011; Hamilton and
Brickman, 2014). Additionally, inhibition of FGF signaling also promotes induction of the
forebrain and midbrain enriched homeobox TxF OTX2 in hESCs. OTX2 in turn directly binds
to the PAX6 promoter and enhances its expression in hESCs (Greber et al., 2011).
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hPSCs CAN MODEL EARLY CORTICAL DEVELOPMENT AND CELL INTRINSIC BEHAVIORS
Based on our multiple assays, we observed striking similarities between hPSC‐derived
neural progenitors and the known behaviors of RGs in vivo. These included not only
molecular markers, but also cell cycle dynamics, self‐organization into complex multi‐
layered structures, as well as signaling requirements. Additionally, the hPSC‐derived
neurons also generated the two other progenitor types found during development,
namely IPs and bRGs. This suggests that brain development is a largely self‐contained
process at the initial stages, with signaling centers in the neural ridge, meninges, and
cortical hem contributing to patterning, progenitor maintenance, neuronal migration,
and axon guidance at later stages. This is also supported by recent studies utilizing three‐
dimensional aggregates of hPSCs that recapitulate of many milestones of corticogenesis
(Kadoshima et al., 2013; Lancaster et al., 2013). In my hands, three‐dimensional organoids
displayed significant inter‐ and intra‐experiment variability and thus may need to be
optimized further before they can be used reliably. Moreover, the single cell tracking and
lineage tracing as we carry out here is either not possible or reliable in 3D space at
present. Once some of these issues are resolved, 3D organoids could be a good model to
study corticogenesis in a 3D environment closer to its natural environment, and also to
study organization that cannot be studied in 2D, such as gyrus formation.
There are specific aspects of the 2D in vitro system that could also use further
optimization. For instance, in our in vitro cultures, there was a gradual depletion in the
number of progenitors in the cultures, and a failure to maintain a rosette state beyond 50

187

days. These may be linked to the lack of self‐renewal cues in the culture conditions, or a
bias towards neuronal differentiation in our cultures. Future studies will need to address
the nature of these self‐renewal cues. Some clues have come from recent studies in
human fetal brains which showed that PDGFD and its cognate receptor PDGFRβ maintain
self‐renewal and basal dispersion of human RGs (Lui et al., 2014). The cerebrospinal fluid
in vivo also provides a rich niche of signaling molecules such as IGF2, BMPs, and RA which
may also contribute to self‐renewal (Lehtinen et al., 2011). Moreover, even though the
composition of the extracellular matrix (ECM) in the OSVZ of the developing brain is not
understood, it is believed to play an important role in maintaining self‐renewal of the
basal progenitors (Fietz et al., 2010; Simone et al., 2012; Denise et al., 2014), as well as
neuronal migration (Boyle et al., 2011). Since we maintain in vitro progenitors in laminin
and fibronectin for the entire duration of differentiation, it is possible that absence of
ECM laid down by non‐neural cells also contributes to failure to maintain the rosette stage
in our cultures. Lastly, the range of neurons produced by the hPSC‐derived progenitors
will need to be documented more thoroughly in terms of their subsequent molecular
profile, and importantly, their hodology upon transplantation into mouse brains.
Overall, the recent proliferation of human genome modification technologies, combined
with live imaging, and single cell resolution analyses provide distinct advantages to the in
vitro system that can complement mouse in vivo work. As an added benefit, hPSCs also
demonstrate human‐specific aspects of corticogenesis. Thus, this system can be used to
model early development as well as disease, and provides an unlimited supply of material
to generate hypothesis that can be tested for in vivo relevance in human fetal samples.
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WNT SIGNALING IS A PATTERNING FACTOR FOR THE CAUDAL TELENCEPHALON
There is considerable interest in using IPSC and hPSC derived neural progenitors to
generate therapeutically relevant, defined populations of neurons that can used for drug
screens, disease modeling, and perhaps cell replacement. However, our ability to
generate defined populations is limited due to the heterogeneous nature of
differentiation, even within forebrain progenitors. By changing the level of WNT signaling,
we were able to pattern the progenitors on the rostrocaudal axis concurrently with their
acquisition of neural fate based on expression of various molecular markers. This provides
direct support for the protomap hypothesis, which postulates that the areal
determination of the cortex is made at the level of early progenitors that map their areal
fate onto the neurons.
Other groups have utilized WNT signaling to promote midbrain fates from hPSCs (Kriks et
al., 2011; Kirkeby et al., 2012); we have also confirmed these findings. The key
breakthrough in our experiments was the realization that moderate to low levels of WNT
signaling could also maintain forebrain fate while promoting a caudal cortical identity.
While a role for WNT signaling has been speculated in determination of caudal cortical
identity in mice, it has never been shown to be a direct areal patterning agent in the
cortex. We suggest that WNT achieves its effect at an early stage of forebrain
specification, which is why mouse studies might have missed the effect since most areal
patterning studies have looked at the cortex after E11, after the rostrocaudal identity has
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already been established. Significantly, in addition to providing insights into arealization
in the mammalian cortex, our results also suggest that by changing the areal pattern, early
WNT signaling may also act as a selector for generation of a six‐layered neocortex versus
a three‐layered archicortex. This is because WNT inhibition upregulates FOXG1 and LHX2,
two TxFs that are known to be essential for neocortical fate, while WNT activation down‐
regulates them both while promoting caudal cortical marker expression. Lastly, we also
observe upregulation of diencephalic markers upon moderate WNT activation. This
supports the notion that the caudal cortex and diencephalon share embryologic origins
(Kimura et al., 2005), and require a similar signaling pathway for their specification. This
raises the intriguing possibility that thalamic tissue could be generated by further
refinement of this protocol – a feat that has not been achieved so far using mouse or
human PSCs.
Further experiments are needed to confirm the stable identity of the post‐mitotic
neurons derived from the areally specified progenitors. This work will be aided by recent
transcriptomic analysis of the fetal human cortex, which found genes enriched in the
rostral or caudal cortices in the different germinal zones as well as the cortical plate
(Miller et al., 2014). Such analysis will be complemented by studies on human fetal
material to confirm RNA expression at the protein level. In this regard, we note that
cortical progenitors generated in the presence of TGFβ and WNT inhibition generate
neurons that stain for AUTS2, which is known to be enriched in the frontal cortex (Bedogni
et al., 2010). Conversely, neurons generated from progenitors subjected to TGFβ
inhibition and moderate WNT activation do not.
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PROGENITOR AND NEURONAL RESTRICTION AND ITS IMPLICATIONS
Based on our analysis of hPSC‐derived single neural progenitors, we surmise that
individual human neural progenitors have the potential to form projection neurons of
different identities. This is in line with observations made in the mouse cortex (Guo et al.,
2013; Gao et al., 2014). Our work does not rule out the possibility that there are lineage‐
restricted progenitors in the primate cortex, however if present, they likely comprise only
small fraction of the progenitor population. This is supported by our studies of conditional
CUX2 reporter hPSCs that can be lineage‐traced based on CUX2 expression. Experiments
in these transgenic lines support the notion that CUX2 expression labels progenitors that
are predestined to form CPNs rather than SCPNs. However, CUX2 lineage traced cells
comprise a very small percentage of progenitors, even at a stage when nearly the entire
culture is comprised of progenitors. More likely, CUX2 marks a fraction of progenitors that
are further down progenitor restriction and have switched to production of CPNs. In
summary, our in vitro studies in human neural progenitors favors the Progenitor
Restriction Model which was originally formulated from lineage‐tracing and
transplantation experiments, and recently established in mouse genetic experiments.
One advantage of the in vitro system we describe here is the complete lack of
interneurons – which arise in the ventral telencephalon – and confound lineage‐tracing
analysis due to their expression of CUX2 (Guo et al., 2013). Induction of interneurons
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requires sustained levels of SHH, which is not present in our cultures, and the generated
neural progenitors uniformly express markers of dorsal telencephalic territory.
Recent microarray analysis of the early second trimester fetal cortex has revealed
transcriptomic patterns of gene expression in the VZ to CP (Miller et al., 2014).
Interestingly, very few genes are found to be differentially expressed between the
superficial and deep layers of the cortical plate at this stage of development, even though
at later stages the expression patterns are more distinct (Johnson et al., 2009). Since the
earlier stage represents the direct output of the VZ and OSVZ progenitors, this suggests
that the superficial and deep layers may share similar gene expression programs, and
perhaps a similar cell‐of‐origin. In our studies of laminar expression in the human fetal
PCW15 cortex, we observed robust expression of CPN‐specific TxFs throughout the
cortical plate, and broad co‐expression of markers of subplate, CThPN, SCPN, and CPN
identity in the earliest born neurons (i.e. deepest in the cortical plate). This is different
from the situation in the mouse cortex, where co‐expression of these determinants is
infrequent and transient. Intriguingly, later born neurons expressed markers of SCPN and
CPN identity, but not of subplate or CThPN identity. Finally, the latest born neurons
expressed markers of CPNs, and a small fraction also expressed SCPN markers. This led us
to propose that the neurons are being restricted in terms of their fate choices over time,
and that this neuronal restriction might be a manifestation of restriction occurring at the
level of progenitors giving rise to these neurons, as we demonstrated in hPSC‐derived
progenitors.
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Several lines of evidence support the observation of neuronal restriction. First, CPN TxFs
are expressed uniformly in the cortical plate in the PCW10 fetal brain; at this time the
majority of the neurons being born are destined for the subplate and layer VI. Second, we
were able to observe co‐expression of CPNs and SCPN markers in neurons generated from
hPSCs over a similar time‐period. Third, even though CPN determinants such as SATB2 is
rarely found to be co‐expressed in SCPNs and CThPN in mice, it is clearly necessary for
their development, as was shown recently (Dino et al., 2014). Moreover, this requirement
is cell intrinsic, as only knockout of SATB2 at early stages of corticogenesis – but not at
later stages – results in loss of SCPNs. Loss of SATB2 also result in altered patterns of
CThPN markers (such as ZFPM2). Fourth, SCPN determinants such as FEZF2 are also
required for proper CThPNs expression of ZFPM2 in in mice (Shim et al., 2012). Together,
these studies support a biological role for co‐expression of various projection neuron
determinants in the early born CThPN/subplate neurons and progressive limitation in the
repertoire of later born CPNs.
It remains possible that a signaling cue in the cortical plate upregulates SCPN TxFs
independently of progenitor restriction. However, we believe that this is an unlikely for
multiple reasons. First, a fraction of SATB2 only cells are seen the deep cortical plate in
the PCW15 cortex. Presumably, these cells are migratory cells on their way to the
superficial cortical plate, which would suggest that they are already specified to their fate.
Second, our in vitro cultures, which lack an organized cortical plate, also show neuronal
restriction. This would suggest that co‐expression of CPN and SCPN determinants is an
intrinsic property of deep layer neurons. Third, in reelin knockout mice, a complete
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inversion of layers is seen, and SATB2 positive CPNs are specified correctly even though
they reach the deepest part of the cortical plate at much later stages and hence are not
dependent on the signaling cues that exist at earlier stages (Britanova et al., 2006).
Taken together, we argue that neuronal restriction might be a general phenomenon, and
perhaps even evolutionarily conserved one in mammals. The observed differences in
mouse and human embryonic brains might be explained by the fact that the mouse
cortical plate receives thalamic input at a much earlier stage (~E13.5) than human
(>20PCW) (Lopez‐Bendito and Molnar, 2003; Lee et al., 2005). Thus, thalamocortical
refinement of gene expression of post‐mitotic neurons in mice (which is known to occur)
may begin earlier and concurrently with generation of the deep layers, leading to domains
of TxF expression that resemble the adult state more closely (Chou et al., 2013; Pouchelon
et al., 2014). In the human fetal cortex, these thalamocortical afferent reach the plate
much later, hence we are able to observe the unrefined expression patterns of neurons
at PCW15 and earlier.
The hierarchical nature of fate determinant expression in the human fetal cortex during
development may reflect a rewiring of the transcriptional machinery for production of
projection neuron class unique to the human brain. Additionally, this also may be a
conserved principle of mammalian development that is exaggerated in human
corticogenesis due to the longer timescale of development. Neuronal restriction also has
important implications when it comes to understanding neuro‐developmental and
psychiatric diseases. Mutations in patients with schizophrenia are commonly in genes
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implicated in autism, and many of these shared genes are transcriptional or chromatin
modifiers (Ronan et al., 2013; McCarthy et al., 2014). The cortex of patients with autism
show characteristic ‘patch’ defects in laminar gene expression and increased numbers of
neurons in the frontal cortex (Stoner et al., 2014). It is conceivable that defects in fate
restriction, either at the level of progenitors or neurons could change the relative ratios
of various neuronal classes, thereby contributing to defects in cortical wiring. It is
tempting to speculate that transcriptional repressors or chromatin modifiers might be
essential for this restriction to take place for appropriate specification of the various
projection neuron types. For example, mutations in a transcriptional repressor – MECP2
– underlie Rett Syndrome. In this disease, patients demonstrate clinical symptoms
resembling autism. MECP2 is expressed in both progenitors as well as neurons (Muotri et
al., 2010) and could potentially fulfil the roles of progenitor and neuronal restriction. This
speculation awaits detailed analysis of laminar marker expression in Rett syndrome
mouse embryonic brains or patient‐derived IPSCs. Neuronal restriction provides a
conceptual link as to how defects in genes that affect progenitors could affect laminar
development and neuronal hodology.
Lastly, our combined studies of hPSC‐derived neurons and comparative analysis of the
human fetal cortex sets the baseline for further studies on refinement of our
differentiation protocol. This will enable us to manipulate the cultures conditions so that
neural progenitors – and their daughter neurons – mimic the in vivo milestones of
corticogenesis more closely, allowing for a more stringent readout of in vivo
development.
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CONCLUSIONS AND FUTURE PERSPECTIVE
This body of work highlights the evolutionary conservation of pathways that operate
during induction and patterning of the neural lineage in the embryo, and at the same time
also demonstrates the evolutionary divergence of primate‐specific features during
corticogenesis. By combining in vitro human genome modification technologies with the
default model of neural induction, we are now able to probe fundamental questions of
human corticogenesis that could previously only be studied in model organisms. This in
vitro system will complement studies in model organisms, and will be particularly useful
to uncover mechanistic principles involved in generation of the various cortical neuronal
projection classes as well as the diversity of neurons within each class. The novel genetic
and analytical tools we describe here can be broadly used for in vitro studies of cell cycle
dynamics, self‐organization, lineage tracing, and live imaging of many PSC‐derived tissue
types.
We have demonstrated that TGFβ signaling inhibition can drive human PSCs to an anterior
neural fate at near complete efficiencies and that this mechanism is conserved between
mouse, primate, and human PSCs. Using FUCCI markers, we observe self‐organization in
radial progenitors, interkinetic nuclear migration, as well as a requirement for Notch
signaling in progenitor maintenance, all of which are hallmarks of human neural
progenitors in vivo. Together with region‐specific marker analysis, we conclude that in
vitro hPSC‐derived neural progenitors are similar to their in vivo counterparts. We further
demonstrate that the in vitro derived neuroepithelium can be patterned on the
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rostrocaudal axis by manipulating WNT signaling. This finding provides insights into
arealization in the mammalian cortex and suggests that early WNT signaling – or lack
thereof – may act as a selector for generation of a six‐layered neocortex versus a three‐
layered archicortex or diencephalic derivatives. We further utilize our in vitro system to
establish that individual neural progenitors can be differentiated into cortical neurons
representative of various projection neuron classes. This supports the “Progressive
Restriction” model of corticogenesis. Combined with CUX2 lineage‐tracing experiments,
we believe that lineage‐restricted progenitors are not a major source of CPNs. Lastly,
based on in vitro experimentation and analysis of human fetal tissue, we propose that
progressive progenitor restriction is manifested in progressive neuronal restriction.
My findings suggest the need to study human brain development directly in parallel with
model organisms and raise several new questions. These include, but are not limited to:
what is the relationship of the various progenitor types to the projection neuron classes
at different stages of corticogenesis? How close are the in vitro generated neurons to
their in vivo counterparts? What are the mechanisms underlying progenitor and neuronal
restriction, and what happens when this restriction is manipulated? How do non‐cell
autonomous factors interact with cell‐intrinsic programs to affect progenitor and
neuronal restriction? Which of these programs plays a larger role in post‐mitotic
refinement of projection neuron classes? In my opinion, answering these questions will
be key to understanding corticogenesis at an evolutionary and developmental level. They
will also provide clues to the underlying pathology in neurodevelopmental disorders and,
down the line, human cognitive ability.
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Chapter 6: APPENDIX
TABLE 6.1: COMPOSITION OF HARVARD UNIVERSITY EMBRYONIC STEM CELL MEDIUM
(HUESM)

HUESM media (500mL)
240mL DMEM w/ L‐glutamine
100mL Knockout serum replacement
10mL B27 supplement w/o Vit A
5mL GlutaMAX
5mL Non‐essential amino acids
5mL Penicillin/Streptomycin
900µL β‐mercaptoethanol

TABLE 6.2: COMPOSITION OF 3N NEURAL INDUCTION MEDIUM

3N media (500mL)
240mL DMEM/F12 w/ L‐glutamine
240mL Neurobasal
5mL B27 with Vitamin A
2.5mL N2 supplement
1.25 mL L‐glutamine
2.5mL GlutaMAX
2.5mL Non‐essential amino acids
2.5mL Sodium pyruvate
5mL Penicillin/Streptomycin
125µL 10mg/mL Insulin
Add fresh during neural induction:
10µM SB431542
100nM LDN193189
Add 1:500 Laminin D25+

All from Life Technologies
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TABLE 6.3: COMPOSITION OF MOUSE ESC BASE MEDIUM
Base medium (500mL)
242mL DMEM/F12 with GlutaMAX
242mL Neurobasal
5mL Chemically defined lipids
5mL B27 supplement w/ RA
5mL Penicillin/Streptomycin
5mL Sodium pyruvate
2.5mL N2 supplement
2.5mL Glutamine
900µL β‐mercaptoethanol
170µL 7.5% BSA fraction V (final: 25µg/mL
of BSA)
0.5mL 10mg/mL Insulin
For mouse maintenance medium, add fresh
to 50mL base medium:
1000U/mL LIF
1µM PD0325901 (MEK inhibitor)
3µM CHIR (GSK3β inhibitor)
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TABLE 6.4: PRIMARY ANTIBODIES USED IN CHAPTER 3

Antibody

Manufacturer

PAX6

DHSB

PAX6

BD Biosciences

SOX2

Cell Signaling

Cat No.

Dilution

Application (s)

200

IF

561552

100

FC

3579

200

FC

Technology
OCT3/4

BD Biosciences

611203

500

IF

OCT3/4

Santa Cruz

sc‐9081

200

IF

Biotechnology
NANOG

Abcam

AB21624

200

IF

CDX2

Abcam

AB15258

100

IF

BRACHYURY

R&D Systems

AF2085

500

IF

SOX17

R&D Systems

MAB1924

200

IF

OTX2

Abcam

ab21990

200

IF

NFH

Abcam

ab28029

1000

IF

PAX3

DHSB

100

IF

EN1

DHSB

4G11

100

IF

EN2

R&D Systems

MAB2600

100

IF

DCX

Cell Signaling

4604

200

IF

Technology
NKX2.1

Epitomics

2044‐1

100

IF

HOXB4

DHSB

I12

100

IF

SOX10

Santa Cruz Biotech

sc‐17342

200

IF

SOX1

R&D Systems

AF3369

500

IF

GFP‐FITC

Abcam

ab6662

400

IF

FOXG1

Neuracell

NCFAB

500

IF

GFP

Invitrogen

A‐11122

500

IF

GFP

Santa Cruz

sc‐9996

200

IF

Biotechnology
NCAM1

BD Biosciences

557699

200

IF; FC

SMAD7

Santa Cruz

sc11392

1000

WB

9510

100

IF; WB

Biotechnology
Phospho‐SMAD2/3

Cell Signaling
Technology

Total SMAD2
Phospho‐

WB
9511

100

IF; WB

SMAD1/5/8
Total SMAD1

WB

Abbreviations ‐ IF: IF; FC: flow cytometry; WB: western blot
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TABLE 6.5: PRIMARY ANTIBODIES USED IN CHAPTER 4
Antibody

Supplier

Cat No.

Type

Dilution

PAX6

BD Biosciences

561462

Ms

200

561664

Ms‐AF488

100

3579S

Rb

400

AF2018

Gt

500

Rb

500

SOX2

Cell Signaling
Technology
R&D Systems

FOXG1

StemCulture

OTX2

Abcam

ab21990

Rb

500

SCBT

sc‐30659

Gt

200

Abcam

ab130256

Ms

200

SCBT

sc‐19344

Gt

50

Calbiochem

OP128L‐

Ms

100

LHX2

PLZF

100UG
SOX1

R&D Systems

AF3369

Gt

500

TBR2

Abcam

ab23345

Rb

400

P‐Vimentin

MBL

D076‐3S

Ms

500

N‐CAD

BD Biosciences

561554

PE

50

Nestin

Neuromics

CH23001

Ch

100

Beta‐

Covance

PRB‐435P

Rb

1000

tubulin III

R&D Systems

MAB1195

Ms

1000

MAP2

Abcam

ab28029

Ms

1000

Synapsin

Cell Signaling

#4329

Rb

200

Technology
ER81

Abcam

ab81086

Rb

500

CTIP2

Abcam

ab18465

Rt

200

TBR1

Abcam

ab31940

Rb

200

sc‐15607

Gt

50

bs‐12148R

Rb

200

FEZF2

Bioss
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MEF2C

Cell Signaling

5030

Rb

400

Technology
BRN2

SCBT

sc6029

Gt

200

CUX1

EMD Millipore

ABE218

Rb

200

CUX2

From David Waxman

Rb

200

SATB2

Abcam

ab51502

Ms

200

NURR1

R&D Systems

AF2156

Gt

100

SOX5

Abcam

ab94396

Rb

500

TLE4

From Stefano Stefani

Rb

1000

ZFPM2

SCBT

Rb

100

GFAP

Aves Lab

Ch

2000

P‐Histone H3

Abcam

ab4178

Rb

500

BrdU‐A488

Life Technologies

B35131

Ms‐AF488

100

V5

Abcam

Ab9116

Rb

500

RFP

Chromotek

5F8

Rt

1000

sc‐10755

conjugate

KEY: Ms, mouse; Rb, rabbit; Ch, chicken; Gt, goat; PE, phycoerythrin
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TABLE 6.6: SECONDARY ANTIBODIES USED

Donkey secondary

Raised against

Manufacturer

Cat No.

Dilution

Alexa Fluor 488

Mouse

Life Technologies

A‐21202

1000

Alexa Fluor 488

Rabbit

Life Technologies

A‐21206

1000

Alexa Fluor 488

Goat

Life Technologies

A‐11055

1000

Alexa Fluor 488

Rat

Life Technologies

A‐21208

1000

Alexa Fluor 555

Mouse

Life Technologies

A‐31570

1000

Alexa Fluor 555

Rabbit

Life Technologies

A‐31572

1000

Alexa Fluor 555

Goat

Life Technologies

A‐21432

1000

Alexa Fluor 568

Mouse

Life Technologies

A‐10037

1000

Alexa Fluor 568

Rabbit

Life Technologies

A‐10042

1000

Alexa Fluor 568

Goat

Life Technologies

A‐11057

1000

Alexa Fluor 594

Mouse

Life Technologies

A‐21203

1000

Alexa Fluor 594

Rabbit

Life Technologies

A‐21207

1000

Alexa Fluor 594

Goat

Life Technologies

A‐11058

1000

Alexa Fluor 647

Mouse

Life Technologies

A‐31571

1000

Alexa Fluor 647

Rabbit

Life Technologies

A‐31573

1000

Alexa Fluor 647

Goat

Life Technologies

A‐21447

1000

Alexa Fluor 647

Chicken

Jackson

703‐605‐155

500

ImmunoResearch
Alexa Fluor 680

Rabbit

Life Technologies

A‐10043

1000

Alexa Fluor 680

Goat

Life Technologies

A‐21084

1000

Alexa Fluor 680

Rat

Jackson

712‐625‐150

500

ImmunoResearch

All secondary antibodies were IgGs
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TALENS / CRISPR AND THEIR TARGETS IN hPSCs:
Below is a list of the sequences of the endogenous loci targeted in hESCs for creating
transgenic lines and the sequences of the respective TALEN pairs or CRISPRs. TALENs were
used for targeting the CUX2, and AAVS1 loci, while CRISPR‐Cas9 system was used for
targeting the FEZF2 locus. The design principles used for generating the TALENs and
CRISPR constructs are detailed in Chapter 2: Materials and Methods.
In the case of the CUX2 locus, the underlined sequence marks the initiation codon and it
lies in the spacer sequence where the FokI endonuclease will cleave and initiate
homologous recombination with the donor construct. In the case of AAVS1 (also known
as PPP1R12C) locus, the target site of the TALEN pairs lies in the 1st intron. The DNA
sequence targeted by right and left TALENs on either side of the spacer is highlighted in
caps. The specificity of TALENs for target DNA is determined by the amino acid sequence
of their arrayed repeats, specifically their “Repeat Variable Dinucleotides” (RVDs). RVDs
comprise two critical amino acids that determine the specificity of a given TALE repeat for
the corresponding DNA base in the target sequence. These are provided for each targeted
locus.
For the FEZF2 locus, the CRISPR target site includes the FEZF2 initiation codon and is
highlighted in yellow; the initiation codon is underlined. The CRISPR‐Cas9 target site is on
the antisense strand and protospacer adjacent motif for Cas9 (NGG) on the antisense
strand has been italicized.
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CUX2 targeted sequence (plus strand):
T GCGCGTCTCGATAGCCCCC aagatggccgccaat GTGGGATCGATGTTTCAAT A
Left RVD:
NH HD NH HD NH NG HD NG HD NH NI NG NI NH HD HD HD HD HD
Right RVD:
NG NG NG HD NG NN NG HD NI HD HD NI NI NG HD HD NG

Figure 6.1: Schematic of the CUX2 genomic locus targeted by the TALEN pair (initiation codon) and
the RVD arrays for left and right TALENs. RVD key: NI→A, HD→C, NH→G, NG→T.

AAVS1 targeted sequence (plus strand):
T CCCCTCCACCCCACAGT ggggccactagggac AGGATTGGTGACAGAAA A
Left RVD:
HD HD HD HD NG HD HD NI HD HD HD HD NI HD NI NN NG
Right RVD:
NG NG NG HD NG NN NG HD NI HD HD NI NI NG HD HD NG

Figure 6.2: Schematic of the AAVS1 (PPP1R12C) genomic locus targeted by the TALEN pair (first
intron) and the RVD arrays for left and right TALENs. RVD key: NI→A, HD→C, NH→G, NG→T.
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FEZF2 targeted sequence (plus strand):
cggctcagctccgcgcgccatggcaagctcggcttccctg
CRISPR sequence:
GCCGAGCTTGCCATGGCGCGCGG
Fig 6.3: Schematic of the FEZF2
genomic locus and CRISPR guide
RNA sequence. The tracrRNA
sequence following the gRNA
sequence is also shown. The
CRISPR target site overlaps with
the FEZF2 initiation codon. A
nickase version of Cas9 – which
only nicks a single DNA strand ‐
was utilized to ensure specificity
for the target site.
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TABLE 6.7: PRIMERS USED FOR RT‐PCR AND QUANTITATIVE PCR

Gene name

Forward

Reverse

SOX2

AACCCCAAGATGCACAACTC

GCTTAGCCTCGTCGATGAAC

SOX1

TCTGTTAACTCACCGGGACC

ACTCCAGGGTACACACAGGG

FOXG1

AGAAGAACGGCAAGTACGAGA

TGTTGAGGGACAGATTGTGGC

LHX2

TTACGGCAGGAAAACACGG

TGCCAGGCACAGAAGTTAAG

ZEB2

CCAATCCCAGGAGGAAAAAC

CAATACCGTCATCCTCAGCA

OTX2

GCTGGCTATTTGGAATTTAAAGG

GGGTTTGGAGCAGTGGAAC

SOX17

GGCGCAGCAGAATCCAGA

CCACGACTTGCCCAGCAT

BRA

ATGACAATTGGTCCAGCCTT

CGTTGCTCACAGACCACAG

SIX3

GCAAGAAACGCGAACTGG

GGTCCAATGGCCTGGTG

ZNF521

TGGGATATTCAGGTTCATGTTG

TTGGCAGGAGAGTCAAAGGT

SOX10

AGCTCAGCAAGACGCTGG

CTTTCTTGTGCTGCATACGG

NKX2.1

AGCACACGACTCCGTTCTCA

CCCTCCATGCCCACTTTCTT

EN2

GTGGGTCTACTGTACGCGCT

CTTGTCCTCTTTGTTCGGGT

HOXB4

CTGGATGCGCAAAGTTCAC

CTTCTCCAGCTCCAAGACCT

TBR2

CGCCACCAAACTGAGATGAT

CACATTGTAGTGGGCAGTGG

EMX2

CTCAGCCTCACGGAAACTCA

TTGCGAATCTGAGCCTTCTT

PAX6

TCACCATGGCAAATAACCTG

CAGCATGCAGGAGTATGAGG

BRN2

CCGCAGCGTCTAACCACTAC

GTGGGACAGCGCGGTGATCC

HES5

TCAGCCCCAAAGAGAAAAAC

GCTTCAGCTGCTCGATGCT

NR2F1

CGAGTACAGCTGCCTCAAAG

GGGTACTGGCTCCTCACGTA

FGF8

TACCAACTCTACAGCCGCAC

CTCTGCTTCCAAAGGTGTCC

FOXB1

CCGCCCTACTCGTACATCTC

CCTGTAGTAGGGGAAGCGGT

DMRT3

CTCTGCAGGCGCAGCTC

AGCCCTTACTCTTTGCCACA

ER81

GGCTTGCAGAAGCTCAGGTA

CTTGATTTTCAGTGGCAGGC

ATP5O

ACTCGGGTTTGACCTACAGC

GGTACTGAAGCATCGCACCT

*ATP5O was used as the housekeeping gene in all experiments
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TABLE 6.8: PRIMERS USED FOR CLONING

Primer name

Sequence

Citrine (XFP) BamHI F

ATAATTGGATCCGCCACCATGGTGAGCAAGGGCGAGGAGC

Citrine (XFP) NotI R

GATATTGCGGCCGCTCACTTGTACAGCTCGTCCATGC

PGK‐TK KpnI F

ATAATTGGTACCAGATTTAAATGCGGAATTCTACC

PGK‐TK KpnI R

GATATTGGTACCTTCTGATGGAATTAGAACTTGG

H2B BamHI F

ATAATTGGATCCGCCACCATGCCAGAGCCAGCGAAGTCTGC

XFP NotI R

GATATTGCGGCCGCTCACTTGTACAGCTCGTCCATGC

NeonGreeenV5 BsrGI F

GTACAAGGGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCTACG
TAAGC

NeonGreeenV5 NotI R

GGCCGCTTACGTAGAATCGAGACCGAGGAGAGGGTTAGGGATAGGCT
TACCCTT

BbsI Lox5171 Cre F

ATAATTGAAGACATGATCATAACTTCGTATAATGTGTACTATACGAAGT
TATACGCCACCATGGCCAATTTACTGACCGTAC

NotI Lox5171 Cre R

GATATTGCGGCCGCATAACTTCGTATAGTACACATTATACGAAGTTATA
TCACAGATCTTCTTCAGAAATAAGTTTTTGTTCCACCGGTCCATCGCCAT
CTTCCAGCAGGCGCAC

Lox2272 TdTomato BclI F

GCGCCTTGATCATTATTGTGCTGTCTCATCATTTTGG

LoxP Tdtomato NotI R

AATATTGCGGCCGCACCTCTTCGAGGGACATAACTTCG

Dragonbow pBS F

CGACCTGCAGCCCAAGCTTGGATCCGATAAAAGTTTTGTTAC

Dragonbow pBS R

TGAACTACCTGCAGGATGCATCATCAATGTATCTTATCATGTCTG

TagBFP2 XmaI F

ATAATTCCCGGGCCACCATGGTGTCTAAGGGCGAAGAGC

TagBFP2 blunt R

/5PHOS/AGAGTTTAATTAAGCTTGTGCCCCAG

PacI Lox2272 TagBFP2 F

GATACATTAATTAAATAACTTCGTATAGGATACTTTATACGAAGTTATC
CGCCACCATGCCAGAGCCAGC

EBFP2 BbvCI R

TCTTGACCTCAGCTTACTTGTACAGCTCGTCCATACCCAG

rtTA‐PURO AgeI F

GATATTACCGGTGCCACCATGTCTAGACTGGACAAGAGCAAAGTC

rtTA‐PURO EcoRV R

AGTCGAGATATCTCAGGCACCGGGCTTGCGGGTCATGC
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TABLE 6.9: PRIMERS USED IN GIBSON ASSEMBLY OF HOMOLOGY DONORS

Primer name

Sequence

pBS F

CCCCGCGGTGGAGCTCCAGC

pBS R

CCGGTACCCAATTCGCCCTATAGTGAGTCG

5' CUX2 F

GCTGGAGCTCCACCGCGGGGACAACAGCAGAAACCTCCGAGG

5' CUX2 R

AATTGGACATCTTGGGGGCTATCGAGACGC

Cre‐ERT2 F

AGCCCCCAAGATGTCCAATTTACTGACCGTAC

Cre‐ERT2 R

TAGGAACTTCGAGAAGAGGGACAGCTATGAC

PGK‐PURO F

CCCTCTTCTCGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCAGTCT
GAAGAGGAGTTTACGTCC

PGK‐PURO R

CCGCACTAACGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTCGCAGC
TTCTGATGGAATTAGAACTTG

3' CUX2 F

TAGGAACTTCGTTAGTGCGGGCAGCGCCGG

3' CUX2 R

TAGGGCGAATTGGGTACCGGAAAGAGCAGGGAAGAGAGGAAAGAAA
CAGAAGAAAAGC

5' FEZF2 F

GCTGGAGCTCCACCGCGGGGTGTTCGGGGCTGGCGCCGGTTC

5' FEZF2 R

ATTGGCTCATGGCGCGCGGAGCTGAGCCGA

Vflox‐PURO F

TTGGCGTAATTCAATTTCTGAGAACTGTCATTCTCGGAAATTGAAGTCT
GAAGAGGAGTTTACGTC

Vflox‐PURO R

CAGAAATTGAGCAGCTTCTGATGGAATTAGAAC

3' FEZF2 F

TCAGAAGCTGCTCAATTTCTGAGAACTGTCATTCTCGGAAATTGAGCAA
GCTCGGCTTCCCTGGA

3' FEZF2 R

TAGGGCGAATTGGGTACCGGTAGGAAACTGAGGCCCAACGAG
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TABLE 6.10: PRIMERS USED FOR GENOTYPING TRANSGENIC LINES

Primer pairs

Sequence

PURO F

TCACCGAGCTGCAAGAACTCTTCC

PURO R

CCAGGAGGCCTTCCATCTGTTG

TK F

GATACCGCACCGTATTGGCAAG

TK R

CTTCCGAGACAATCGCGAACATC

CUX2 5' MA F

TGTCATGTTGCAAAGAACGGAGCC

CUX2 5' MA R

AATGCAGGCAAATTTTGGTGTACGG

CUX2 MA F

CCATGCATCGATGATATCAGATCC

CUX2 MA R

CAGAGAACACCTCCAAATCTAGG

CUX2 NA F

AAGATGGCCGCCAATGTGGGATCG

CUX2 GDNA 1R

ACTAGCGCTTCTCCATGGTCGC

CUX2 GDNA 1F

GATATTGAGTGCAGCCATTGAG

Cre‐ERT2 R

TAGGAACTTCGAGAAGAGGGACAGCTATGAC

CreERT2‐3 (F)

GCAGGGAGAGGAGTTTGTGTGC

CUX2 GDNA 1R

ACTAGCGCTTCTCCATGGTCGC

FEZF2 5' MA F

GTCCATGCGCCACATCCTAATGAGG

FEZF2 5' MA R

GATATTGCGGCCGCTCACTTGTACAGCTCGTCCATGC

FEZF2 3' MA F

CCATGCATCGATGATATCAGATCC

FEZF2 3' MA R

AGAAACCAGAGCCTTTTTCAG

FEZF2 NA F

CGACTAGGTGCTTATTAAATTGC

FEZF2 NA R

TTTCCAGAGCTCCGAGTAACTG

AAVS1 5' MA F

CACTTTGAGCTCTACTGGCTTCTGC

AAVS1 5' MA R

CAAGAATGCATGCGTCAATTTTACG

AAVS1 3' MA F

CAGACCGATAAAACACATGCGTC

AAVS1 3' MA R

GAGTGAGTTTGCCAAGCAGTCACC
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GROSS ANATOMY OF HUMAN FETAL BRAINS

Figure 6.4: Human fetal brain gross anatomy. A) PCW10 brain, sagittal view. B) PCW15 brain,
sagittal view. C) PCW15 brain, transverse view. D) PCW15 brain dissected into three parts for
mounting and cryosectioning. Sagittal view is shown. E) Embedding the dissected brain areas in
D) using custom 3D printed molds. F) Sectioned brain slices on slides. Scale bars: 1cm.
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SUPPLEMENTARY FIGURE(S)

Figure 6.5: The mouse cortex displays distinct segregation of projection neuron classes while the
human cortex does not at comparable stages of development. A) Mouse brain section from mid‐
corticogenesis (E15.5), a stage when CPNs are actively generated. The panel shows that CPNs
(marked by SATB2), SCPNs (marked by CTIP2) and CThPN/subplate neurons (marked by NURR1)
are largely found in distinct layers at this stage and the markers rarely overlap. Arrowheads
indicate examples of cells co‐expressing CTIP2 and SATB2 while arrows point to cells co‐expressing
SATB2, CTIP2 and NURR1. B) Low magnification view of human PCW15 frontal brain sections
showing uniform staining across various cortical areas. The three panels emphasize that extensive
co‐expression of CPN determinants in the deep layers with SCPN and CThPN determinants is also
seen when using different TxFs to identify projection neuron classes, i.e. the phenomenon of
progressive neuronal restriction is not specific to an antibody or marker. C) Higher magnification
view of the areas highlighted in B) demonstrating expression of various CPN TxFs (SATB2, MEF2C)
in the deep cortical plate (CP). SCPN determinants (CTIP2, ER81) and CThPN genes (TBR1, TLE4,
NURR1) are also co‐expressed deep cortical plate. Scale bars: A) 100µm, B) 1cm, and C) 100µm.
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TABLE 6.11: LIST OF GENES CHANGING BY MORE THAN 2‐FOLD IN FIGURE 3.3A‐B IN THE
ORDER DISPLAYED ON THE HEATMAP
A) Pluripotency
NANOG
PIM2
POU5F1
STC1
SEMA6A
DNAJB6
FABP5
NOLC1
ATP5H
CD24
GULP1
HMGB3
GFPT2
NASP
DNMT3B
BCOR
PODXL
UGP2
HEY2
UBE2C
ASMTL
FZD5
OTX2

B) Neural
GAL
PCSK9
THY1
DNER
CLDN11
FGF13
NLGN4X
LRP8
MBP

HMGCS1
VCAN
SLC7A5
ADM
SOX3
LPPR4
PAK1
VLDLR
RORB
SOD2
TUBB3
NME1
JARID2
MYLIP
CNTN1
SH3GL3
PRNP
LAMC3
GPM6B
CD9
BCL11A
TNIK
ACSL3
SHC1
BEX1
ID3
TIMP4
COL5A2
PFN1
TUBB2A
DYNLL2
DNMT3B
CD24
SATB2
SEMA6A
SLC1A3
PDPN
SMARCA2

OVOL2
COBL
CDH1
CDK6
ZIC3
FGF2
NPTX1
RCAN2
BCL11B
ADCY1
PLA2G10
BCAN
NEFM
SH3GL2
CBS
NFIB
UGT8
DCLK1
ATF5
CEBPB
SPOCK1
TAGLN3
COL2A1
FABP7
OTX1
LHX2
FOXA1
PCDHB2
COL5A1
FZD3
CACNA1H
LRP2
EFNB1
GLI3
SIX3
MEG3
EFHD1
CNTNAP1
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MDK
TTC3
HES5
RAX
NBL1
LGALS1
BTG2
GPR56
POU3F2
NR2F2
RTN1
CAP2
ITGA5
BBS2
ACVR1B
CDKN1C
SEMA6B
JAG1
AHNAK
SEMA5B
COL4A5
HES1
LEF1
RGMB
NRCAM
FGF8
IRX5
BMP7
FZD8
LHX5
FZD5
ACCN1
CNTN2
LGI1
FEZ1
BMP2
ID2
POU3F1

LPAR1
LMX1A
IL1RAPL1
RGMA
SOX11
CACNB3
CDH2
CNTNAP2
SFRP1
PCDH18
EFNB2
COL1A1
UNC5A
HMX2
FZD7
KNDC1
WNT4
WNT5A
SOX9
FGFR3
CITED2
ZEB2
NTF3
HES4
DLL1
GAS1
FZD2
FEZF1
NNAT
MAP2
CNTFR
PAX6
ENC1
HESX1
FRZB
EPHA4
OTX2
CYP26A1

TABLE 6.12: LIST OF FOREBRAIN‐ASSOCIATED GENES CHANGING BY MORE
THAN 2‐FOLD IN FIGURE 3.7E IN THE ORDER DISPLAYED ON THE HEATMAP
Forebrain
associated
genes
OTX2
ZEB2
LMX1A
POU3F1
NR2F2
POU3F2
PAX6
RAX
HES5
LHX2
OTX1
GLI3
SIX3
LHX5
FGF8
HES1
LEF1
CNTN2
HESX1
BCL11B
NFIB
SOX3
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TABLE 6.13: LIST OF MAPK‐PATHWAY GENES CHANGING BY MORE THAN
1.5‐FOLD IN FIGURE 3.9A IN THE ORDER DISPLAYED ON THE HEATMAP
MAPKpathway
DUSP5
PLA2G3
MAPK13
GADD45G
ARRB1
CASP3
MYC
RAC3
TGFBR2
STMN1
FOS
DUSP6

DUSP14
DUSP1
RRAS2
CACNG6
MAP4K3
PRKX
CHUK
MAP2K3
MAPK9
FGF19
RASGRP2
PPM1B
SRF

FGFR4
ELK1
DAXX
MAP2K1
HSPA2
RPS6KA1
FGF13
PAK1
PLA2G10
NFKB1
FLNB
GNA12
FGF2
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PRKCA
HSPA8
RPS6KA2
ATF4
DDIT3
JUND
JUN
CRK
RRAS
PDGFRB
EGFR
FGF9
HSPA1A

CACNA1H
RASA1
CACNA1E
MAP4K4
CACNA2D2
FGF8
FLNC
DUSP4
GADD45A
CACNB3
MAPK10
FGFR3
NTF3

CHAPTER 7: EPILOGUE
What kind of cortical neurons
Do human neural progenitors make?
That was the question,
I naïvely wanted to undertake.
Only later would I realize how often,
My decision would keep me awake!
You see, human pluripotent cells,
Take a long time to differentiate.
After all it is embryogenesis,
They are trying to recapitulate.
At least I had plenty of time to plan,
In the 15 weeks neurons took to generate!
"Please work the first time!"
That was my weekly prayer.
If all went well, the cultures would yield
Cortical neurons, layer by layer.
Right next to radial glia that serve as,
The source of neurons and the cellular conveyor.
So here is what I learned,
In order to reach radial glial fate:
Just inhibit Nodal and BMP signaling;
Neural tube organization the cells will recreate.
And if superficial layers are what you need,
Plan wisely, you might have to wait!
What are the mechanisms that underlie,
Formation of a layer‐specific neuron?
I created transgenic lines to observe the changes,
Progenitors and their daughters had undergone.
Using a spectrum of fluorescent reporters,
Integrated randomly or knocked into an exon.
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Via lineage‐tracing I was able to see,
Clones expressing hues of red, green and blue.
And single progenitors giving rise to pyramidal cells,
Expressing markers from NURR1 to SATB2!
I also found clones containing neurons and glia,
Together these findings support an old model anew.
Does development in vivo follow predictions,
Made in vitro from a transgenic clone?
In the first trimester brain I searched,
From the cortical plate to the ventricular zone.
I found strong evidence for neuronal restriction,
Which till now had been unknown.
How these results make the human brain unique,
That is a problem I am still trying to navigate.
A few years and several failed experiments,
The answer will require to elucidate!
Within corticogenesis lay the key explanation,
That is the view towards which I gravitate.
Perhaps it is time to sign off now,
For a week or two at any rate.
I most look forward to not saying,
Each time I am on a lovely date:
"Can we please make this short?
I need to go check my culture plate!"
Support, resources, and great people,
Rockefeller provided all in profusion.
My gratitude to all involved,
They made it easier, the wee hours in seclusion.
With enough fond memories to last me a while,
What better way to reach my conclusion!
~The Rhyme of My Graduate Life, Zeeshan Ozair
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